name,mean_cp,mean_odds,uniq_a,uniq_b,shared,score,treeLevel
Indomethacin/pharmacology,4.22e-08,0.11,2,14,0,2.29,4.0
Heart Failure/ethnology,6.95e-11,11.98,6,72,10,6.5,3.0
Cataract Extraction,1.76e-16,0.05,1,12,1,1.08,4.0
Blood Proteins,9.56e-29,0.02,1,8,0,1.12,3.0
Primary Health Care,2.02e-06,1.37,159,259,17,256.61,4.0
Inflammation/etiology,1.29e-27,3.64,75,195,9,103.85,3.0
Venous Thromboembolism/etiology,3.22e-36,9.51,42,128,12,55.78,5.0
Diabetes Complications/complications,4.57e-23,8.88,29,69,5,41.19,3.0
Spermatozoa,3.4e-07,0.1,6,2,0,2.67,3.0
Swine/metabolism,7.26e-09,0.07,1,11,0,1.09,7.0
Medical Records,1.32e-75,0.08,23,78,1,29.78,4.0
Muscle Contraction,1.13e-12,0.16,26,4,0,4.62,4.0
Internship and Residency,1.47e-17,0.32,23,158,4,26.35,4.0
"Endothelium, Vascular/cytology",9.25e-11,0.15,4,31,0,4.52,4.0
"Muscle, Skeletal/physiopathology",1.45e-15,2.44,168,61,12,83.15,3.0
"Anastomosis, Roux-en-Y",9.1e-07,8.2,22,21,9,41.05,3.0
Insulin/pharmacology,4.83e-06,0.82,159,60,0,82.64,7.0
Glucose Tolerance Test,1.12e-14,3.28,155,28,9,33.06,4.0
Hyperglycemia/etiology,3.66e-21,5.3,38,91,6,53.87,4.0
Staphylococcal Infections/drug therapy,7.04e-11,1.35,1,358,1,1.0,4.0
"Drug Resistance, Bacterial",4.43e-19,0.86,2,378,0,2.01,3.0
Skin/injuries,3.91e-07,0.27,3,43,0,3.21,2.0
Bacterial Proteins/metabolism,2.78e-84,0.13,1,222,0,1.0,3.0
Smoking Cessation/statistics & numerical data,4.06e-06,2.95,28,127,1,34.17,5.0
"Polymorphism, Single Nucleotide/genetics",4.5e-12,3.36,382,438,13,715.16,4.0
DNA/analysis,4.44e-25,0.09,8,27,2,10.37,3.0
Food Services,7.39e-10,1.9,35,4,1,4.46,4.0
C-Reactive Protein/metabolism,6.08e-209,12.6,718,644,58,1221.63,4.0
Action Potentials,3.29e-12,0.04,1,8,0,1.12,3.0
Longevity/physiology,7.33e-09,4.58,23,279,15,24.9,2.0
Vaginal Smears,1.79e-09,0.25,6,54,0,6.67,3.0
Diabetes Mellitus/physiopathology,2.83e-06,3.44,146,169,19,272.13,2.0
Transients and Migrants/statistics & numerical data,1.63e-12,4.64,28,71,1,39.04,2.0
Radiotherapy,2.27e-19,0.18,1,73,0,1.01,2.0
Escherichia coli Proteins,2.98e-35,0.02,1,13,0,1.08,4.0
Fluorobenzenes/therapeutic use,9.08e-11,5.45,20,102,6,23.92,5.0
Respiration/drug effects,1.57e-10,0.14,5,25,0,6.0,4.0
Transcription Factors,1.56e-24,0.13,2,64,0,2.06,3.0
Humidity,5.09e-06,0.3,1,41,1,1.02,4.0
Ankle/blood supply,4.23e-09,4.91,15,40,4,20.62,5.0
Hospitalization/statistics & numerical data,4.79e-23,5.8,101,2143,51,105.76,3.0
Hypertension/epidemiology,2.83e-82,16.25,1211,425,87,574.15,3.0
"Muscle, Smooth, Vascular/physiology",7.05e-11,0.07,3,7,0,4.29,4.0
Adolescent Behavior/psychology,1.67e-19,2.3,167,60,1,81.56,3.0
Kidney Diseases/physiopathology,8.04e-13,2.8,48,165,9,61.96,3.0
Prostatic Neoplasms/surgery,6.51e-84,4.67,200,789,36,250.7,4.0
Peptide Fragments/chemistry,5.23e-15,0.05,1,12,0,1.08,3.0
Psychoanalytic Therapy,1.78e-15,0.02,1,3,0,1.33,3.0
Emergencies,4.44e-08,0.73,3,372,3,3.02,3.0
Brain Neoplasms/diagnosis,2.11e-19,0.86,2,402,1,2.01,4.0
Pain,1.36e-12,0.1,9,8,0,15.11,3.0
"Recombination, Genetic",1.04e-34,0.07,2,41,0,2.1,3.0
"Sodium, Dietary",2.32e-07,0.08,2,7,0,2.57,3.0
Activities of Daily Living,1.3e-16,2.76,296,483,38,477.4,2.0
Energy Metabolism/drug effects,4.63e-10,1.79,75,41,4,63.41,3.0
Peripheral Arterial Disease/epidemiology,1.14e-17,10.82,18,44,5,25.36,4.0
Hyperglycemia/physiopathology,1.34e-09,3.36,36,78,2,52.62,4.0
Body Image/psychology,3.54e-06,19.33,205,2,1,2.02,4.0
Cerebrovascular Circulation,3.9e-21,0.33,17,192,0,18.51,5.0
Face/surgery,2.22e-07,0.1,1,14,0,1.07,3.0
Immunologic Memory,5.44e-07,0.28,3,45,0,3.2,4.0
Calcium/physiology,8.94e-25,0.04,3,12,0,3.75,3.0
"Antineoplastic Agents, Phytogenic/therapeutic use",2.53e-09,1.72,1,367,0,1.0,5.0
"Renal Insufficiency, Chronic/physiopathology",1.65e-37,9.12,52,139,5,71.45,5.0
Growth,3.36e-28,1.38,182,38,1,45.93,4.0
Spleen/cytology,9.13e-07,0.11,1,14,0,1.07,3.0
Independent Living,1.33e-08,5.6,20,35,4,31.43,3.0
DNA-Binding Proteins/metabolism,1.7e-80,0.18,8,299,0,8.21,3.0
"T-Lymphocytes, Helper-Inducer/immunology",7.03e-08,0.25,5,44,0,5.57,8.0
Malnutrition/therapy,2.81e-24,10.77,30,123,6,37.32,3.0
Peptide Fragments/immunology,1.35e-08,0.24,1,45,0,1.02,3.0
Metals/chemistry,7.36e-13,0.04,1,7,0,1.14,2.0
Schools,4.73e-29,1.3,205,32,0,37.0,2.0
Hypothalamus/physiology,3.75e-16,0.08,8,7,0,13.12,5.0
Social Responsibility,2.06e-16,0.16,1,54,0,1.02,4.0
Motor Neurons/physiology,7.83e-25,0.05,5,14,0,6.79,4.0
Immunoassay/methods,9.59e-08,0.2,7,29,0,8.69,3.0
Lipids/blood,3.39e-45,4.72,1147,213,38,252.55,1.0
"Lupus Erythematosus, Systemic/immunology",4.98e-16,0.25,5,93,0,5.27,3.0
Kidney Diseases/blood,1.57e-08,3.0,27,81,4,36.0,3.0
"Fractures, Bone",9.3e-21,0.05,6,1,0,1.17,2.0
Feeding Behavior/psychology,7.8e-16,18.07,454,3,2,3.02,3.0
Electroencephalography/methods,7.39e-15,0.21,5,68,0,5.37,4.0
"Leukemia, Myeloid, Acute/drug therapy",4.53e-07,2.53,2,625,4,2.01,5.0
Androgen Antagonists/adverse effects,1.34e-13,5.36,26,76,3,34.89,3.0
Cystatin C/blood,7.65e-46,9.65,63,144,3,90.56,4.0
"Homosexuality, Male",2.4e-06,0.27,2,38,0,2.11,5.0
Biosensing Techniques/methods,3.54e-22,0.05,1,18,0,1.06,3.0
Pre-Eclampsia/diagnosis,1.05e-18,4.31,47,102,2,68.66,4.0
Organizational Culture,2.91e-06,0.19,5,22,0,6.14,3.0
Child Behavior,6.12e-35,2.17,115,7,1,7.43,3.0
Protein-Tyrosine Kinases/metabolism,1.82e-20,0.14,1,59,0,1.02,7.0
Hispanic Americans,1.42e-07,4.22,204,187,14,358.42,4.0
Hematologic Tests,3.31e-06,0.08,2,6,0,2.67,3.0
Gastric Acid/secretion,1.84e-08,0.08,4,4,0,8.0,4.0
Inflammation/epidemiology,2.66e-29,19.43,76,59,11,104.8,3.0
Cognitive Therapy,2.82e-12,1.51,68,31,4,45.13,4.0
Liver Neoplasms/epidemiology,3.57e-16,5.32,42,245,5,49.2,3.0
Fertilization in Vitro,5.03e-14,1.17,127,38,2,49.37,4.0
Gastric Bypass/adverse effects,8.06e-39,17.72,170,81,49,119.59,3.0
Nitrogen/chemistry,2.78e-08,0.04,1,3,0,1.33,3.0
Myocardial Infarction/therapy,1.69e-06,4.96,13,3565,34,13.05,4.0
Hearing Aids,4.81e-09,0.03,1,1,0,2.0,3.0
Depression/complications,8.13e-29,4.21,83,174,13,122.59,4.0
Laparoscopy/methods,0.0,6.69,926,1437,236,1522.71,4.0
Laparoscopy/standards,2.34e-06,4.22,14,31,9,20.32,4.0
Tyrosine/metabolism,5.63e-13,0.05,1,11,0,1.09,5.0
Stomach Neoplasms/drug therapy,6.21e-11,3.3,4,1088,1,4.01,4.0
"Waste Disposal, Fluid",1.67e-06,0.16,2,19,0,2.21,7.0
Macrophages/drug effects,9.54e-19,0.19,1,75,0,1.01,3.0
Knowledge,7.6e-09,0.13,3,19,0,3.47,2.0
Fibroblasts/physiology,4.82e-09,0.09,1,14,0,1.07,3.0
Malnutrition/diet therapy,4.83e-26,11.59,29,54,4,44.57,3.0
Hyperglycemia/complications,1.54e-28,5.95,55,208,8,69.54,4.0
"Sodium, Dietary/adverse effects",1.3e-09,5.23,18,51,2,24.35,3.0
Appendicitis/surgery,2.11e-07,2.34,42,142,1,54.42,4.0
Teaching/methods,9.77e-24,0.1,8,32,1,10.0,2.0
Veins,7.1e-11,0.06,1,7,1,1.14,3.0
Colonic Neoplasms,3.17e-07,0.08,1,10,0,1.1,6.0
Acrylic Resins/chemistry,1.08e-07,0.03,1,1,0,2.0,5.0
"Hypertrophy, Left Ventricular/epidemiology",3.36e-29,17.61,60,54,15,102.6,4.0
Anastomotic Leak/surgery,8.75e-10,11.38,7,55,7,7.89,4.0
Electric Stimulation,1.35e-09,0.1,7,4,0,6.29,3.0
Protein Biosynthesis,2.65e-50,0.04,5,28,0,5.89,4.0
Obesity/epidemiology,1.34e-66,43.51,5139,273,352,287.5,4.0
Hearing,2.92e-12,0.03,2,1,0,1.5,4.0
Reflex/physiology,7.67e-11,0.1,7,9,0,12.44,3.0
Enoxaparin/administration & dosage,3.3e-17,7.86,24,69,4,32.35,6.0
Mental Disorders,3.28e-48,0.03,4,14,0,5.14,1.0
Cystatins/blood,8.1e-07,4.73,19,34,3,29.62,3.0
Residence Characteristics/statistics & numerical data,1.92e-51,6.55,96,185,3,145.82,3.0
Biodiversity,2.34e-26,0.23,2,125,0,2.03,4.0
Specialization,3.69e-21,0.25,4,116,0,4.14,2.0
Polymerase Chain Reaction,1.85e-15,0.22,1,70,0,1.01,4.0
Minimally Invasive Surgical Procedures/methods,1.04e-16,3.07,74,352,10,89.56,2.0
Cattle/physiology,4.74e-28,0.23,5,138,0,5.18,8.0
Microscopy/methods,3.18e-10,0.08,1,15,0,1.07,2.0
Certification,5.08e-11,0.1,1,20,0,1.05,4.0
Apolipoproteins/blood,2.48e-06,2.31,45,14,2,18.36,3.0
Malnutrition/prevention & control,1.45e-22,6.99,32,94,8,42.89,3.0
Outpatients/statistics & numerical data,2.48e-06,3.62,18,40,0,26.1,3.0
Pyrazines/therapeutic use,1.42e-08,3.26,36,151,0,44.58,3.0
Kidney Calculi/surgery,4.98e-11,2.47,61,11,1,12.98,5.0
Excitatory Amino Acid Antagonists/pharmacology,1.08e-07,0.12,1,18,0,1.06,6.0
Electrocardiography/statistics & numerical data,7.57e-08,6.59,11,114,8,12.06,4.0
Monocytes/immunology,2.67e-09,0.39,10,108,0,10.93,3.0
Diabetes Mellitus,3.26e-06,0.36,32,72,2,46.22,2.0
Inflammation/diagnosis,8.23e-12,4.0,34,72,2,50.06,3.0
Coronary Artery Disease/complications,1.39e-57,7.49,82,300,23,104.41,5.0
Sleep,1.82e-09,2.4,201,114,16,178.66,3.0
Research Personnel,3.42e-06,0.09,1,9,0,1.11,3.0
"Blood Loss, Surgical/statistics & numerical data",2.97e-08,7.0,14,25,2,21.84,4.0
Tuberculin Test,2.1e-06,0.15,6,11,0,9.27,5.0
Neoplasms/epidemiology,1.79e-20,3.32,125,1284,44,137.17,1.0
Concept Formation,1.11e-10,0.04,1,5,0,1.2,4.0
Ureter,1.66e-07,0.06,2,3,0,3.33,3.0
Genes,8.15e-69,0.01,1,7,0,1.14,5.0
B-Lymphocytes/metabolism,3.01e-09,0.16,2,29,0,2.14,3.0
Melanoma/genetics,1.1e-08,1.02,2,218,0,2.02,4.0
Calcium/pharmacology,5.29e-26,0.05,6,11,0,9.27,3.0
"Diabetes Mellitus, Type 2/physiopathology",1.16e-24,8.81,650,301,49,440.39,3.0
Melanoma/drug therapy,5.18e-10,1.97,3,564,1,3.02,4.0
Liver,1.31e-26,0.09,6,39,0,6.92,2.0
Breast Neoplasms/epidemiology,3.96e-125,6.93,397,548,40,684.61,3.0
Ethnic Groups/statistics & numerical data,1.32e-110,7.22,168,355,19,247.5,3.0
Superoxides/metabolism,7.09e-10,0.15,4,26,0,4.62,4.0
Atherosclerosis/complications,9.95e-44,8.1,60,138,9,86.09,5.0
Bariatric Surgery/statistics & numerical data,4.3e-26,33.61,27,24,16,45.33,2.0
Coronary Artery Disease/etiology,2.33e-67,7.84,105,199,14,160.4,5.0
"Hypertrophy, Left Ventricular/drug therapy",1.68e-10,4.65,21,87,6,26.07,4.0
Orthopedic Procedures,1.08e-06,0.31,13,54,0,16.13,2.0
Severity of Illness Index,7.18e-80,4.61,273,2177,63,307.23,7.0
Sulfonamides/pharmacology,5.2e-10,0.34,7,91,1,7.54,3.0
Knee Prosthesis,8.48e-12,1.38,78,30,0,41.54,4.0
Amphetamine/pharmacology,1.95e-08,0.04,1,3,0,1.33,6.0
Atherosclerosis/epidemiology,1.44e-43,15.57,131,107,17,194.4,5.0
Apoptosis/genetics,4.04e-07,0.35,4,78,0,4.21,4.0
RNA/metabolism,1.29e-17,0.07,3,16,0,3.56,3.0
Liver Diseases/epidemiology,2.67e-13,6.91,21,94,5,25.69,2.0
Nuclear Proteins/metabolism,8.33e-35,0.27,11,222,0,11.55,3.0
Metabolic Syndrome X/physiopathology,2.04e-19,16.92,279,92,22,122.34,3.0
Smoking/adverse effects,8.14e-206,4.57,540,1128,85,798.51,4.0
"Cardiac Pacing, Artificial/methods",3.05e-08,1.24,3,281,0,3.03,3.0
"RNA, Viral/genetics",7.07e-15,0.21,3,69,0,3.13,4.0
Calcitriol/pharmacology,7.64e-08,0.13,1,19,0,1.05,7.0
Isoenzymes/metabolism,3e-25,0.18,6,98,0,6.37,3.0
Renal Dialysis/methods,5.78e-10,3.77,48,620,24,51.72,3.0
Coronary Artery Disease/ethnology,2.83e-24,15.79,30,43,6,50.93,5.0
Lumbar Vertebrae/radiography,1.31e-19,2.09,67,6,0,6.54,5.0
Edema,8.41e-10,0.03,1,2,0,1.5,3.0
Brain Diseases/diagnosis,6.46e-12,0.29,3,92,0,3.1,3.0
Fresh Water/chemistry,4.41e-06,0.27,1,39,0,1.03,3.0
Hysterectomy/methods,5.59e-28,6.24,121,154,6,216.07,4.0
Costs and Cost Analysis,1.99e-08,0.17,5,27,0,5.93,3.0
Gestational Age,1.69e-25,2.98,107,362,6,138.63,3.0
Cysteine Endopeptidases/metabolism,1.03e-10,0.12,1,25,0,1.04,6.0
Occupational Exposure/adverse effects,1.85e-13,2.33,140,803,8,164.41,5.0
"Range of Motion, Articular/physiology",6.46e-13,1.32,85,14,0,16.31,3.0
"Diabetes Mellitus, Type 2/diagnosis",7.45e-19,9.87,231,131,12,205.29,3.0
Polyethylene Glycols/therapeutic use,4.36e-06,2.43,64,130,1,95.51,3.0
Proteins/pharmacology,8.75e-07,0.13,2,15,0,2.27,2.0
Metabolic Syndrome X/epidemiology,1.05e-43,26.9,1096,200,68,236.5,3.0
"Stress, Physiological",1.45e-06,0.52,30,175,2,35.14,3.0
1-Alkyl-2-acetylglycerophosphocholine Esterase/blood,4.47e-08,11.27,25,24,1,47.04,9.0
Hyperlipidemias/blood,4.65e-09,2.7,60,12,0,14.4,5.0
Peripheral Arterial Disease/blood,9.46e-09,10.96,9,17,2,13.76,4.0
"Anastomosis, Roux-en-Y/methods",4.46e-13,10.12,19,29,7,31.45,3.0
Life Expectancy,2.26e-11,5.69,19,1024,55,19.35,4.0
"Water Pollutants, Chemical/analysis",1.09e-44,0.13,12,108,0,13.33,5.0
Osteoprotegerin/blood,2.99e-19,11.76,51,54,4,99.17,9.0
DNA/metabolism,2.88e-51,0.05,11,18,0,17.72,3.0
Stomach Neoplasms/metabolism,3.99e-07,2.67,2,544,1,2.01,4.0
Blood Platelets,1.53e-09,0.15,4,24,1,4.67,3.0
Drug Therapy,4.83e-38,0.06,4,32,0,4.5,2.0
Bone Neoplasms/pathology,3.1e-12,1.08,1,294,0,1.0,3.0
Nursing Care/standards,3.68e-13,0.08,1,19,0,1.05,3.0
Extracorporeal Circulation,5.32e-10,0.25,1,56,0,1.02,2.0
Skin/cytology,8.26e-08,0.07,2,5,0,2.8,2.0
Chronic Disease/epidemiology,2.21e-58,5.93,99,250,17,138.2,4.0
Bone Density Conservation Agents/therapeutic use,8.35e-12,2.59,62,214,1,79.96,4.0
"Gene Expression Regulation, Neoplastic",1.23e-36,1.31,19,1495,1,19.24,4.0
"Carcinoma, Renal Cell/epidemiology",1.75e-23,12.42,42,55,4,74.07,5.0
Lung/pathology,1.1e-13,1.0,15,543,3,15.41,2.0
Tissue Plasminogen Activator/therapeutic use,2.18e-06,2.15,1,432,3,1.0,3.0
Metal Nanoparticles/chemistry,1.17e-27,0.05,1,27,0,1.04,5.0
Cardiovascular Diseases/etiology,0.0,12.08,1028,1873,197,1592.22,1.0
Angiography,2.66e-31,0.08,3,48,0,3.19,4.0
Inpatients/statistics & numerical data,1.4e-08,5.71,26,272,5,28.49,3.0
Acculturation,3.19e-08,3.01,93,25,2,31.72,5.0
Hospitals/standards,1.44e-09,1.58,1,374,1,1.0,3.0
Adipose Tissue/anatomy & histology,2.95e-12,14.57,410,5,8,5.06,3.0
Ammonia/metabolism,1.61e-07,0.11,1,16,0,1.06,3.0
Animal Nutritional Physiological Phenomena,6.53e-09,0.35,6,83,1,6.43,4.0
"Antibodies, Bacterial/analysis",4.09e-12,0.08,2,14,0,2.29,7.0
"Students, Nursing",4.06e-07,0.13,8,6,0,10.5,4.0
Prostatic Neoplasms/complications,3.8e-09,3.97,39,69,4,61.04,4.0
Spermatozoa/physiology,2.33e-11,0.17,10,32,0,13.12,3.0
Kidney,3.91e-37,0.08,8,39,1,9.64,3.0
Menopause,1.69e-17,2.06,163,77,6,113.37,4.0
Heart Failure/physiopathology,1.34e-12,3.1,90,1026,38,97.89,3.0
Immunoglobulin G/immunology,8.28e-13,0.19,3,51,0,3.18,8.0
Ovarian Neoplasms/genetics,1.54e-08,1.53,8,473,0,8.14,3.0
"Ventricular Function, Left/physiology",2.72e-35,3.03,140,342,13,197.31,5.0
Dyslipidemias/epidemiology,1.5e-15,22.83,131,42,15,55.47,4.0
Allergens/immunology,3.67e-10,0.16,10,23,0,14.35,3.0
Osteoporotic Fractures/epidemiology,5.55e-17,11.91,35,41,6,64.88,3.0
Functional Laterality/physiology,4.77e-22,0.06,4,17,0,4.94,4.0
"RNA, Messenger/genetics",1.62e-23,0.27,15,157,1,16.43,4.0
Atherosclerosis/prevention & control,8.48e-11,3.04,38,109,2,51.25,5.0
Pre-Eclampsia/etiology,1.57e-06,6.47,69,55,5,98.84,4.0
"Indians, North American/statistics & numerical data",4.17e-38,7.01,69,192,1,93.8,5.0
Asthma/blood,3.17e-15,2.24,54,5,0,5.46,3.0
"Diabetes Mellitus, Type 1/psychology",6.72e-09,1.65,39,9,1,11.08,3.0
"Absorptiometry, Photon",4.52e-09,8.19,156,6,2,6.23,5.0
"RNA, Messenger/metabolism",8.24e-36,0.17,25,114,0,30.48,4.0
Cystectomy/adverse effects,1.36e-10,8.07,12,61,6,14.36,4.0
Hypoglycemic Agents/administration & dosage,1.17e-17,5.86,298,236,10,422.9,4.0
Cereals,1.54e-08,2.41,81,29,4,39.38,1.0
Breast Neoplasms/blood,3.26e-25,4.5,112,181,12,181.3,3.0
Intestinal Mucosa/immunology,1.58e-07,0.25,3,42,0,3.21,4.0
Molecular Chaperones/metabolism,1.4e-08,0.13,1,21,0,1.05,3.0
Transforming Growth Factor beta/pharmacology,1.25e-11,0.07,1,15,0,1.07,4.0
Subtraction Technique,5.71e-09,0.08,3,7,0,4.29,4.0
Seizures,1.37e-08,0.03,1,2,0,1.5,3.0
Glycoproteins/metabolism,2.83e-17,0.29,6,121,0,6.3,3.0
Electric Power Supplies,6.47e-07,0.1,1,13,0,1.08,3.0
Adipocytes/metabolism,1.07e-26,2.46,125,15,3,16.8,3.0
Personal Satisfaction,5.68e-15,3.14,207,59,2,75.82,3.0
Facial Expression,2.89e-07,0.13,8,3,1,4.12,4.0
Arousal,5.11e-08,0.1,5,6,0,9.17,3.0
Head and Neck Neoplasms/pathology,7.95e-07,1.72,2,431,5,2.01,3.0
Attitude to Health,3.89e-19,1.11,361,501,14,621.12,3.0
Nuclear Proteins,5.22e-08,0.3,11,62,0,12.95,3.0
Thromboembolism/epidemiology,4.21e-06,4.84,14,99,4,15.98,4.0
Religion and Medicine,5.1e-08,0.33,10,71,1,11.41,3.0
Vitamins/administration & dosage,5.21e-08,4.0,79,101,5,140.79,4.0
Membrane Glycoproteins/physiology,6.97e-08,0.31,3,64,0,3.14,4.0
Iron,1.02e-12,0.09,1,18,1,1.06,4.0
Peptides/chemistry,5.43e-47,0.02,1,16,0,1.06,2.0
Neuronal Plasticity,6.04e-07,0.04,1,2,0,1.5,4.0
Chromosome Mapping/methods,1.41e-07,0.13,6,12,0,9.0,3.0
Brain Neoplasms/drug therapy,1.35e-13,2.5,1,815,1,1.0,4.0
Growth Hormone/pharmacology,3.21e-06,0.19,8,18,0,11.56,6.0
Exercise Tolerance,4.42e-22,7.01,108,115,14,209.43,4.0
Skin Neoplasms/surgery,1.66e-12,0.89,3,291,1,3.03,3.0
Family Practice/education,1.7e-15,0.07,3,16,0,3.56,4.0
"Surgery, Plastic",8.12e-19,0.06,5,10,0,7.5,4.0
Adrenergic alpha-Agonists/pharmacology,5.65e-08,0.07,1,8,0,1.12,7.0
Aortic Valve Stenosis/surgery,8.39e-08,5.87,31,1224,37,31.79,4.0
"Pulmonary Disease, Chronic Obstructive/epidemiology",4.75e-48,8.3,68,243,14,87.03,4.0
"Radiography, Thoracic",6.07e-11,0.26,10,68,0,11.47,5.0
Obesity,1.87e-09,7.72,488,30,50,31.84,4.0
Pelvis,4.01e-09,0.1,3,12,0,3.75,3.0
"Hypertrophy, Left Ventricular/blood",4.27e-08,14.83,38,25,1,41.45,4.0
Nervous System Physiological Phenomena,1.46e-32,0.01,1,3,0,1.33,2.0
Obesity/diet therapy,5.95e-11,17.84,668,16,11,16.38,4.0
Birth Weight,8.29e-24,6.75,556,354,21,579.39,4.0
Peptide Hydrolases/metabolism,1.89e-15,0.12,2,34,0,2.12,4.0
Bicycling/physiology,1.81e-11,3.41,99,15,1,17.27,5.0
Freezing,7.4e-13,0.11,1,27,0,1.04,4.0
Coronary Artery Disease/therapy,2.69e-06,6.1,39,1373,26,40.11,5.0
Femur/radiography,3.22e-09,2.49,41,5,0,5.61,6.0
"Chemistry Techniques, Analytical/methods",1.68e-06,0.05,1,4,0,1.25,2.0
Melanoma/metabolism,4.04e-07,0.89,3,173,0,3.05,4.0
Dog Diseases/pathology,2.17e-12,1.17,1,321,0,1.0,2.0
Pharmaceutical Services,2.91e-06,0.11,2,8,1,2.5,3.0
Insulin/physiology,8.51e-21,2.28,101,18,1,21.21,7.0
Chromosomes,7.63e-25,0.02,1,4,0,1.25,3.0
Marketing of Health Services,1.8e-09,0.04,1,5,0,1.2,4.0
Hydrocortisone/pharmacology,2.13e-12,0.07,2,14,0,2.29,6.0
Neurons/physiology,6.51e-140,0.03,5,54,0,5.46,2.0
Secondary Prevention/methods,3.57e-12,7.31,23,137,3,26.86,2.0
Lymphography,4.65e-06,0.04,1,2,0,1.5,5.0
Uterine Prolapse/surgery,1.07e-07,1.91,44,17,0,23.57,5.0
Neoplasm Proteins/genetics,3.93e-08,1.05,15,387,0,15.58,3.0
Food Analysis/methods,1.11e-06,0.07,3,2,0,3.33,2.0
Epilepsy/physiopathology,5.8e-09,0.25,9,53,0,10.53,4.0
Vascular Stiffness/physiology,1.86e-13,10.54,75,55,7,95.33,3.0
Attitude of Health Personnel,2.37e-51,0.34,83,536,5,95.85,3.0
Gene Expression Regulation/drug effects,4.59e-21,0.24,14,120,0,15.63,3.0
Cytodiagnosis,1.5e-12,0.07,1,15,0,1.07,3.0
Pain/drug therapy,4.46e-20,0.3,21,162,1,23.72,3.0
"Diet, Mediterranean",6.3e-57,13.5,135,137,24,268.03,4.0
Cattle/genetics,2.11e-14,0.13,1,37,0,1.03,8.0
Swine/genetics,4.84e-06,0.28,2,38,0,2.11,7.0
Policy Making,4.52e-06,0.34,3,68,0,3.13,3.0
Cornea/surgery,7.22e-11,0.03,1,2,0,1.5,4.0
Uterus/drug effects,1.23e-09,0.07,1,11,0,1.09,4.0
Carbohydrates/chemistry,2.27e-07,0.04,1,3,0,1.33,1.0
Laboratories,9.82e-13,0.13,6,26,0,7.38,3.0
"Tumor Markers, Biological/metabolism",1.1e-11,3.99,20,2504,4,20.16,1.0
Liver Cirrhosis/pathology,7.73e-09,2.27,49,136,3,66.65,3.0
"Emergency Service, Hospital",1.61e-06,1.39,26,616,0,27.1,4.0
Premenopause,1.1e-06,9.76,109,56,2,84.77,5.0
"Fatty Acids, Omega-3/therapeutic use",9.23e-09,3.56,32,149,2,38.87,4.0
HLA Antigens/immunology,5.58e-09,1.19,2,263,0,2.02,5.0
Vasodilation/physiology,3.18e-08,1.92,87,53,8,85.29,5.0
Bariatric Surgery/methods,9.99e-48,28.98,226,70,57,91.68,2.0
Aromatase Inhibitors/therapeutic use,1.41e-07,4.44,22,146,4,25.32,6.0
Pancreatic Fistula/etiology,3.28e-16,8.82,19,79,7,23.57,3.0
Health Behavior,4.92e-17,6.75,1305,605,86,885.48,3.0
Cell Adhesion,2.18e-08,0.11,3,13,0,3.69,3.0
Skin Neoplasms/therapy,9.63e-09,1.43,1,283,0,1.0,3.0
Substance-Related Disorders/prevention & control,5.57e-09,0.21,2,40,0,2.1,2.0
Burns/therapy,1.8e-07,0.94,4,239,3,4.07,2.0
Radiation Dosage,4.65e-19,1.64,154,103,1,171.89,3.0
"Stress, Physiological/physiopathology",7.65e-07,0.24,9,34,1,11.38,3.0
"Transcription, Genetic/drug effects",3.33e-14,0.08,1,20,0,1.05,4.0
Insulin/genetics,8.91e-08,1.73,31,5,0,5.81,7.0
Crime,8.3e-07,0.27,4,42,0,4.38,3.0
Phenols/analysis,4.12e-06,0.1,4,4,0,8.0,6.0
Immunosuppressive Agents/therapeutic use,3.69e-09,1.78,53,1586,8,54.77,5.0
Fatty Liver/epidemiology,1.63e-08,28.48,191,37,7,44.17,3.0
DNA Damage/drug effects,1.19e-06,0.23,2,32,0,2.12,3.0
Disease Outbreaks/prevention & control,5e-10,1.09,6,340,0,6.11,3.0
"Adaptation, Physiological",1.54e-06,0.47,61,177,0,82.02,3.0
Chlamydia Infections/diagnosis,3.51e-06,0.07,1,6,0,1.17,4.0
Superoxide Dismutase/metabolism,3.93e-08,0.29,6,58,1,6.62,4.0
Uterus,5.75e-20,0.02,1,4,0,1.25,4.0
Anthropometry,2.12e-10,11.08,639,24,38,24.9,2.0
Hispanic Americans/psychology,2.02e-13,2.44,87,21,0,26.07,4.0
Tumor Necrosis Factor-alpha/blood,6.87e-11,9.41,140,82,3,130.03,4.0
Disease Progression,3.16e-22,3.63,76,365,13,91.82,4.0
Transforming Growth Factor beta/physiology,8.93e-07,0.16,1,21,0,1.05,4.0
"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods",7.51e-11,0.12,3,23,0,3.39,4.0
European Continental Ancestry Group/psychology,1.28e-06,4.03,116,26,1,31.83,4.0
Diffusion of Innovation,2.01e-17,0.2,2,72,0,2.06,3.0
Electrophysiology,5.32e-15,0.02,1,2,0,1.5,4.0
"Fracture Fixation, Internal/instrumentation",2.18e-06,0.34,5,56,0,5.45,4.0
Gastrectomy,7.35e-10,1.84,94,419,23,115.09,3.0
"Nursing Staff, Hospital",3.7e-08,0.24,8,43,0,9.49,4.0
Choice Behavior,9.63e-08,1.09,106,97,4,185.76,5.0
Anti-Arrhythmia Agents/therapeutic use,2.44e-07,1.89,12,627,0,12.23,5.0
Hyperglycemia/epidemiology,5.04e-42,17.21,77,86,5,145.94,4.0
Managed Care Programs/organization & administration,3.07e-09,0.13,2,22,0,2.18,4.0
Glioma/drug therapy,8.59e-07,2.02,1,320,0,1.0,5.0
Drug Eruptions/etiology,1.35e-10,0.23,4,53,0,4.3,4.0
Robotics/methods,2.38e-06,3.63,106,126,11,195.17,4.0
Acetylcholine/metabolism,3.6e-13,0.04,1,7,0,1.14,4.0
Esophageal Neoplasms/pathology,1.74e-06,2.8,5,734,3,5.03,4.0
Body Fluids,7.49e-40,0.03,2,15,1,2.27,2.0
Pulmonary Artery/abnormalities,6.92e-08,0.85,2,183,1,2.02,4.0
Antibodies/analysis,1.44e-21,0.04,3,7,0,4.29,6.0
"Obesity, Morbid/surgery",1.26e-304,32.21,1890,392,491,473.3,5.0
DNA/radiation effects,7.15e-09,0.04,1,5,0,1.2,3.0
Nutritional Status/physiology,1.41e-13,17.71,215,59,24,75.19,4.0
"Obstetric Labor, Premature/epidemiology",1.9e-07,4.87,17,55,0,22.25,4.0
Cardiovascular Diseases/prevention & control,0.0,7.02,611,2353,108,769.66,1.0
Anthelmintics/therapeutic use,3.76e-08,0.27,1,49,1,1.02,6.0
"Sleep Apnea, Obstructive/complications",3.41e-33,15.5,271,126,26,184.58,5.0
Colectomy/adverse effects,8.07e-15,6.49,24,128,8,28.5,3.0
Cardiac Output,2.47e-06,0.27,12,39,1,15.69,4.0
Neutrophils/physiology,5.35e-13,0.25,9,77,1,10.05,3.0
"Hemoglobin A, Glycosylated/metabolism",2.5e-35,11.69,324,184,19,288.49,3.0
Disinfection/methods,3.39e-09,0.18,1,34,0,1.03,7.0
Morphine/pharmacology,3.66e-24,0.05,3,17,0,3.53,5.0
Nerve Tissue Proteins/analysis,1.65e-07,0.11,1,16,0,1.06,3.0
"Regulatory Sequences, Nucleic Acid",3.51e-09,0.04,1,4,0,1.25,4.0
Carcinogens/metabolism,4.72e-06,0.04,1,2,0,1.5,4.0
Nurse-Patient Relations,2.34e-30,0.11,9,58,0,10.4,4.0
Carbohydrates,1.35e-07,0.1,5,6,0,9.17,1.0
Nitric Oxide/metabolism,4.32e-08,0.48,46,199,3,56.63,3.0
Venous Thromboembolism/blood,5.76e-10,7.69,15,29,0,22.76,5.0
Extracellular Matrix Proteins/metabolism,1.25e-06,0.25,1,36,0,1.03,4.0
Space Perception/physiology,1.99e-21,0.03,3,1,0,1.33,4.0
Sodium Channels/metabolism,3.48e-06,0.1,1,11,0,1.09,6.0
Peripheral Vascular Diseases/epidemiology,1.38e-24,9.78,29,77,6,39.92,3.0
Serotonin/metabolism,3.18e-22,0.09,8,26,0,10.46,4.0
Hot Temperature,1.62e-30,0.29,38,241,0,43.99,4.0
Brain Chemistry,1.43e-35,0.04,1,22,0,1.05,2.0
"Antigens, CD",1.35e-06,0.24,1,34,0,1.03,4.0
"Protein Processing, Post-Translational",1.6e-18,0.13,6,41,0,6.88,5.0
Population Growth,4.66e-07,0.35,4,72,0,4.22,4.0
Indoles/pharmacology,1.88e-14,0.22,6,72,0,6.5,3.0
"DNA, Bacterial/analysis",1.61e-12,0.1,1,25,0,1.04,4.0
"Osteoarthritis, Knee/therapy",1.08e-10,4.01,55,1,0,1.02,4.0
European Continental Ancestry Group/statistics & numerical data,7.96e-254,11.52,309,757,30,435.13,4.0
Hypersensitivity/immunology,3.62e-08,0.13,4,17,0,4.94,2.0
Nutritional Status,5.83e-21,8.34,1563,520,203,693.0,4.0
Acute Coronary Syndrome/epidemiology,2.35e-08,9.53,11,134,6,11.9,4.0
Diabetic Angiopathies/blood,2.2e-10,8.54,59,47,10,84.44,3.0
Gastric Emptying/physiology,4.09e-11,3.03,57,5,0,5.44,5.0
Prenatal Diagnosis,8.65e-07,0.45,13,221,1,13.76,4.0
Vagina,7.69e-07,0.08,3,4,0,5.25,4.0
Fish Diseases/parasitology,4.21e-08,0.86,1,161,0,1.01,2.0
Pregnancy/physiology,1.21e-11,3.17,157,44,1,56.33,5.0
Nursing Care,1.63e-27,0.03,1,13,0,1.08,3.0
Protein-Energy Malnutrition/therapy,2.36e-06,5.33,9,38,4,11.13,6.0
Risk Assessment/methods,1.11e-106,6.02,261,2228,75,291.57,4.0
Serine Endopeptidases/metabolism,2.96e-09,0.25,3,53,0,3.17,6.0
Proline/analogs & derivatives,3.23e-06,0.15,2,17,0,2.24,5.0
Bone Development/physiology,5.53e-12,1.95,43,6,1,6.84,5.0
Skin Physiological Phenomena,6.61e-07,0.16,11,7,0,11.45,2.0
"Embryo, Mammalian/cytology",1.21e-06,0.1,1,11,0,1.09,2.0
"Air Pollution, Indoor/analysis",5.52e-07,0.15,3,19,0,3.47,5.0
Heart Ventricles/ultrasonography,7.15e-10,4.04,82,110,14,143.13,3.0
Equipment and Supplies,4.76e-25,0.06,6,9,1,10.0,1.0
"Nursing Staff, Hospital/psychology",1.93e-16,0.16,5,54,0,5.46,4.0
Health Services Research,2.95e-09,0.35,5,86,1,5.29,2.0
Heart Failure/rehabilitation,3.6e-06,4.49,17,87,1,20.32,3.0
Anemia/complications,3.4e-06,4.7,15,225,12,16.0,3.0
Joint Prosthesis,2.84e-06,0.13,6,6,0,12.0,3.0
Immunity,5.84e-18,0.09,5,25,0,6.0,2.0
Phosphatidylinositol 3-Kinases/metabolism,3.16e-09,0.34,9,86,0,9.94,6.0
Blood Transfusion,3.14e-13,0.41,14,269,2,14.73,3.0
Bariatric Surgery/adverse effects,7.44e-44,16.71,72,76,25,140.21,2.0
Extracellular Space/metabolism,4.53e-07,0.05,1,5,0,1.2,3.0
Automatic Data Processing,1.12e-08,0.11,3,15,0,3.6,3.0
Diaphragm,2.08e-07,0.09,3,7,0,4.29,5.0
"Milk, Human/chemistry",1.18e-16,1.81,71,19,0,24.08,3.0
Biopsy,4.31e-16,0.16,5,49,2,5.51,2.0
Coronary Artery Disease/physiopathology,7.58e-39,5.15,93,183,13,140.26,5.0
Consumer Participation,6.3e-08,0.3,8,60,1,9.07,4.0
Brain/physiopathology,1.08e-13,0.4,45,209,0,54.69,3.0
"Arthritis, Rheumatoid/immunology",2.56e-09,0.22,10,37,2,12.7,3.0
Ventricular Remodeling/physiology,2.04e-12,4.24,37,227,8,43.03,3.0
Skin Neoplasms/diagnosis,9.7e-20,0.99,2,443,0,2.01,3.0
Digestion,7.23e-16,0.06,5,4,0,7.2,4.0
Disabled Persons/statistics & numerical data,1.55e-31,4.91,65,229,14,83.45,2.0
Vascular Endothelial Growth Factor A/metabolism,4.83e-06,1.03,7,229,0,7.21,5.0
Veterans,2.38e-08,2.19,39,142,13,49.71,2.0
Swimming/physiology,3.86e-16,2.27,69,10,0,11.45,3.0
Lymphocyte Activation,1.4e-42,0.06,2,43,0,2.09,3.0
T-Lymphocytes/metabolism,1.9e-15,0.17,5,51,0,5.49,6.0
"Pulmonary Disease, Chronic Obstructive/classification",1.84e-07,15.91,11,11,5,22.0,4.0
Gastroplasty/adverse effects,8.49e-23,19.16,90,32,41,43.38,3.0
Cystic Fibrosis/complications,9.33e-21,2.86,87,222,19,121.09,3.0
Lipids,1.29e-11,0.07,4,8,0,6.0,1.0
Nurses/psychology,2.92e-09,0.18,11,25,0,15.84,3.0
Cerebellum/metabolism,1.93e-08,0.05,1,6,0,1.17,7.0
Depression/epidemiology,6.93e-10,4.26,273,252,9,484.62,4.0
Pregnancy Outcome/epidemiology,2.93e-71,7.92,114,463,18,142.07,3.0
"Diabetes Mellitus, Type 1/complications",1.07e-26,3.46,192,326,18,305.08,3.0
Health Services/utilization,2.01e-06,1.89,53,158,3,70.78,2.0
Catholicism,1.03e-10,0.12,1,25,0,1.04,4.0
Renal Dialysis,4.69e-91,2.84,357,1934,161,422.9,3.0
Brain Ischemia/epidemiology,4.58e-18,5.98,34,142,6,42.14,4.0
Gastroesophageal Reflux/surgery,5.62e-16,3.37,80,159,13,120.25,6.0
Atrial Fibrillation/etiology,9.04e-18,3.85,50,201,9,62.44,4.0
"Kidney Failure, Chronic/complications",4.1e-36,4.08,122,1313,69,133.34,6.0
Androgens/blood,2.79e-09,6.72,149,10,1,10.67,6.0
Mutation/genetics,3.89e-13,0.97,44,781,3,46.48,3.0
"Oncogene Proteins, Fusion/genetics",4.65e-06,1.38,1,193,0,1.01,5.0
Breast Neoplasms/genetics,1.76e-10,1.93,197,1149,10,230.78,3.0
Enzyme Inhibitors,4.72e-06,0.05,1,3,0,1.33,4.0
"Pulmonary Disease, Chronic Obstructive/surgery",4.53e-07,10.51,4,76,8,4.21,4.0
"Receptors, Immunologic/metabolism",2.31e-06,0.37,4,74,1,4.22,5.0
Heart Arrest/therapy,3.06e-07,3.55,7,1301,7,7.04,3.0
Copper/metabolism,4.41e-14,0.1,2,27,0,2.15,4.0
Hepatitis C/complications,7.71e-08,2.85,59,422,6,67.25,3.0
"Neurons, Afferent/physiology",2.59e-15,0.04,3,3,0,6.0,3.0
Vitamin D/blood,1.09e-07,10.62,228,90,6,125.53,4.0
Health Services Accessibility,5.44e-08,1.32,27,735,7,27.99,3.0
Coronary Artery Disease/blood,3.92e-56,8.02,182,222,20,331.21,5.0
Cystic Fibrosis/epidemiology,1.19e-11,6.26,14,34,7,19.76,3.0
Hypothyroidism/physiopathology,3.96e-06,1.8,33,14,0,19.94,3.0
Ascorbic Acid,2.16e-07,0.04,1,2,0,1.5,3.0
Camptothecin/analogs & derivatives,8.84e-07,2.23,4,476,0,4.03,3.0
Maternal-Fetal Exchange,1.03e-12,0.16,10,32,0,13.12,6.0
Ribavirin/therapeutic use,3.53e-15,2.75,69,169,0,97.17,4.0
Acetylcholinesterase/metabolism,3.06e-12,0.1,1,22,0,1.05,7.0
Repressor Proteins/physiology,2.37e-06,0.21,1,27,0,1.04,4.0
Amino Acids/metabolism,7.13e-26,0.09,14,15,0,27.07,2.0
"Diabetes Mellitus, Type 2/prevention & control",4.76e-19,9.98,315,154,22,229.29,3.0
Postpartum Period,9.48e-08,1.22,85,86,0,169.01,3.0
Stroke/ethnology,4.22e-06,7.34,10,102,4,10.98,4.0
Workplace,2.69e-09,1.76,69,39,0,61.04,4.0
Job Satisfaction,1.17e-13,0.15,9,27,2,12.0,4.0
Patient Selection,2.07e-17,2.96,146,1349,33,161.8,3.0
Prostatectomy/methods,3.09e-49,4.75,194,320,18,311.61,5.0
Lung Neoplasms/secondary,7.46e-17,2.26,2,938,1,2.0,3.0
Ecology,1.29e-11,0.28,4,77,0,4.21,3.0
"Fractures, Spontaneous/epidemiology",2.19e-06,6.68,10,23,0,14.35,3.0
Lung Neoplasms/pathology,1.75e-29,2.24,7,2157,11,7.02,3.0
Acid-Base Equilibrium,9.38e-10,0.16,2,26,2,2.15,2.0
"Models, Biological",3.61e-26,0.6,312,1481,20,377.73,3.0
Wound Healing,7.22e-12,0.37,41,153,3,51.99,4.0
Wine/analysis,2.37e-06,0.09,1,10,0,1.1,4.0
Professional-Patient Relations,3.63e-07,0.26,22,37,0,35.08,3.0
Endometrial Neoplasms/surgery,4.67e-80,10.79,86,178,20,127.55,6.0
Cardiovascular Diseases/genetics,1.94e-56,7.98,147,204,14,252.93,1.0
Computer Graphics,5.51e-08,0.12,2,13,1,2.31,3.0
Catecholamines/metabolism,1.89e-09,0.1,4,11,0,5.45,3.0
Mammography,1.96e-24,2.87,111,383,5,143.17,5.0
"Education, Medical, Undergraduate",2.5e-17,0.04,1,10,0,1.1,4.0
MicroRNAs/genetics,4.62e-17,1.08,17,674,0,17.43,4.0
"Ventricular Dysfunction, Left/blood",6.02e-15,7.07,24,56,1,34.29,4.0
Multigene Family,9.45e-17,0.08,5,16,0,6.56,6.0
Algorithms,1.29e-21,0.48,205,668,17,267.91,2.0
Anti-HIV Agents/adverse effects,2.91e-14,2.76,56,148,4,77.19,7.0
Hip Joint/radiography,1.36e-08,1.79,33,4,0,4.48,4.0
Ovarian Neoplasms/epidemiology,5.69e-16,5.21,43,77,6,67.01,3.0
Pediatrics,1.54e-15,0.35,25,170,0,28.68,3.0
Biological Assay,1.06e-12,0.06,1,13,0,1.08,2.0
"Diabetes Mellitus, Type 2/therapy",2.29e-36,7.23,291,254,15,475.7,3.0
Cooperative Behavior,6.07e-15,0.41,21,199,2,23.22,4.0
Serotonin/physiology,4.5e-09,0.11,7,6,0,11.14,4.0
Brain Neoplasms/pathology,4.33e-29,1.23,1,753,0,1.0,4.0
Food Preferences/psychology,8.73e-12,6.53,98,1,0,1.01,4.0
Gastrointestinal Hemorrhage/etiology,3.12e-13,1.09,5,432,2,5.06,3.0
Arteries/physiopathology,2.15e-13,5.34,97,108,11,184.12,3.0
Glucose/metabolism,1.9e-11,0.82,311,100,5,132.15,4.0
"Kidney Failure, Chronic/genetics",4.68e-07,3.95,19,67,1,24.39,6.0
Biological Assay/methods,2.33e-07,0.32,3,60,0,3.15,2.0
Heart Failure/complications,1.37e-13,4.85,43,716,31,45.58,3.0
Adipokines/blood,7.46e-07,29.73,248,37,9,42.52,3.0
Eating/psychology,2.86e-07,14.94,210,5,0,5.12,4.0
Neuroglia/physiology,8.82e-07,0.04,1,2,0,1.5,2.0
Military Medicine,8.2e-14,0.24,21,73,0,27.04,3.0
Immunologic Factors/therapeutic use,5.23e-08,1.3,5,325,0,5.08,4.0
Prolactin/secretion,1.3e-06,0.13,8,2,0,2.5,6.0
Larynx,4.82e-11,0.07,2,10,0,2.4,2.0
Adipose Tissue/drug effects,9.32e-14,3.5,90,6,3,6.4,3.0
Mitogen-Activated Protein Kinases/metabolism,1.38e-17,0.15,3,55,0,3.16,4.0
Ultrasonics,3.44e-19,0.06,4,14,0,5.14,4.0
HIV Infections,1.32e-07,0.25,4,42,1,4.38,3.0
"Plants, Medicinal",3.51e-47,0.07,5,57,0,5.44,3.0
Cost of Illness,2.38e-07,3.13,77,1056,27,82.61,4.0
Prisoners/psychology,7.5e-07,0.23,3,34,0,3.26,2.0
"Pulmonary Disease, Chronic Obstructive/blood",3.67e-30,11.53,60,75,10,108.0,4.0
Language,1.33e-23,0.16,24,48,1,36.0,3.0
Antibody Formation,2.07e-42,0.05,2,35,0,2.11,3.0
Dislocations/surgery,7.21e-10,0.1,2,17,0,2.24,2.0
Socioeconomic Factors,3.93e-34,2.6,163,560,20,210.44,2.0
"Behavior, Animal/drug effects",6.1e-39,0.18,3,146,0,3.06,3.0
NF-kappa B/metabolism,6.88e-08,0.44,15,261,0,15.86,4.0
Population Surveillance/methods,7.6e-23,3.64,109,764,15,124.55,4.0
Stroke/drug therapy,1.16e-06,3.17,8,900,1,8.07,4.0
Health Care Costs,1.58e-08,2.49,79,619,19,89.08,3.0
Research Support as Topic,8.18e-12,0.1,1,19,1,1.05,4.0
Laser Therapy,7.37e-28,0.2,9,118,1,9.69,2.0
"Legislation, Drug",4.87e-09,0.09,1,15,0,1.07,4.0
Kidney Transplantation/statistics & numerical data,2.38e-09,5.81,23,244,8,25.17,3.0
Primary Prevention/methods,2.85e-08,3.92,33,339,12,36.21,4.0
Cross-Cultural Comparison,2.11e-13,1.28,139,144,3,273.17,5.0
Muscles/metabolism,2.83e-35,0.03,4,6,0,6.67,2.0
Thrombolytic Therapy,1.37e-15,2.04,1,745,1,1.0,3.0
Duodenum/surgery,1.69e-06,3.54,72,98,23,124.9,4.0
Hydrocortisone/secretion,9.02e-07,1.77,31,11,0,14.9,6.0
Oxygen,2.22e-24,0.03,1,11,0,1.09,3.0
Body Image,6.24e-45,11.8,992,20,5,20.4,4.0
Spine,1.58e-08,0.1,6,6,0,12.0,4.0
Ultraviolet Rays,2.87e-45,0.12,9,102,1,9.79,4.0
Atherosclerosis/etiology,1.29e-44,7.44,111,166,8,185.22,5.0
Health Planning,1.75e-16,0.22,6,82,0,6.44,2.0
Body Weight,6.7e-21,9.6,1936,163,108,176.72,3.0
Evaluation Studies as Topic,8.28e-13,0.1,3,22,0,3.41,2.0
"Blood Pressure Monitoring, Ambulatory",1.64e-25,5.86,89,130,9,149.93,5.0
Antioxidants/pharmacology,1.78e-23,0.37,35,273,1,39.49,4.0
Exercise/physiology,1.23e-07,5.87,1765,488,81,622.93,2.0
Cachexia/diagnosis,1.84e-07,16.78,7,9,5,12.44,7.0
Self-Assessment,2.67e-06,1.59,59,50,5,92.37,5.0
Perception,2.78e-08,1.06,105,63,3,100.8,3.0
Autoantigens/immunology,5.78e-09,0.2,3,38,0,3.24,3.0
Immunoglobulin M/analysis,2.3e-07,0.07,2,5,0,2.8,8.0
Thorax,2.6e-07,0.13,4,10,1,5.6,3.0
Metabolic Syndrome X/therapy,1.87e-10,15.86,90,43,2,63.54,3.0
Body Constitution,2.51e-06,6.62,243,27,16,30.0,2.0
Skin Neoplasms/drug therapy,3.06e-10,1.48,4,450,1,4.04,3.0
Duodenum,6.46e-12,0.04,1,7,0,1.14,4.0
Mammaplasty/methods,1.08e-07,3.86,180,50,4,63.89,3.0
Visual Fields,2.73e-13,0.03,2,1,0,1.5,2.0
Calcium-Binding Proteins/metabolism,1.33e-07,0.31,5,58,1,5.43,4.0
"Diabetes Mellitus, Type 2/drug therapy",9.08e-121,6.51,1058,979,47,1884.9,3.0
Exercise Test/methods,5.59e-20,4.22,145,203,6,248.57,3.0
Poultry,7.25e-10,0.16,2,32,0,2.12,4.0
Robotics,2.71e-29,4.91,217,261,33,397.42,4.0
Pharmaceutical Preparations/metabolism,7.34e-15,0.07,4,11,0,5.45,1.0
Evoked Potentials/physiology,1.1e-13,0.07,5,7,0,8.57,3.0
Role,4.45e-09,0.12,7,9,0,12.44,4.0
Palliative Care,6.99e-15,1.66,9,911,5,9.09,3.0
Hospitals,8.97e-72,0.12,8,161,0,8.4,3.0
Antineoplastic Agents/pharmacology,1.12e-60,0.29,5,671,0,5.04,4.0
Fishes/anatomy & histology,1.24e-06,0.07,1,7,0,1.14,5.0
Sodium-Potassium-Exchanging ATPase/metabolism,1.24e-09,0.14,6,21,0,7.71,6.0
Mice/genetics,3.18e-07,0.09,2,9,0,2.44,9.0
Peritoneal Dialysis/adverse effects,7.4e-12,4.23,38,322,13,42.48,4.0
Cytokines/blood,7.44e-57,5.22,278,388,13,477.19,3.0
Students,1.1e-17,1.25,138,35,1,43.88,2.0
Acute Coronary Syndrome/blood,2.51e-11,6.79,22,191,7,24.53,4.0
Weight Gain,2.93e-09,24.35,1150,106,76,115.77,5.0
Physicians,1e-47,0.16,23,142,1,26.73,3.0
Brain Chemistry/physiology,3.18e-07,0.11,2,13,0,2.31,2.0
Reimbursement Mechanisms,3.41e-06,0.1,1,10,0,1.1,5.0
Delivery of Health Care,3.26e-17,0.34,8,183,1,8.35,2.0
Thyroid Neoplasms/epidemiology,6.19e-08,3.2,27,78,0,36.35,3.0
Obesity Hypoventilation Syndrome/therapy,6.96e-07,16.12,8,10,3,14.4,5.0
Professional-Family Relations,2.47e-07,0.36,7,73,0,7.67,4.0
Income,2.9e-08,1.99,76,207,4,103.9,3.0
"Behavior, Animal",2.21e-28,0.26,6,168,0,6.21,3.0
Renal Dialysis/statistics & numerical data,3.7e-26,10.3,27,217,18,30.36,3.0
Growth Substances/pharmacology,1.1e-08,0.06,2,6,0,2.67,4.0
Propranolol/pharmacology,6.05e-07,0.15,7,13,0,10.77,4.0
Obesity/blood,1.12e-11,27.98,1751,18,44,18.19,4.0
Surgical Wound Infection/epidemiology,7.42e-67,7.07,112,216,20,170.07,4.0
Hyperglycemia/prevention & control,8.25e-32,6.69,55,126,2,79.01,4.0
Cardiovascular Diseases/enzymology,3.99e-07,5.55,10,27,3,13.7,1.0
Osteopontin/blood,1e-10,7.51,19,33,0,29.94,4.0
Matrix Metalloproteinase 9/blood,1.31e-12,4.74,33,64,2,50.02,8.0
Light,1.61e-57,0.08,14,61,1,17.21,3.0
Capillary Permeability,1.86e-09,0.12,1,22,0,1.05,3.0
Long-Term Potentiation/physiology,4.52e-06,0.06,2,2,0,4.0,5.0
Hippocampus/physiopathology,3.31e-07,0.14,2,18,0,2.22,5.0
Heart Valve Prosthesis/adverse effects,1.61e-06,1.57,2,318,2,2.01,3.0
Lymphocytes/physiology,1.19e-06,0.17,2,22,0,2.18,5.0
Membrane Proteins/metabolism,3.75e-59,0.22,16,291,0,16.88,3.0
Weight Loss,6.74e-32,24.87,2116,194,211,211.79,5.0
Vitamin D/analogs & derivatives,6.27e-42,11.19,454,247,28,381.38,4.0
Frontal Lobe/physiology,5.4e-10,0.04,2,3,0,3.33,8.0
"Receptors, Cell Surface/blood",3.52e-26,7.52,41,93,2,59.08,4.0
"Antibodies, Monoclonal",5.3e-25,0.07,2,32,0,2.12,7.0
Feces,2.83e-09,0.17,1,31,1,1.03,2.0
Creatinine/blood,1.96e-53,5.23,104,349,22,134.99,5.0
Hospitalization,4.92e-06,2.1,116,1130,41,127.91,3.0
Antineoplastic Combined Chemotherapy Protocols/therapeutic use,6.1e-67,3.96,52,11681,36,52.23,4.0
"Cell Transformation, Neoplastic",1.27e-28,0.17,1,97,0,1.01,4.0
Staphylococcal Infections/microbiology,1.78e-11,1.16,3,342,0,3.03,4.0
T-Lymphocyte Subsets/immunology,1.06e-09,0.39,7,163,2,7.3,7.0
Plastics,4.48e-14,0.08,2,17,0,2.24,3.0
Anoxia/epidemiology,4.68e-06,7.14,7,19,2,9.58,4.0
Myocardial Infarction/blood,1.13e-21,3.58,95,624,16,109.46,4.0
Adrenomedullin/blood,1.28e-10,11.32,12,58,3,14.48,4.0
Proteins/chemistry,1.46e-72,0.01,4,5,0,7.2,2.0
Weight Loss/physiology,2.67e-07,25.13,776,74,48,81.06,5.0
Conservation of Natural Resources,2.59e-06,0.38,2,205,1,2.02,2.0
"Image Processing, Computer-Assisted",5.5e-10,0.3,32,83,0,44.34,3.0
Hygiene,2.19e-14,0.12,2,32,0,2.12,2.0
Eating Disorders/psychology,8.89e-12,11.93,338,10,4,10.3,1.0
Cell Culture Techniques/methods,4.61e-21,0.06,1,25,0,1.04,3.0
Sodium/metabolism,7.6e-34,0.11,12,53,2,14.72,4.0
Colectomy/methods,2.16e-87,8.69,101,572,56,118.83,3.0
Phenotype,4.08e-07,1.23,118,207,11,185.27,2.0
Congresses as Topic,2.3e-12,0.23,3,63,0,3.14,3.0
Acquired Immunodeficiency Syndrome,3.6e-13,0.07,2,14,0,2.29,3.0
Patient Compliance/statistics & numerical data,3.69e-22,3.64,93,185,5,139.75,4.0
Probability,1.65e-10,0.23,1,51,0,1.02,2.0
Ovulation Induction,2.82e-12,1.87,46,4,0,4.35,4.0
Insecticides/analysis,6.05e-10,0.21,1,44,0,1.02,4.0
"Students, Nursing/psychology",3.79e-12,0.09,6,10,0,9.6,4.0
Organic Chemicals/chemistry,5.54e-08,0.03,1,2,0,1.5,1.0
Lung Neoplasms/metabolism,1.4e-07,2.22,11,760,1,11.16,3.0
Cyclic AMP-Dependent Protein Kinases/metabolism,2.94e-10,0.07,1,12,0,1.08,5.0
Esophagus,3.65e-17,0.12,1,42,0,1.02,4.0
Diabetic Angiopathies/physiopathology,1.04e-19,4.58,46,99,5,67.37,3.0
Eye Diseases/etiology,4.14e-08,0.18,1,31,0,1.03,1.0
Cognitive Therapy/methods,2.18e-13,1.28,103,39,1,53.77,4.0
Lactic Acid/chemistry,1.09e-07,0.08,1,10,0,1.1,5.0
Vision Disorders/diagnosis,1.19e-06,0.1,1,12,0,1.08,2.0
Enteral Nutrition/methods,3.86e-14,3.76,51,279,7,60.32,3.0
Gastroscopy/methods,6.32e-11,3.36,34,98,2,45.8,5.0
Naval Medicine,4.37e-07,0.16,7,15,0,10.27,3.0
Acute Disease,4.9e-17,0.05,1,13,0,1.08,4.0
Malnutrition/drug therapy,4.46e-09,16.09,12,16,1,21.0,3.0
"Image Interpretation, Computer-Assisted/methods",3.35e-10,0.34,69,101,2,116.14,3.0
Complementary Therapies,8.35e-07,0.21,6,27,0,7.33,2.0
"Arthroplasty, Replacement, Knee/adverse effects",2.56e-17,4.15,85,140,10,136.61,4.0
Coronary Disease/rehabilitation,2.62e-15,4.23,40,86,6,58.6,4.0
Lung Neoplasms/epidemiology,3.24e-08,3.65,47,423,6,52.22,3.0
Nursing Homes/statistics & numerical data,1.18e-06,3.89,17,150,10,18.93,4.0
Neurons/enzymology,2.06e-10,0.09,1,17,0,1.06,2.0
Atherosclerosis/physiopathology,2.03e-17,5.43,67,99,2,112.34,5.0
Knee Joint/surgery,2.41e-13,1.35,95,45,4,66.32,4.0
"Tomography, Emission-Computed",1.34e-14,0.21,5,65,1,5.38,5.0
Nicotine/pharmacology,4.15e-13,0.12,3,27,0,3.33,4.0
Kidney/blood supply,3.77e-07,0.51,19,152,1,21.38,3.0
Radioisotopes,1.65e-30,0.01,1,4,0,1.25,3.0
Antineoplastic Agents/administration & dosage,6.6e-15,1.73,26,1306,4,26.52,4.0
Thoracic Surgery,5.69e-12,0.31,4,92,3,4.17,4.0
Survivors/statistics & numerical data,1.22e-30,10.29,48,500,16,52.61,2.0
"Delivery, Obstetric/statistics & numerical data",1.02e-14,7.0,29,172,4,33.89,3.0
Biliopancreatic Diversion/methods,3.67e-20,35.92,53,15,25,19.25,3.0
Tissue Donors/statistics & numerical data,5.26e-10,7.91,16,341,15,16.75,2.0
Residence Characteristics,1.73e-16,3.56,247,321,8,437.06,3.0
Sympathectomy,7.51e-07,0.12,3,11,0,3.82,5.0
Carbon Dioxide,1.84e-09,0.11,4,14,0,5.14,3.0
Heart Transplantation/physiology,1.96e-06,2.69,25,116,7,30.39,4.0
State Medicine/organization & administration,7.74e-25,0.13,1,66,0,1.02,2.0
Hemolysis,1.67e-14,0.18,2,56,0,2.07,3.0
Respiratory Mechanics/physiology,4e-07,1.31,56,44,2,78.57,5.0
Cell Differentiation/physiology,3.58e-24,0.1,4,42,0,4.38,3.0
Bone Density/physiology,4.49e-18,10.15,725,46,11,48.92,3.0
Blood,9.28e-59,0.02,1,20,0,1.05,2.0
Neutrophils/enzymology,3.4e-09,0.09,1,14,0,1.07,3.0
Anoxia/metabolism,1.03e-07,0.28,10,52,0,11.92,4.0
Lung/metabolism,4.41e-18,0.34,11,201,0,11.6,2.0
Data Collection,1.24e-11,0.26,14,69,1,16.84,2.0
"Fatty Acids, Nonesterified/metabolism",6.85e-07,1.4,37,5,0,5.68,3.0
Intestinal Absorption,2.42e-11,0.15,19,9,0,13.26,4.0
Aorta/physiopathology,5.4e-14,4.37,51,91,10,79.58,4.0
"Medical Staff, Hospital",3.47e-06,0.35,6,59,1,6.61,4.0
Health Transition,5.12e-18,8.78,25,90,4,31.94,3.0
Central Nervous System/drug effects,1.07e-07,0.17,3,24,0,3.38,2.0
Cross Infection/epidemiology,1.97e-06,2.6,16,1034,3,16.25,3.0
Organizational Policy,4e-06,0.32,4,48,0,4.33,4.0
"Anesthesia, General",2.36e-06,0.43,39,125,2,51.17,3.0
Rehabilitation,6.73e-18,0.06,3,12,0,3.75,2.0
"Kidney Failure, Chronic/therapy",1.85e-97,4.89,231,2474,156,252.57,6.0
Accidental Falls/statistics & numerical data,1.89e-21,3.86,62,202,5,81.03,4.0
Women's Health/statistics & numerical data,2.28e-07,7.65,9,25,2,12.24,3.0
Autoimmune Diseases/immunology,4.2e-17,0.2,5,72,2,5.35,2.0
"Databases, Genetic",7.07e-11,0.16,3,33,0,3.27,5.0
Erythrocytes,4.93e-28,0.08,4,35,1,4.46,3.0
Gene Expression,1.13e-15,0.49,46,336,1,52.3,3.0
Phosphates/metabolism,2.11e-14,0.23,5,75,0,5.33,5.0
Acromegaly/complications,6.27e-07,3.38,20,49,8,28.16,4.0
Food Analysis,1.32e-07,0.1,5,5,0,10.0,2.0
Pancreatectomy/adverse effects,2.5e-14,9.63,13,119,12,14.42,3.0
Hysterectomy/statistics & numerical data,2.84e-10,6.6,15,44,3,20.11,4.0
Frail Elderly,1.81e-28,4.34,73,374,20,87.25,5.0
Adenoidectomy,1.67e-09,1.93,35,6,0,7.03,3.0
Mitochondria/drug effects,2.19e-10,0.3,3,79,0,3.11,4.0
Parathyroid Hormone/pharmacology,1.26e-06,0.04,1,2,0,1.5,4.0
Hemodynamics/physiology,3.81e-06,1.58,86,284,6,112.04,3.0
Lung Neoplasms/therapy,6.04e-13,2.9,2,1019,2,2.0,3.0
Glutathione/metabolism,1.71e-13,0.17,7,46,0,8.07,4.0
Reaction Time/physiology,1.61e-08,0.14,11,5,0,7.27,3.0
Blood Glucose/metabolism,5.62e-10,6.96,1567,651,48,921.45,5.0
Proto-Oncogene Proteins/metabolism,8.37e-11,0.38,9,191,0,9.42,5.0
Writing,2.81e-18,0.03,1,7,0,1.14,5.0
Malnutrition/epidemiology,8.91e-70,22.11,247,140,42,219.35,3.0
Membrane Proteins,9.23e-13,0.18,8,43,0,9.49,3.0
Famous Persons,9.09e-19,0.25,2,106,0,2.04,2.0
Genetic Counseling,8.55e-07,0.17,2,23,0,2.17,4.0
Anticoagulants/administration & dosage,6.54e-07,2.77,66,563,9,73.74,5.0
Brain/blood supply,3.65e-17,0.33,15,155,0,16.45,3.0
p38 Mitogen-Activated Protein Kinases/metabolism,4.58e-08,0.24,1,41,0,1.02,5.0
Hyperlipidemias/genetics,7.72e-08,2.57,35,4,0,4.46,5.0
"Diabetes Mellitus, Type 1/metabolism",1.61e-07,2.91,99,32,3,42.34,3.0
"Mammary Glands, Animal/metabolism",1.15e-07,0.1,1,14,0,1.07,2.0
Lung Neoplasms/radiotherapy,1.3e-10,2.55,4,766,0,4.02,3.0
Neutrophils/metabolism,5.13e-14,0.32,4,112,4,4.14,3.0
Signal Transduction/physiology,4.46e-73,0.2,17,307,1,17.94,3.0
Child Nutritional Physiological Phenomena,2.26e-10,3.7,169,40,3,49.47,4.0
Hyperuricemia/complications,3.44e-14,9.87,19,33,3,29.94,3.0
Water/chemistry,8.21e-52,0.05,4,47,0,4.34,4.0
"Antigens, Bacterial",6.28e-08,0.1,2,13,0,2.31,3.0
Interleukin-10/blood,5.6e-09,4.06,26,100,1,32.76,5.0
Stem Cell Transplantation/methods,1.97e-06,2.03,3,375,0,3.02,4.0
Testosterone/blood,1.96e-12,4.76,427,92,19,111.82,6.0
Aerospace Medicine,1.69e-10,0.2,12,35,1,16.11,3.0
Cerebral Cortex/physiopathology,7.64e-08,0.17,10,16,0,16.25,7.0
Biosensing Techniques/instrumentation,7.26e-13,0.08,2,18,0,2.22,3.0
Protein-Energy Malnutrition/etiology,4.83e-20,9.81,22,42,11,33.52,6.0
Wound Healing/drug effects,3.32e-07,0.32,14,65,1,17.02,4.0
Lipoproteins/blood,6.59e-42,1.91,232,76,12,100.9,2.0
Drosophila Proteins/genetics,2.74e-08,0.14,1,23,0,1.04,5.0
Stents,1.51e-17,2.87,58,4048,19,58.83,3.0
Microcomputers,1.22e-15,0.03,1,7,0,1.14,5.0
Myocardial Infarction,3.63e-11,0.12,1,26,0,1.04,4.0
Education,1.88e-07,0.18,9,19,1,13.26,1.0
"Antiretroviral Therapy, Highly Active",3.35e-13,4.28,54,699,25,58.17,4.0
"Diabetes Mellitus, Type 2/surgery",1.57e-22,22.68,158,49,30,64.2,3.0
"Water Pollutants, Chemical/chemistry",3.12e-16,0.05,1,14,0,1.07,5.0
Fibroblasts/drug effects,3.78e-11,0.11,3,22,0,3.41,3.0
"Hemoglobin A, Glycosylated/analysis",8.95e-07,5.69,202,133,14,220.57,3.0
Quality of Life,2.34e-266,3.15,1211,2724,119,1749.37,2.0
Colorectal Surgery/methods,4.07e-11,7.91,12,61,7,14.36,4.0
Oxygen/chemistry,1.16e-12,0.06,3,8,0,4.12,3.0
Skin Neoplasms/pathology,3.93e-42,1.16,13,1374,3,13.12,3.0
Urinary Tract Infections/drug therapy,3.85e-10,0.24,3,55,0,3.16,3.0
Mercury/analysis,1.87e-08,0.1,4,9,0,5.78,4.0
Morals,2.52e-11,0.1,3,17,0,3.53,3.0
"Muscle, Skeletal/anatomy & histology",7.97e-09,4.76,112,7,9,7.44,3.0
Reactive Oxygen Species/metabolism,8.34e-23,0.29,10,158,1,10.63,3.0
Radiation Effects,6.1e-55,0.01,1,7,0,1.14,3.0
Pancreatic Fistula/epidemiology,2.9e-08,21.02,6,24,2,7.5,3.0
Arginine/analogs & derivatives,7e-10,2.47,74,172,9,105.84,4.0
Environmental Exposure/adverse effects,7.19e-12,2.62,95,589,9,110.32,4.0
Lung Neoplasms/diagnosis,4.04e-17,1.8,6,1007,5,6.04,3.0
Intraocular Pressure/physiology,6.35e-10,1.51,49,4,0,4.33,2.0
Repressor Proteins/metabolism,3.92e-25,0.22,1,120,0,1.01,4.0
Government Regulation,6.51e-18,0.17,3,62,0,3.15,3.0
Orthopedics,4.87e-12,0.14,4,30,0,4.53,4.0
Sports/psychology,9.95e-07,1.74,26,4,0,4.62,4.0
Vitamin E/pharmacology,2.33e-07,0.24,4,39,0,4.41,4.0
Mediastinum,1.19e-06,0.08,1,9,0,1.11,5.0
Hip Fractures/epidemiology,2.33e-45,8.76,54,139,15,74.98,3.0
Sports/statistics & numerical data,2.79e-06,7.49,42,37,0,69.6,4.0
Proteinuria/epidemiology,7.72e-11,9.08,21,31,0,35.23,4.0
Myocardial Contraction/drug effects,2.92e-19,0.11,2,39,0,2.1,4.0
Bone and Bones/physiology,8.44e-10,1.25,71,13,0,15.38,3.0
Intellectual Disability/genetics,7.62e-09,0.17,5,28,0,5.89,3.0
"Obesity, Abdominal/complications",2.54e-07,43.32,116,11,14,12.04,5.0
Nomograms,3e-10,5.79,25,211,6,27.96,2.0
Ovarian Neoplasms/drug therapy,8.9e-08,2.06,13,882,6,13.19,3.0
Base Sequence,3.03e-07,0.08,1,10,0,1.1,3.0
African Americans/genetics,1.84e-14,6.82,71,78,4,135.63,4.0
"Education, Special",1.61e-07,0.05,2,1,0,1.5,3.0
Sleep Apnea Syndromes/epidemiology,1.69e-07,21.02,163,35,12,42.52,4.0
Television,2.36e-31,2.43,178,32,6,37.75,4.0
Hypertension,8.55e-15,0.15,17,12,3,20.47,3.0
Cerebral Cortex/drug effects,2.53e-13,0.05,1,12,0,1.08,7.0
Insulin/metabolism,2.38e-39,2.05,233,71,6,92.64,7.0
Radiation Tolerance,7.48e-07,0.28,1,50,0,1.02,3.0
Geriatrics,2.14e-37,0.17,5,128,5,5.2,3.0
Respiration,7.15e-14,0.3,88,86,4,170.05,4.0
Obesity/economics,1.87e-08,29.34,155,20,20,22.58,4.0
Blood Circulation,7.13e-22,0.05,1,18,0,1.06,4.0
Death,2e-07,0.76,5,374,7,5.07,3.0
Mitral Valve/surgery,6.06e-09,3.12,1,1021,7,1.0,4.0
Veterans/statistics & numerical data,1.99e-20,5.7,39,199,11,46.64,2.0
Language Development,5.44e-13,0.02,1,1,0,2.0,4.0
Brain/cytology,3.53e-11,0.08,2,13,0,2.31,3.0
Hormones/blood,1.09e-12,2.72,113,29,3,36.44,2.0
Uterine Cervical Neoplasms/pathology,1.42e-10,1.02,7,390,4,7.13,6.0
"Faculty, Medical",2.36e-07,0.07,1,5,1,1.2,3.0
Diabetes Complications/diagnosis,1.1e-07,5.07,17,55,0,22.25,3.0
Brain Ischemia/metabolism,1.1e-07,0.28,3,50,0,3.18,4.0
"Neoplasm Recurrence, Local/etiology",7.87e-08,5.59,14,178,11,15.1,3.0
Multiple Sclerosis/diagnosis,2.93e-06,0.14,3,15,0,3.6,4.0
Hypertension/drug therapy,1.14e-37,1.91,419,1753,41,519.15,3.0
Magnetic Resonance Imaging,7.32e-15,0.53,202,680,3,262.01,5.0
Myocardial Infarction/drug therapy,1.33e-17,2.24,14,1568,5,14.12,4.0
Anti-Inflammatory Agents/pharmacology,4.95e-17,0.33,10,149,0,10.67,4.0
Dental Implants,1.5e-21,0.08,3,30,0,3.3,3.0
"Muscle, Smooth/physiology",5.45e-15,0.03,2,4,0,3.0,3.0
"Hernia, Ventral/surgery",5.47e-12,5.83,142,118,23,216.06,5.0
Neoplasms,9.09e-168,0.03,14,46,0,18.26,1.0
Insulin/secretion,2.01e-82,2.04,296,23,4,24.79,7.0
Gastric Bypass/methods,7.66e-94,33.26,408,109,121,138.12,3.0
Bacterial Physiological Phenomena,1.2e-09,0.15,1,28,0,1.04,2.0
Signal Transduction,3e-70,0.25,25,402,2,26.55,3.0
Evidence-Based Medicine,3.1e-06,1.1,34,622,13,35.86,3.0
Mental Disorders/nursing,9.07e-07,0.12,1,16,0,1.06,1.0
Stomach Neoplasms/genetics,1.55e-08,1.72,6,486,0,6.07,4.0
Postoperative Complications/surgery,1.74e-07,1.95,74,467,29,85.73,3.0
Clinical Competence/standards,1.07e-10,0.39,11,152,0,11.8,3.0
Brain Ischemia/drug therapy,2.55e-11,1.56,1,395,0,1.0,4.0
Physician's Role,1.59e-11,0.47,26,267,1,28.53,6.0
Obstetrics,4.52e-18,0.18,3,69,0,3.13,4.0
Colorectal Neoplasms/epidemiology,1e-91,7.5,138,287,13,204.36,5.0
Schizophrenia/therapy,6.52e-07,0.2,8,23,1,10.78,3.0
Th2 Cells/immunology,2.53e-06,0.33,2,73,0,2.05,9.0
Histamine H1 Antagonists/therapeutic use,8.96e-07,0.06,1,6,0,1.17,7.0
Radiotherapy/methods,1.22e-06,0.98,1,150,0,1.01,2.0
Adiposity,1.28e-09,40.27,842,30,70,31.07,4.0
Proteins/metabolism,2.89e-10,0.39,143,171,5,262.58,2.0
Sulfonamides,5.73e-09,0.09,2,12,0,2.33,3.0
Auditory Perception,2.54e-17,0.01,1,1,0,2.0,4.0
Heart/drug effects,1.81e-25,0.32,26,225,0,29.0,2.0
Bacteria/metabolism,1.01e-31,0.04,4,17,0,4.94,1.0
Postoperative Complications/epidemiology,2.45e-266,8.0,376,2063,144,444.53,3.0
Cardia/pathology,4.51e-07,5.45,13,29,0,18.83,5.0
Dietary Fats/metabolism,2.75e-21,2.0,77,10,1,11.3,3.0
Microfluidic Analytical Techniques/instrumentation,5.9e-08,0.07,1,9,0,1.11,3.0
Blood Pressure Determination,6.15e-07,0.26,24,30,1,43.2,4.0
Vitamin B Complex/administration & dosage,1.85e-08,4.07,18,44,3,25.36,7.0
Nitric Oxide Synthase/metabolism,2.81e-07,0.37,9,79,0,10.03,6.0
Cesarean Section/adverse effects,7.7e-09,2.83,62,125,3,92.75,4.0
Tetrazoles/therapeutic use,2.7e-17,4.57,54,342,8,62.53,4.0
Ubiquitin/metabolism,6.81e-09,0.12,1,21,0,1.05,4.0
Arterial Occlusive Diseases/surgery,3.49e-06,1.45,4,336,3,4.05,3.0
Cervical Vertebrae/injuries,6.31e-07,0.84,2,166,1,2.02,5.0
Fibroblasts/cytology,3.22e-12,0.06,1,12,0,1.08,3.0
Androgen Antagonists/therapeutic use,6.07e-12,4.43,46,424,10,50.99,3.0
Health Status Disparities,9.03e-89,6.57,189,1150,33,220.06,4.0
Aorta,2.56e-15,0.15,1,47,0,1.02,4.0
"Polymorphism, Genetic",9.46e-08,2.49,1134,966,23,1788.89,3.0
Renal Dialysis/adverse effects,9.28e-13,2.77,80,884,52,87.24,3.0
Animal Feed,6.94e-16,0.31,6,120,1,6.3,4.0
Membrane Lipids/metabolism,7.85e-07,0.09,3,5,0,4.8,2.0
Cesarean Section/methods,5.95e-09,3.23,27,72,2,37.12,4.0
Cytochrome P-450 Enzyme System/metabolism,1.2e-26,0.09,4,44,0,4.36,3.0
Substance-Related Disorders,2.29e-20,0.07,1,24,1,1.04,2.0
Contrast Media,8.11e-09,0.39,34,128,1,43.03,3.0
Diet,3.02e-40,3.55,1867,731,101,1017.21,4.0
Nurse's Role,7.37e-14,0.43,22,245,0,23.98,4.0
Genome,1.83e-16,0.09,4,24,0,4.67,3.0
Positive-Pressure Respiration/methods,3.28e-10,3.33,43,241,6,50.67,4.0
Exercise Test/statistics & numerical data,3.77e-12,10.15,14,62,4,17.16,3.0
Peptides/therapeutic use,2.33e-06,2.69,67,123,2,103.5,2.0
Gene Expression Regulation,3.26e-37,0.28,84,269,4,110.23,3.0
"Diabetes Mellitus, Type 1/surgery",3.42e-06,2.64,26,135,8,31.01,3.0
Prostatic Neoplasms/epidemiology,3.15e-88,7.95,118,255,22,172.6,4.0
"Insurance, Health",1.67e-11,0.29,8,84,2,8.76,5.0
Antineoplastic Agents/therapeutic use,3.21e-80,1.98,30,4923,11,30.18,4.0
Carbon/metabolism,3.3e-09,0.27,2,56,0,2.07,3.0
"Behavior, Animal/physiology",2.27e-19,0.27,13,127,2,14.33,3.0
"Nursing Service, Hospital/organization & administration",2.45e-09,0.03,1,3,0,1.33,4.0
Brain Neoplasms/therapy,1.45e-09,2.66,3,687,0,3.01,4.0
Recognition (Psychology)/physiology,2.06e-08,0.06,3,1,0,1.33,5.0
Central Nervous System/physiology,1.39e-10,0.05,3,2,0,3.33,2.0
Milk/chemistry,4.54e-09,0.18,8,28,0,10.29,3.0
Immunoglobulin G/analysis,7.54e-14,0.08,3,15,0,3.6,8.0
Hospital Departments,4e-06,0.22,3,28,0,3.32,4.0
"Pulmonary Disease, Chronic Obstructive/therapy",1.17e-15,5.12,40,447,21,43.58,4.0
Lipopolysaccharides/toxicity,1.8e-06,1.13,1,171,0,1.01,2.0
"Urinary Incontinence, Stress/surgery",4.38e-29,2.28,107,10,0,10.93,5.0
"Aortic Aneurysm, Thoracic/surgery",7.43e-08,5.64,2,1552,4,2.0,5.0
Pancreas/enzymology,1.48e-08,0.11,3,13,0,3.69,2.0
Dietary Fats/pharmacology,1.8e-13,1.47,81,34,0,48.27,3.0
"Chromatography, High Pressure Liquid",3.39e-06,0.07,1,6,0,1.17,5.0
Motor Activity/physiology,4.61e-19,4.69,787,191,30,237.35,3.0
Periodicals as Topic/standards,1.99e-08,0.04,1,4,0,1.25,5.0
Delayed Graft Function/etiology,1.3e-07,11.49,4,16,5,5.0,3.0
Adenocarcinoma/pathology,5.06e-20,1.69,24,1575,9,24.37,5.0
Job Description,1.51e-09,0.06,3,4,0,5.25,4.0
Pancreaticoduodenectomy,3.33e-06,6.81,11,326,14,11.37,3.0
Hemoglobins,4.17e-17,0.08,2,24,0,2.17,4.0
Malnutrition/diagnosis,6.67e-60,28.88,179,93,37,141.32,3.0
Cardiovascular Diseases/diagnosis,4.17e-86,5.42,152,491,42,199.05,1.0
Autonomic Nervous System/physiopathology,3.53e-08,2.69,85,164,19,129.05,3.0
Coronary Artery Disease/rehabilitation,1.11e-14,9.73,21,35,4,33.6,5.0
Hypoglycemic Agents/pharmacology,6.92e-12,1.44,109,104,3,203.23,4.0
Point Mutation,1.32e-08,0.44,29,155,0,34.43,4.0
"Lupus Erythematosus, Systemic/epidemiology",1.22e-08,4.31,21,75,2,26.88,3.0
Colectomy,2.85e-07,3.21,26,209,13,29.23,3.0
Heart Ventricles,5.04e-07,0.28,1,56,0,1.02,3.0
Breast Neoplasms/radiography,2.44e-13,2.42,92,413,7,112.49,3.0
Pregnancy in Diabetics/epidemiology,1.12e-11,10.7,23,29,4,41.24,3.0
Maternal Age,4.07e-06,2.07,44,173,5,55.19,3.0
Surgical Wound Dehiscence/etiology,7.63e-10,4.2,20,53,4,27.55,4.0
Food Contamination/analysis,2.69e-15,0.19,12,58,0,14.48,4.0
Coronary Vessels,4.71e-08,0.27,4,51,0,4.31,4.0
Erythrocytes/drug effects,5.91e-09,0.16,5,27,0,5.93,3.0
Asthma/physiopathology,1.31e-12,1.26,115,82,2,140.47,3.0
"Monitoring, Ambulatory/instrumentation",1.22e-09,2.86,77,17,0,20.75,4.0
"Diabetes Mellitus, Type 1/epidemiology",2.88e-08,7.1,147,95,4,156.39,3.0
Estradiol/pharmacology,9.31e-19,0.17,26,45,0,41.02,5.0
Membrane Potentials/physiology,2.41e-06,0.04,1,2,0,1.5,2.0
Iodine,5.99e-16,0.02,1,2,0,1.5,4.0
Macrophages/metabolism,1.36e-17,0.28,15,123,0,16.83,3.0
Preoperative Care/methods,2.02e-16,3.05,78,425,13,92.32,3.0
Educational Status,1.63e-17,3.29,196,300,15,324.05,3.0
"Metals, Heavy/analysis",1.16e-11,0.1,2,20,0,2.2,3.0
"Ventricular Dysfunction, Left/etiology",1.79e-23,4.66,56,193,6,72.25,4.0
Abdominal Cavity,1.49e-08,0.13,2,18,1,2.22,4.0
Gastroplasty/instrumentation,1.42e-06,24.29,47,7,15,8.04,3.0
Reaction Time,4.3e-08,0.15,10,10,0,20.0,3.0
State Medicine/economics,3.04e-07,0.19,1,28,0,1.04,2.0
Pancreatic Neoplasms/drug therapy,2.62e-10,3.08,2,788,0,2.01,3.0
Protein Kinase C/metabolism,5.93e-29,0.06,4,27,0,4.59,8.0
Osteoblasts/drug effects,5.86e-08,0.09,1,13,0,1.08,3.0
"Antibodies, Monoclonal/administration & dosage",2.77e-06,2.1,7,563,2,7.09,7.0
Fungi,1.77e-11,0.04,1,7,0,1.14,2.0
Alzheimer Disease/metabolism,6.21e-14,0.13,11,23,0,16.26,4.0
Health Status Indicators,4.81e-124,5.12,288,1222,45,355.88,5.0
Albuminuria/diagnosis,1.78e-08,4.34,17,66,5,21.38,5.0
Skin Diseases/drug therapy,3.65e-09,0.07,1,11,0,1.09,2.0
Erythrocytes/metabolism,1.12e-14,0.23,35,59,1,55.76,3.0
Tumor Suppressor Protein p53/metabolism,1.2e-06,0.67,1,387,1,1.0,4.0
Cystectomy/methods,1.7e-13,6.38,32,314,9,35.26,4.0
"Sexual Behavior, Animal",2.21e-06,0.33,5,54,0,5.46,5.0
Cell Respiration,3.08e-13,0.04,3,1,0,1.33,3.0
Coronary Disease/prevention & control,6.11e-17,2.86,84,541,27,97.04,4.0
Sound,9.19e-12,0.08,4,10,0,5.6,4.0
"Drug Resistance, Multiple, Bacterial",1.13e-08,1.68,2,368,0,2.01,4.0
Breast Neoplasms,9.23e-10,0.17,10,25,0,14.0,3.0
Autopsy,8.84e-07,1.12,1,255,5,1.0,2.0
Psychomotor Performance/physiology,1.35e-07,0.27,51,17,1,22.67,2.0
Magnetics,8.27e-21,0.09,3,32,0,3.28,3.0
Nurse Practitioners,1.22e-07,0.22,4,35,0,4.46,4.0
Cisplatin/administration & dosage,3.02e-07,2.62,1,437,0,1.0,3.0
"Muscle, Skeletal/ultrasonography",3.22e-06,2.41,20,1,0,1.05,3.0
Stomach Neoplasms/epidemiology,6.53e-16,4.08,44,149,3,56.99,4.0
Physical Education and Training,2.65e-13,1.3,90,11,0,12.34,3.0
Smoking Cessation,6.12e-11,2.34,64,228,5,81.96,5.0
"Mitochondria, Liver/metabolism",3.02e-16,0.03,1,8,0,1.12,5.0
Child Nutrition Disorders/epidemiology,1.52e-18,11.17,66,63,1,123.14,3.0
Thyroxine/blood,2.51e-06,1.15,60,31,0,47.02,4.0
"Dental Restoration, Permanent",3.91e-07,0.07,3,1,0,1.33,3.0
"Drug Resistance, Microbial",1.11e-27,0.15,1,86,0,1.01,2.0
Nerve Tissue Proteins/blood,1.7e-12,5.34,26,52,1,39.0,3.0
"Pulmonary Disease, Chronic Obstructive/physiopathology",2.92e-61,7.79,200,242,38,365.29,4.0
Testicular Neoplasms/pathology,6.01e-09,0.87,1,175,0,1.01,3.0
Multienzyme Complexes/metabolism,5.19e-11,0.11,3,19,0,3.47,3.0
Mental Recall/physiology,2.65e-06,0.13,7,5,0,8.57,5.0
"Genital Neoplasms, Female/surgery",2.79e-13,3.6,34,87,5,47.29,4.0
Trans-Activators/genetics,2.79e-08,0.37,8,85,0,8.75,4.0
Behavior Therapy,1.2e-34,1.81,145,25,4,29.31,3.0
Ovum,1.72e-06,0.08,1,8,0,1.12,2.0
Cholangiography,3.21e-06,0.13,2,13,0,2.31,4.0
Pancreatic Neoplasms/epidemiology,1.39e-29,11.98,74,79,10,143.32,3.0
Intestinal Mucosa/metabolism,1.61e-08,0.28,11,59,0,13.05,4.0
Publishing/standards,4.56e-07,0.06,1,6,0,1.17,2.0
"Hypertrophy, Left Ventricular/diagnosis",8.9e-22,8.74,60,71,14,110.7,4.0
Lasers,7.57e-27,0.08,6,27,1,7.33,3.0
"Drugs, Chinese Herbal/pharmacology",1.01e-11,0.3,14,93,0,16.11,2.0
"Nursing Staff, Hospital/education",1.5e-10,0.17,1,37,0,1.03,4.0
Skin Diseases/pathology,1.99e-10,0.24,2,55,0,2.07,2.0
Aged,1.89e-07,0.5,23,163,3,26.25,4.0
African Americans/ethnology,8.18e-12,7.41,42,50,3,77.28,4.0
DNA Transposable Elements/genetics,5.61e-08,0.06,1,7,0,1.14,4.0
Inflammation/complications,4.07e-43,5.62,104,192,8,160.33,3.0
Cognition/physiology,2.2e-06,0.87,156,93,4,148.44,3.0
Surgical Mesh,4.79e-07,2.54,105,192,12,162.42,3.0
Antigen-Presenting Cells/immunology,1.61e-07,0.14,1,20,0,1.05,2.0
Myocardial Ischemia/etiology,7.51e-10,3.8,26,162,11,30.17,3.0
Health Facilities,2.12e-12,0.13,1,32,0,1.03,2.0
Bone and Bones/metabolism,8.19e-37,1.78,203,81,3,113.32,3.0
Hypoglycemic Agents/adverse effects,1.52e-11,3.4,45,241,7,53.4,4.0
Stem Cells/cytology,7.39e-18,0.23,16,90,0,18.84,2.0
Lymphocytes/drug effects,1.28e-09,0.18,9,29,0,11.79,5.0
Coronary Vessels/drug effects,1.5e-06,0.21,3,29,0,3.31,4.0
"Antibodies, Monoclonal/immunology",7.89e-44,0.14,2,126,0,2.03,7.0
Visual Perception,9e-23,0.1,18,9,0,13.5,4.0
Vitamin D Deficiency/drug therapy,4.01e-06,4.35,30,45,0,50.0,6.0
HIV Infections/prevention & control,5.23e-25,0.3,5,254,1,5.1,3.0
Genetics,7.23e-13,0.04,2,3,0,3.33,4.0
Asthma/etiology,2.69e-18,1.63,107,56,1,85.31,3.0
Hypertension/prevention & control,1.54e-10,3.25,119,181,9,197.24,3.0
Heart Diseases/blood,3.18e-06,4.09,14,58,3,17.38,2.0
Artificial Intelligence,2.1e-21,0.16,9,64,0,10.27,3.0
B-Lymphocytes/immunology,1.33e-52,0.13,4,137,0,4.12,3.0
Adrenocorticotropic Hormone/pharmacology,4.22e-12,0.09,5,12,0,7.08,7.0
Interleukin-8/blood,1.36e-07,3.86,22,72,0,28.72,5.0
Oceanic Ancestry Group,1.56e-12,2.48,57,161,5,77.18,4.0
Stem Cell Transplantation,1.42e-07,2.33,10,745,0,10.13,4.0
"DNA, Complementary/genetics",4.84e-09,0.07,1,11,0,1.09,5.0
Fundoplication/methods,1.37e-10,3.23,35,84,2,49.58,3.0
Politics,3.13e-46,0.17,7,162,1,7.3,2.0
Vascular Calcification/epidemiology,2.08e-09,15.48,17,19,1,32.21,5.0
Schizophrenia/blood,3.36e-14,3.24,74,5,0,5.34,3.0
Adipocytes/physiology,3.83e-06,1.94,25,6,0,7.44,3.0
Liver/enzymology,8.39e-15,0.29,112,54,5,80.04,2.0
Knee Joint/physiopathology,2.49e-28,2.96,115,4,0,4.14,4.0
Bone and Bones,3.35e-17,0.07,6,8,0,10.5,3.0
Radiometry,1.97e-15,0.04,1,6,1,1.17,2.0
"Pulmonary Disease, Chronic Obstructive/rehabilitation",4.44e-06,5.01,50,53,7,97.17,4.0
Nerve Tissue Proteins,2.69e-14,0.08,3,15,0,3.6,3.0
Sepsis/drug therapy,5.91e-08,5.28,2,1081,0,2.0,3.0
Homocysteine/blood,6.8e-16,5.61,299,236,14,422.27,4.0
"Polymorphism, Single Nucleotide",3.97e-16,3.97,1055,900,21,1667.77,4.0
"Hypertrophy, Left Ventricular/complications",5.39e-24,9.71,44,63,10,74.73,4.0
Macrophages/immunology,2.93e-31,0.26,6,183,0,6.2,3.0
"Renal Insufficiency, Chronic/epidemiology",2.6e-44,8.63,58,142,10,81.69,5.0
Nerve Tissue Proteins/biosynthesis,3.4e-09,0.15,1,28,0,1.04,3.0
"Ventricular Dysfunction, Left/ultrasonography",6.89e-28,3.69,78,200,6,108.42,4.0
"Carcinoma, Hepatocellular/metabolism",5.92e-10,1.16,5,342,0,5.07,4.0
NAD/metabolism,1.93e-08,0.05,1,6,0,1.17,3.0
DNA-Binding Proteins/physiology,4.3e-23,0.13,1,61,0,1.02,3.0
"Kidney Tubules, Proximal/metabolism",6.63e-07,0.1,2,10,0,2.4,6.0
Hyperglycemia/diagnosis,8.93e-19,7.36,30,57,3,45.79,4.0
Puberty,1.06e-26,2.62,103,5,1,5.24,3.0
Liver Neoplasms/diagnosis,6.86e-16,1.06,4,433,0,4.04,3.0
"Spectrum Analysis, Raman/methods",1.58e-07,0.12,3,14,0,3.64,4.0
Visual Perception/physiology,8.16e-29,0.09,19,6,1,7.89,4.0
Risk Factors,6.33e-09,3.51,20,66,7,26.06,5.0
Social Work,1.28e-11,0.05,1,10,0,1.1,3.0
Carbon Dioxide/chemistry,4.67e-06,0.08,1,7,0,1.14,3.0
Hypoglycemic Agents/therapeutic use,3.2e-154,6.85,899,946,46,1753.34,4.0
"Denture, Partial, Removable",1.37e-08,0.03,1,1,0,2.0,6.0
"Ultrasonography, Prenatal/methods",4.81e-06,2.12,48,192,1,60.0,5.0
Bone Marrow Cells/cytology,2.62e-08,0.27,4,53,0,4.3,2.0
Smoking,2.01e-07,1.03,117,104,10,196.44,4.0
Rectal Neoplasms/surgery,2.27e-21,4.18,90,1293,53,96.26,6.0
Inflammation/blood,1.19e-44,10.78,301,207,23,349.36,3.0
Migraine Disorders/epidemiology,1.01e-07,3.44,46,4,0,4.35,6.0
Mesenchymal Stromal Cells/cytology,6.84e-16,0.19,4,65,0,4.25,4.0
Mass Screening,7.68e-15,2.11,175,943,14,207.48,3.0
Colorectal Neoplasms/surgery,7.24e-18,6.85,58,1269,31,60.65,5.0
Pregnancy Complications/epidemiology,2.31e-120,7.83,287,425,32,480.81,2.0
Cytoskeletal Proteins/metabolism,1.1e-06,0.34,3,77,0,3.12,3.0
Halothane/pharmacology,3.18e-07,0.05,1,5,0,1.2,4.0
Anesthesia,2.8e-57,0.15,18,162,2,20.0,2.0
Research/standards,6.01e-07,0.15,1,20,0,1.05,3.0
Colonic Diseases/surgery,1.74e-24,4.81,38,289,35,43.0,4.0
Career Mobility,4.88e-10,0.06,4,2,0,3.0,4.0
Pirenzepine/analogs & derivatives,1.02e-07,1.83,31,8,0,10.06,6.0
Leadership,1.03e-39,0.09,9,56,0,10.45,3.0
Lithium/pharmacology,4.28e-07,0.05,1,4,0,1.25,4.0
Testis/metabolism,9.37e-14,0.06,2,12,0,2.33,4.0
Crohn Disease/surgery,1.71e-08,2.63,28,87,9,37.01,5.0
Coronary Artery Disease/genetics,1.26e-18,5.61,108,129,8,198.42,5.0
Bone Marrow Transplantation,2.18e-10,0.71,7,573,2,7.09,4.0
Thinking,1.28e-09,0.13,9,11,0,16.36,3.0
Blood Chemical Analysis,5.38e-09,0.14,12,4,1,5.33,4.0
Osteogenesis,3.3e-12,0.04,1,6,0,1.17,6.0
"Renal Insufficiency, Chronic/etiology",1.15e-16,9.27,20,53,4,27.55,5.0
Chronic Disease/prevention & control,1.99e-07,3.86,24,108,1,29.33,4.0
Skin,3.09e-16,0.12,15,11,0,19.07,2.0
Testis,1.08e-07,0.03,1,1,0,2.0,4.0
Patient Education as Topic,2.13e-14,1.27,194,288,15,324.68,4.0
Cell Communication/physiology,1.01e-08,0.08,1,11,0,1.09,3.0
"Diabetes Mellitus, Experimental/metabolism",3.06e-16,0.16,3,52,0,3.17,3.0
Thinness/complications,6.33e-20,55.36,64,3,33,3.14,4.0
Continuous Positive Airway Pressure,2.23e-30,10.49,129,116,6,220.31,5.0
Heart Failure/blood,5.79e-37,6.74,66,644,35,72.76,3.0
Physical Education and Training/methods,1.87e-14,3.63,90,5,2,5.28,3.0
Internal Medicine/education,3.2e-07,0.18,1,27,0,1.04,3.0
Biotechnology/methods,5.88e-18,0.03,1,8,0,1.12,3.0
"Evoked Potentials, Auditory",5.06e-09,0.02,1,1,0,2.0,4.0
Insulin/administration & dosage,2.45e-06,3.11,214,258,9,391.5,7.0
"Adaptation, Psychological",3.86e-13,0.43,108,288,6,148.5,2.0
Pharmacology,3.13e-74,0.01,1,4,0,1.25,2.0
"Signal Processing, Computer-Assisted",7.7e-14,0.25,25,75,2,33.33,3.0
Proteins,5.03e-30,0.04,3,17,0,3.53,2.0
Asian Continental Ancestry Group/ethnology,1.83e-10,9.32,65,46,11,78.55,4.0
Ethnic Groups,5.91e-21,1.51,244,239,12,473.1,3.0
Hemodynamics,2.4e-15,0.48,52,341,5,59.93,3.0
Cell Physiological Phenomena,1.57e-07,0.04,1,3,0,1.33,1.0
Skin Transplantation,5.64e-33,0.06,2,38,0,2.11,4.0
Career Choice,2.65e-24,0.05,3,15,0,3.6,6.0
Mandible/surgery,8.28e-07,0.26,13,39,0,17.33,3.0
Tibial Fractures/surgery,4.8e-06,0.22,7,21,2,9.33,3.0
Melanoma/pathology,2.7e-19,1.37,7,802,3,7.06,4.0
Mycobacterium tuberculosis,2.15e-08,0.18,1,29,1,1.03,7.0
Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics,4.12e-08,1.49,1,279,0,1.0,5.0
Digestive System Surgical Procedures/methods,2.19e-09,4.68,30,452,19,31.99,2.0
Globins/genetics,3.63e-11,0.04,1,6,0,1.17,4.0
Trans-Activators/metabolism,1.55e-26,0.21,1,117,1,1.01,4.0
Skin Tests,1.82e-13,0.02,1,2,0,1.5,4.0
Islets of Langerhans/physiopathology,9.89e-07,2.76,32,3,1,3.28,3.0
Anticholesteremic Agents/therapeutic use,6.63e-17,2.98,86,407,6,104.17,6.0
Managed Care Programs,2.51e-06,0.19,1,25,0,1.04,4.0
Arteries,4e-19,0.05,2,15,0,2.27,3.0
Alzheimer Disease/drug therapy,1.12e-06,0.4,13,87,0,14.94,4.0
Dopamine/physiology,2.73e-13,0.07,6,4,0,6.67,4.0
State Medicine,6.44e-10,0.16,6,27,0,7.33,2.0
"Cardiac Pacing, Artificial",2.79e-06,1.04,4,222,2,4.07,3.0
Peritoneal Dialysis/methods,7.81e-07,4.24,15,152,11,16.48,4.0
Proteins/isolation & purification,2.18e-10,0.02,1,1,0,2.0,2.0
Asthma/drug therapy,1.9e-06,0.63,77,370,1,93.02,3.0
Myocardial Infarction/etiology,1.45e-12,3.12,64,588,28,70.97,4.0
Renal Insufficiency/blood,1.91e-07,5.81,11,48,4,13.52,4.0
Trans-Activators,1.06e-12,0.18,1,47,0,1.02,4.0
Arteriosclerosis,1.3e-11,0.02,1,1,0,2.0,4.0
Visual Acuity,2.77e-08,0.13,4,14,1,5.14,2.0
Operating Rooms,5.69e-07,0.21,3,30,0,3.3,4.0
Transforming Growth Factor beta/metabolism,7.65e-08,0.38,7,92,0,7.53,4.0
Diabetes Complications/surgery,4.82e-07,10.97,9,46,1,10.76,3.0
Clinical Enzyme Tests,9.78e-08,0.13,7,8,0,13.12,4.0
Marriage,1.66e-07,0.21,10,27,1,13.7,5.0
Food Handling/methods,1.34e-10,0.14,4,27,0,4.59,4.0
Radiation Protection,7.79e-15,0.06,2,14,0,2.29,4.0
Neuroglia/metabolism,2.4e-09,0.07,1,10,0,1.1,2.0
Gastric Mucosa/drug effects,8.75e-12,0.06,1,12,0,1.08,4.0
Learning,5.03e-30,0.1,16,29,2,24.83,3.0
Progesterone/pharmacology,2.32e-18,0.05,2,15,0,2.27,5.0
Bone Transplantation,3.5e-16,0.09,5,18,0,6.39,3.0
Glomerular Filtration Rate/physiology,1.08e-60,7.59,91,180,13,137.01,3.0
Energy Intake,2.81e-06,9.93,919,111,29,124.41,5.0
DNA Replication,3.89e-33,0.03,2,11,0,2.36,3.0
Critical Care,5.9e-12,1.8,11,975,8,11.12,3.0
Academies and Institutes,1.88e-10,0.08,1,12,1,1.08,3.0
Physician-Patient Relations,1.37e-25,0.3,55,213,3,69.2,4.0
Tissue Engineering,1.2e-07,0.15,2,21,0,2.19,5.0
Viral Proteins/genetics,8.23e-15,0.26,2,101,0,2.04,3.0
"Air Pollutants, Occupational/analysis",1.1e-08,0.15,3,24,0,3.38,5.0
Water/analysis,1.58e-06,0.14,4,14,0,5.14,4.0
Liver Neoplasms/therapy,6.22e-10,3.87,6,1545,5,6.02,3.0
Hydrogen/metabolism,7.91e-08,0.04,1,3,0,1.33,3.0
Cholecystectomy/methods,8.03e-08,3.7,26,120,2,31.63,4.0
Neoplasm Proteins/metabolism,6.74e-21,0.84,2,456,0,2.01,3.0
Disease Outbreaks,3.23e-28,1.08,37,1261,2,38.09,3.0
"Echocardiography, Transesophageal",1.02e-06,0.86,4,174,0,4.09,6.0
Diabetes Complications,5.61e-08,1.56,112,444,24,140.25,3.0
"Dominance, Cerebral/physiology",1.91e-10,0.05,2,6,0,2.67,3.0
Nerve Growth Factors/blood,2.31e-09,4.39,24,49,1,35.76,3.0
Blood Transfusion/adverse effects,1.44e-10,1.14,4,423,6,4.04,3.0
Blood Coagulation Tests,5.81e-08,0.12,1,18,0,1.06,4.0
Stem Cells/physiology,3.6e-06,0.36,15,69,0,18.26,2.0
Hyperhomocysteinemia/complications,1.47e-06,3.25,20,59,1,26.78,4.0
Pyridines/pharmacology,8.85e-17,0.25,3,94,1,3.1,3.0
Neuromuscular Junction/drug effects,3.67e-09,0.04,1,5,0,1.2,4.0
Neuronal Plasticity/physiology,5.85e-23,0.04,3,8,0,4.12,4.0
Transplantation,2.14e-07,0.34,3,64,2,3.14,2.0
Enteral Nutrition,1.02e-08,2.16,56,249,13,68.59,3.0
Ophthalmologic Surgical Procedures,3.84e-11,0.06,1,10,0,1.1,2.0
Atropine/pharmacology,5.44e-08,0.08,1,10,0,1.1,5.0
Neurotransmitter Agents/metabolism,5.1e-08,0.13,4,12,1,5.33,4.0
Rural Population/statistics & numerical data,4.57e-116,6.95,196,386,14,295.52,3.0
Polycystic Ovary Syndrome/metabolism,1.77e-08,17.46,216,1,1,1.0,4.0
Blood Platelets/enzymology,4.64e-06,0.09,2,6,0,2.67,3.0
Men's Health,2.07e-07,4.1,12,48,7,15.0,3.0
Dental Care,1.42e-15,0.05,2,9,0,2.44,2.0
"Water Pollutants, Chemical/metabolism",5.91e-10,0.2,5,43,0,5.58,5.0
Cardiovascular Diseases/immunology,2.42e-06,5.26,11,39,2,14.1,1.0
Neoplasms/therapy,1.95e-15,0.76,32,1040,8,32.98,1.0
T-Lymphocytes/physiology,7.18e-10,0.19,4,39,0,4.41,6.0
Sedentary Lifestyle,6.1e-21,22.12,511,116,25,142.33,4.0
Liver Cirrhosis/diagnosis,5.28e-19,3.2,63,168,4,86.62,3.0
Vascular Surgical Procedures,2.37e-08,0.81,8,312,2,8.21,3.0
Diabetes Mellitus/epidemiology,3.05e-177,12.64,577,514,79,971.88,2.0
Schizophrenia/diagnosis,7.12e-09,0.21,13,27,2,19.26,3.0
Foot/anatomy & histology,7.26e-06,1.92,20,3,0,3.45,4.0
Diabetes Complications/etiology,3.99e-20,8.56,25,59,5,35.59,3.0
Gas Chromatography-Mass Spectrometry/methods,1.54e-12,0.09,5,14,0,6.79,4.0
Birth Weight/physiology,7.26e-08,16.7,214,61,4,78.39,4.0
Coronary Disease/blood,3.63e-24,3.76,158,256,19,255.52,4.0
Aryl Hydrocarbon Hydroxylases,8.87e-07,0.04,1,3,0,1.33,4.0
Blood Pressure/physiology,3.41e-32,5.88,1050,678,80,1115.79,4.0
Kidney/drug effects,1.68e-14,0.46,29,248,2,32.39,3.0
Skin/metabolism,2.27e-13,0.2,20,40,2,30.0,2.0
Glycosaminoglycans/metabolism,1.53e-06,0.12,3,11,0,3.82,3.0
"Cartilage, Articular/pathology",1.91e-28,2.53,99,4,0,4.16,4.0
Nitric Oxide/pharmacology,2.76e-08,0.14,1,22,0,1.05,3.0
Computer Communication Networks,1.4e-10,0.05,2,5,0,2.8,4.0
"Pulmonary Disease, Chronic Obstructive/complications",1.88e-84,9.15,107,377,28,137.37,4.0
"Hospitals, General",1.27e-07,0.21,3,32,1,3.28,4.0
Melanoma/secondary,7.49e-07,2.98,3,586,0,3.02,4.0
Atherosclerosis/diagnosis,9.11e-23,6.36,51,88,7,80.56,5.0
Adenosine Triphosphatases/metabolism,1.84e-28,0.04,1,19,0,1.05,5.0
Anastomotic Leak/prevention & control,7.47e-07,8.55,7,43,4,8.14,4.0
Hydrocortisone/blood,2.88e-11,1.72,165,142,2,264.21,6.0
Cerebrospinal Fluid,4.28e-08,0.11,2,15,0,2.27,4.0
Hand-Assisted Laparoscopy,2.35e-06,12.83,3,8,4,4.12,5.0
Health Behavior/ethnology,2.47e-12,7.82,128,93,5,160.57,3.0
Face,1.35e-10,0.17,17,19,0,32.21,3.0
Kidney Transplantation/methods,2.67e-19,3.9,65,334,9,77.65,3.0
Continuous Positive Airway Pressure/methods,3.91e-27,9.93,95,99,2,186.16,5.0
Professional Competence,3.61e-15,0.12,3,34,0,3.26,3.0
European Continental Ancestry Group/ethnology,1.36e-18,9.95,46,54,8,85.19,4.0
Periodicals as Topic/history,2.01e-08,0.06,1,8,0,1.12,5.0
Speech,6.79e-18,0.05,3,11,0,3.82,4.0
Interleukin-6/blood,1.64e-82,7.43,291,358,36,527.54,5.0
Oxygen/metabolism,1.72e-07,0.45,54,176,1,70.57,3.0
Drug-Induced Liver Injury,1.44e-06,0.36,5,62,0,5.4,3.0
Child Development/physiology,2.53e-15,3.49,218,53,0,65.89,3.0
Albuminuria/complications,9.08e-32,8.97,40,80,6,60.0,5.0
Neuromuscular Junction/physiology,3.02e-06,0.1,5,1,0,1.2,4.0
Mobility Limitation,1.46e-07,6.91,92,67,6,115.79,3.0
Operative Time,1.13e-09,13.12,34,26,5,45.88,4.0
Obesity/diagnosis,1.27e-07,41.13,791,23,64,23.67,4.0
"Ethics, Research",6.14e-07,0.12,1,16,0,1.06,3.0
Prostatic Neoplasms/ethnology,9.17e-13,7.65,19,97,5,22.72,4.0
Bone Marrow/drug effects,2.19e-07,0.22,1,34,0,1.03,3.0
Preoperative Period,7.26e-23,8.06,29,63,6,42.35,3.0
Diabetic Nephropathies/complications,8.88e-07,3.8,18,86,4,21.77,4.0
Liver Cirrhosis/etiology,7.74e-07,3.44,63,94,4,105.22,3.0
"Antiretroviral Therapy, Highly Active/methods",1.29e-06,4.56,20,232,9,21.72,4.0
Cell Differentiation,8.27e-42,0.18,4,160,0,4.1,3.0
Attitude to Death,1.96e-17,1.0,1,399,1,1.0,3.0
Anesthesiology,3.18e-30,0.11,6,61,0,6.59,3.0
Myocardial Infarction/genetics,5.71e-23,4.06,59,147,3,82.68,4.0
Motor Cortex/physiology,6.98e-19,0.02,1,2,0,1.5,9.0
Electroconvulsive Therapy,1.03e-14,0.06,1,16,0,1.06,4.0
Skin Diseases,1.78e-25,0.01,1,1,0,2.0,2.0
Biological Clocks/physiology,4.17e-07,0.1,3,8,0,4.12,4.0
Adenocarcinoma/diagnosis,1.41e-06,1.61,13,577,4,13.29,5.0
"Abortion, Induced",2.83e-23,0.09,4,35,0,4.46,3.0
Antibodies/immunology,2.66e-06,0.36,10,65,1,11.54,6.0
Immunization,2.2e-24,0.12,2,55,0,2.07,3.0
"Renal Insufficiency, Chronic/diagnosis",3.06e-12,6.65,20,96,5,24.17,5.0
Hydrocortisone/metabolism,5.12e-11,2.38,97,33,3,44.23,6.0
Action Potentials/physiology,1.47e-18,0.07,7,10,0,11.9,3.0
"Adjuvants, Immunologic/pharmacology",3.45e-12,0.26,1,88,0,1.01,5.0
Orthopedic Procedures/adverse effects,1.61e-07,3.49,21,110,7,25.01,2.0
Coronary Artery Disease/diagnosis,1.21e-24,3.99,80,406,12,95.76,5.0
Steroids,5.13e-10,0.05,2,3,0,3.33,2.0
Semantics,3.43e-24,0.04,3,9,0,4.0,5.0
Body Temperature,4.32e-08,0.31,19,66,1,24.47,2.0
Thyroid Neoplasms/pathology,7.3e-10,1.32,7,463,2,7.11,3.0
Metabolic Syndrome X/complications,7.56e-104,19.57,495,259,67,394.52,3.0
"Infant, Low Birth Weight",6.38e-28,2.9,119,419,11,152.8,5.0
Social Desirability,3.98e-12,2.19,44,5,0,5.57,4.0
Cachexia/etiology,4.02e-18,6.46,25,55,12,36.36,7.0
HIV-1/physiology,3.15e-13,0.22,4,62,0,4.26,7.0
Disability Evaluation,1.21e-06,1.08,146,244,7,233.36,3.0
Public Health Administration,2.53e-13,0.18,2,50,0,2.08,3.0
"Tumor Markers, Biological/analysis",1.12e-16,2.99,24,2537,7,24.23,1.0
Anniversaries and Special Events,1.17e-07,0.11,1,16,0,1.06,3.0
Contrast Media/adverse effects,4.19e-07,1.57,8,430,0,8.15,3.0
Antifungal Agents/therapeutic use,4.25e-19,2.38,2,1104,1,2.0,5.0
"Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors",2.19e-07,0.14,1,20,0,1.05,8.0
Diet Records,1.81e-06,7.57,82,2,1,2.05,4.0
Ankle Brachial Index,1.04e-43,12.59,40,83,13,59.28,5.0
"Receptors, Tumor Necrosis Factor, Type I/blood",3.64e-09,9.43,13,22,1,20.68,5.0
Perioperative Period,2.19e-06,7.5,10,45,1,12.22,2.0
Pediatric Nursing,8.55e-08,0.08,2,9,0,2.44,4.0
Ophthalmology,1.34e-15,0.02,1,4,0,1.25,4.0
DNA Mutational Analysis/methods,2.44e-06,0.23,1,30,0,1.03,5.0
HIV Infections/drug therapy,1.68e-23,2.35,271,2073,63,306.43,3.0
Intercellular Signaling Peptides and Proteins,6.31e-16,4.14,167,19,3,21.16,2.0
School Health Services,5.74e-23,1.57,115,12,0,13.25,4.0
Nutrition Assessment,4.93e-17,7.96,459,196,91,279.69,4.0
Cardiovascular Diseases/economics,2.78e-08,6.83,11,76,6,12.59,1.0
Mitochondria/physiology,1.14e-06,0.21,5,27,1,5.93,4.0
Venous Thromboembolism/prevention & control,1.47e-18,5.8,43,349,13,48.3,5.0
Metabolic Syndrome X/surgery,5.63e-08,37.82,28,10,5,13.57,3.0
"Diagnosis, Differential",2.92e-34,0.05,7,19,0,9.58,2.0
Propranolol/therapeutic use,1.69e-07,0.29,2,56,0,2.07,4.0
Blood Coagulation,2.22e-09,0.36,27,113,2,33.45,5.0
Hypolipidemic Agents/therapeutic use,1.36e-23,3.31,89,355,9,111.31,5.0
Coronary Disease/ethnology,1.68e-27,10.31,28,78,10,38.05,4.0
Cell Cycle Proteins/metabolism,2.55e-10,0.31,1,156,0,1.01,3.0
Parenting/psychology,5.81e-07,1.16,56,12,0,14.57,5.0
Polyploidy,1.16e-07,0.16,1,24,0,1.04,3.0
Stroke/therapy,4.65e-06,3.01,5,719,2,5.03,4.0
Fluorescence,1.75e-12,0.07,4,8,0,6.0,5.0
General Surgery/education,2.53e-08,0.36,3,113,2,3.08,4.0
Continental Population Groups/ethnology,3.42e-07,7.05,10,21,1,14.76,3.0
Ventricular Remodeling,9.6e-26,4.98,57,228,10,71.25,3.0
Bacteria/classification,3.7e-10,0.26,4,62,0,4.26,1.0
Motion Pictures as Topic,6.01e-07,0.12,1,15,0,1.07,4.0
Neoplasms/metabolism,3.94e-09,0.47,32,194,5,37.28,1.0
Kidney/enzymology,1.97e-18,0.05,1,16,0,1.06,3.0
Synaptic Transmission,2.2e-14,0.04,2,4,0,3.0,4.0
Neural Inhibition/physiology,1.51e-12,0.03,1,5,0,1.2,4.0
Coronary Artery Disease/psychology,4.84e-09,7.11,11,37,4,14.27,5.0
Amino Acids/pharmacology,1.16e-06,0.11,5,5,0,10.0,2.0
Uric Acid/blood,4.49e-18,6.01,286,220,23,389.23,4.0
Anti-Inflammatory Agents/therapeutic use,3.32e-09,0.89,34,502,2,36.3,4.0
"Carcinoma, Non-Small-Cell Lung/drug therapy",3.82e-16,4.57,6,2526,5,6.01,5.0
"Hepatitis C, Chronic/epidemiology",2.93e-13,5.03,29,73,0,40.52,4.0
Materials Testing,1.6e-08,0.11,2,17,0,2.24,2.0
"Carcinoma, Squamous Cell/diagnosis",1.03e-06,1.6,6,422,2,6.09,5.0
Information Services,6.4e-14,0.08,1,21,0,1.05,2.0
Urinary Bladder Neoplasms/drug therapy,3.03e-10,1.58,1,364,0,1.0,4.0
Vitamin A Deficiency/epidemiology,1.84e-06,5.5,16,27,1,25.48,6.0
Anemia/epidemiology,1.29e-50,7.49,78,207,9,107.39,3.0
Liver/injuries,3.23e-06,1.69,2,275,0,2.01,2.0
Anti-Retroviral Agents/therapeutic use,6.59e-10,3.94,36,369,16,39.51,6.0
Urban Health,4.28e-08,2.15,49,154,3,64.59,3.0
First Aid,3.08e-07,0.17,1,24,0,1.04,3.0
Phosphorus/metabolism,4.01e-08,0.21,5,35,1,5.71,3.0
Hypertension/ethnology,7.24e-15,13.3,177,74,18,104.94,3.0
Radiography,2.36e-32,0.02,2,6,0,2.67,4.0
DNA-Binding Proteins,5.15e-15,0.18,11,52,0,13.33,3.0
Heart Failure/diet therapy,4.53e-06,8.92,7,19,1,9.58,3.0
Reoperation/statistics & numerical data,1.51e-12,10.28,17,110,4,19.63,2.0
"Diet, Mediterranean/statistics & numerical data",8.83e-08,22.42,16,12,3,21.0,4.0
Diabetic Angiopathies/prevention & control,8.21e-15,5.37,32,158,6,38.48,3.0
"Cholecystectomy, Laparoscopic/methods",3.39e-25,4.49,66,137,5,97.8,5.0
Mitosis/drug effects,7.64e-08,0.05,1,4,0,1.25,5.0
Colonic Neoplasms/pathology,1.26e-08,1.3,13,506,2,13.33,6.0
Soil,3.63e-15,0.15,1,47,0,1.02,2.0
Work,3.92e-09,0.24,32,21,5,34.78,2.0
Coronary Stenosis/radiography,3.56e-09,3.28,26,77,4,34.78,5.0
Gene Expression Regulation/physiology,7.59e-14,0.23,19,69,0,24.23,3.0
Inflammatory Bowel Diseases/complications,2.99e-06,2.72,27,95,1,34.67,4.0
Protein-Energy Malnutrition/diagnosis,3.36e-09,11.69,28,17,18,27.32,6.0
Sesquiterpenes/pharmacology,8.47e-07,0.2,1,28,0,1.04,4.0
"Pattern Recognition, Visual",9.69e-20,0.05,5,3,0,4.8,5.0
Sports/physiology,3.11e-13,4.5,191,27,3,30.82,4.0
Pregnancy,1.88e-06,0.35,53,64,2,96.89,5.0
"Anesthesia, Inhalation",1.14e-08,0.14,7,12,1,11.08,4.0
"Endothelium, Vascular/physiopathology",2.67e-24,4.76,293,308,23,571.73,4.0
Poverty Areas,3e-11,3.21,44,169,2,55.46,4.0
Thyrotropin/blood,2.01e-08,2.36,121,60,5,89.75,6.0
Brain Neoplasms/secondary,2.88e-10,3.65,2,1012,1,2.0,4.0
Carrier Proteins/physiology,3.17e-14,0.11,2,29,0,2.14,3.0
Myocardial Perfusion Imaging/methods,7.41e-08,3.2,26,95,3,33.12,5.0
Fermentation,2.17e-07,0.17,11,14,0,19.64,4.0
Dyslipidemias/drug therapy,7.44e-24,5.48,50,209,8,61.96,4.0
Schizophrenia,3.5e-09,0.1,3,11,1,3.82,3.0
Phenols/chemistry,8.49e-10,0.06,1,9,0,1.11,6.0
Energy Metabolism,3.27e-55,2.44,445,126,14,161.68,3.0
"Infertility, Female/therapy",5.51e-19,2.53,100,14,3,15.96,5.0
Asian Americans/statistics & numerical data,8.93e-17,7.59,53,67,4,94.93,4.0
Mental Disorders/therapy,1.57e-32,0.17,14,105,3,15.87,1.0
Osteoblasts/cytology,2.83e-09,0.05,2,4,0,3.0,3.0
Ion Channels/metabolism,7.65e-08,0.16,10,14,0,17.14,5.0
Neuroprotective Agents/therapeutic use,4.6e-09,0.93,6,266,0,6.14,5.0
alpha-Linolenic Acid/administration & dosage,3.09e-06,6.36,12,21,0,18.86,5.0
Rheology,3.92e-08,0.05,1,5,0,1.2,2.0
Metabolic Syndrome X/diagnosis,4.17e-16,26.65,326,62,24,73.79,3.0
Osteoporosis/epidemiology,4.46e-14,10.48,164,93,4,145.74,4.0
Biomedical Research,3.11e-71,0.08,2,114,0,2.04,4.0
Psoriasis/blood,4.87e-06,3.08,33,3,1,3.27,4.0
DNA Transposable Elements,4.01e-09,0.15,10,14,0,17.14,4.0
Colonic Neoplasms/epidemiology,2.23e-09,4.82,47,65,9,80.98,6.0
C-Reactive Protein/analysis,2.25e-162,10.77,534,535,55,1067.0,4.0
Immunosuppressive Agents/pharmacology,2.49e-12,0.35,8,115,0,8.56,5.0
Colorectal Neoplasms/prevention & control,7.03e-08,3.66,45,412,6,49.92,5.0
Genetic Predisposition to Disease,1.9e-10,2.2,500,860,17,790.7,3.0
Endothelial Cells/metabolism,6.92e-07,0.43,14,102,0,15.92,3.0
Sarcoma/pathology,3.03e-07,1.69,1,281,0,1.0,4.0
Somatotypes,5.47e-09,3.59,42,1,0,1.02,3.0
International Cooperation,1.16e-11,0.39,10,275,0,10.36,3.0
Orientation/physiology,3.62e-13,0.04,2,3,0,3.33,3.0
"Hypertension, Pulmonary/drug therapy",4.12e-06,2.11,3,413,1,3.02,3.0
Dementia/epidemiology,1.23e-15,3.1,48,133,8,65.32,3.0
Bone Neoplasms/secondary,3.76e-14,1.63,4,671,2,4.02,3.0
Inuits/statistics & numerical data,5.95e-16,8.05,27,88,0,35.28,4.0
Balneology,4e-08,0.03,1,1,0,2.0,2.0
Magnesium/pharmacology,6.58e-07,0.14,5,14,0,6.79,4.0
Spermatozoa/metabolism,4.62e-07,0.13,6,9,0,10.0,3.0
Blindness/etiology,1.81e-06,0.26,1,38,0,1.03,3.0
"Hypertrophy, Left Ventricular/ethnology",7.51e-07,18.48,11,9,5,16.36,4.0
"Vision, Ocular/physiology",3.51e-11,0.06,4,2,0,3.0,3.0
"Heart Failure, Systolic/epidemiology",4.87e-06,23.97,2,8,3,2.5,4.0
Alcoholism/rehabilitation,1.69e-07,0.16,4,22,0,4.73,4.0
Societies,2.33e-14,0.04,2,5,0,2.8,3.0
Touch,2.34e-08,0.06,2,4,0,3.0,4.0
"Osteoarthritis, Knee/physiopathology",5.55e-10,11.67,166,1,1,1.01,4.0
"Models, Cardiovascular",1.05e-11,0.38,18,144,3,20.25,4.0
Functional Laterality,9.9e-07,0.21,11,19,1,17.37,4.0
Adrenal Gland Neoplasms/surgery,3.21e-08,3.11,31,189,10,36.08,3.0
Phosphoprotein Phosphatases/metabolism,1.4e-08,0.1,1,15,0,1.07,6.0
Contraception,7.21e-08,0.15,5,18,0,6.39,3.0
Ethanol,3.47e-09,0.09,1,14,0,1.07,3.0
Sexual Behavior,1.03e-13,0.24,30,68,0,43.24,3.0
Dendritic Cells/metabolism,4.74e-06,0.28,1,44,0,1.02,3.0
"Carcinoma, Squamous Cell/therapy",7.25e-07,3.91,2,1077,6,2.0,5.0
Pyrroles/therapeutic use,7.33e-13,3.67,59,348,2,69.0,4.0
Hypotension/epidemiology,2.27e-06,7.97,9,35,1,11.31,3.0
Cardiopulmonary Bypass,5.26e-08,0.94,5,263,3,5.1,3.0
Oocytes/physiology,6.03e-07,0.17,10,14,0,17.14,4.0
Immunotherapy,4.42e-09,0.74,1,300,0,1.0,4.0
"Receptors, Cell Surface/metabolism",4.77e-26,0.23,15,140,1,16.61,4.0
"Accidents, Occupational",5.96e-09,0.28,3,58,0,3.16,4.0
"DNA, Neoplasm/genetics",5.6e-07,0.97,3,187,0,3.05,4.0
Diabetes Mellitus/drug therapy,1.64e-07,1.82,77,303,8,96.57,2.0
Nerve Growth Factors/pharmacology,1.17e-07,0.03,1,2,0,1.5,3.0
Mothers/psychology,2.01e-17,1.29,150,95,1,155.17,3.0
Muscles,2.35e-23,0.04,3,1,2,1.33,2.0
Interpersonal Relations,5.01e-09,0.38,81,127,8,132.66,3.0
Water Supply/analysis,4.13e-06,0.38,8,67,0,8.96,4.0
Questionnaires,5.22e-42,1.79,468,320,18,538.8,1.0
Heart Failure/drug therapy,2.45e-09,3.38,19,2374,18,19.15,3.0
"DNA, Viral",1.76e-06,0.05,1,3,0,1.33,4.0
Adipose Tissue/physiology,2.18e-08,8.26,214,13,5,13.79,3.0
Genetic Techniques,2.06e-10,0.09,1,18,0,1.06,2.0
Norepinephrine/physiology,1.21e-06,0.07,2,5,0,2.8,4.0
Cachexia/physiopathology,3.31e-09,7.76,15,25,5,24.0,7.0
Endopeptidases/metabolism,2.71e-14,0.1,3,23,0,3.39,5.0
Antineoplastic Combined Chemotherapy Protocols/administration & dosage,8.19e-09,5.14,8,2004,4,8.03,4.0
"Plants, Medicinal/chemistry",4.85e-27,0.12,1,62,0,1.02,3.0
Culture Techniques,5.99e-16,0.01,1,1,0,2.0,3.0
Hematopoietic Stem Cells/cytology,1.37e-13,0.21,8,62,0,9.03,3.0
Protein Kinase Inhibitors/therapeutic use,2.45e-08,2.89,3,718,1,3.01,5.0
"Spectrometry, Mass, Electrospray Ionization/methods",5.94e-21,0.05,2,17,0,2.24,4.0
Fibroblast Growth Factors/blood,5.05e-37,11.04,59,91,3,97.25,3.0
"Microscopy, Confocal/methods",4.3e-07,0.08,1,9,0,1.11,3.0
"Hospitals, Psychiatric",6.84e-15,0.09,5,13,1,6.92,5.0
Proto-Oncogene Proteins/blood,3.33e-21,8.82,31,77,1,43.48,5.0
Lithotripsy/methods,3.73e-06,1.47,31,10,1,13.23,2.0
Computer Systems,1.49e-10,0.07,1,12,0,1.08,3.0
"Proctocolectomy, Restorative/methods",1.44e-09,4.96,19,40,8,28.02,4.0
Piperidines/pharmacology,3e-08,0.23,11,38,0,14.18,3.0
Protein Precursors/metabolism,2.89e-09,0.19,2,36,1,2.11,3.0
Video Games,8.03e-10,3.29,50,3,0,3.18,4.0
"Cell Transformation, Neoplastic/pathology",4.23e-07,1.02,2,202,1,2.02,4.0
Space Perception,2.12e-12,0.03,1,3,0,1.33,4.0
Mexican Americans/statistics & numerical data,1.14e-09,10.39,55,39,6,66.65,5.0
Self Care,1.61e-09,1.32,91,100,2,173.81,2.0
Mast Cells/metabolism,4.46e-07,0.11,1,14,0,1.07,3.0
Nanoparticles,2.93e-08,0.28,3,53,0,3.17,4.0
Physical Endurance/physiology,1.55e-22,3.77,236,31,8,35.07,3.0
"Receptors, Nicotinic/metabolism",1.66e-07,0.14,2,20,0,2.2,6.0
"Diabetes Mellitus, Type 2/genetics",7.18e-12,10.16,826,83,7,91.34,3.0
Bone Transplantation/methods,1.11e-08,0.25,6,50,0,6.72,3.0
Ion Channels/physiology,2.95e-16,0.03,1,6,0,1.17,5.0
Conflict (Psychology),9.17e-10,0.14,6,21,0,7.71,3.0
Biological Evolution,2.15e-75,0.26,18,451,2,18.72,3.0
Membrane Proteins/chemistry,6e-18,0.03,1,6,0,1.17,3.0
Poverty,1.54e-27,2.92,223,427,8,339.46,3.0
Acetates/metabolism,2.37e-06,0.04,1,2,0,1.5,4.0
Pancreas,5.7e-13,0.08,5,9,0,7.78,2.0
"Diagnosis, Computer-Assisted",7.91e-07,0.18,6,17,1,8.12,2.0
Hepatocytes/metabolism,3.96e-09,0.21,3,40,0,3.23,3.0
Apoptosis,9.12e-29,0.36,18,474,1,18.68,4.0
Esophageal Neoplasms/epidemiology,1.38e-27,5.76,51,122,4,72.32,4.0
"Carcinoma, Hepatocellular/epidemiology",2.11e-11,5.22,30,188,4,34.79,4.0
"Pregnancy, Twin/statistics & numerical data",2.23e-07,17.1,7,31,1,8.58,4.0
"Sequence Analysis, DNA",4.63e-07,0.27,5,44,0,5.57,4.0
Liver Cirrhosis/virology,1.43e-08,4.88,22,113,2,26.28,3.0
Autoantibodies/analysis,8.17e-09,0.19,15,21,1,25.71,7.0
Obesity/surgery,2.59e-57,20.66,469,130,107,166.03,4.0
Hypoglycemia/prevention & control,5.18e-13,4.4,29,66,2,41.74,4.0
Sodium Chloride/pharmacology,4.67e-09,0.18,6,29,1,7.24,3.0
Scoliosis/physiopathology,1.17e-06,1.94,22,2,0,2.18,5.0
Enzymes/metabolism,2.08e-12,0.06,2,9,0,2.44,2.0
Enzyme-Linked Immunosorbent Assay,2.88e-07,0.12,3,13,0,3.69,5.0
Prostaglandins/biosynthesis,3.93e-08,0.06,1,7,0,1.14,5.0
Ovary,3.7e-13,0.04,2,6,0,2.67,4.0
"Quality Assurance, Health Care",2.12e-10,0.81,14,471,5,14.42,2.0
Dendritic Cells/immunology,4.79e-07,0.38,2,288,0,2.01,3.0
Blood Platelets/physiology,5.03e-07,0.34,16,72,1,19.56,3.0
Tumor Necrosis Factor-alpha/pharmacology,1.16e-14,0.12,7,25,0,8.96,4.0
Heart Ventricles/physiopathology,3.61e-10,2.06,67,201,9,89.33,3.0
"Heart Defects, Congenital/diagnosis",8.45e-08,0.98,2,193,0,2.02,3.0
Wasting Syndrome/epidemiology,4.08e-06,15.14,3,8,3,4.12,3.0
Hypertension/complications,5.93e-73,4.79,493,637,70,874.55,3.0
Surgical Wound Dehiscence/epidemiology,7.97e-07,7.66,8,22,2,10.91,4.0
Skin/drug effects,4.81e-18,0.1,2,35,0,2.11,2.0
Length of Stay/statistics & numerical data,1.19e-15,6.02,41,696,26,43.42,4.0
Cardiovascular Diseases/psychology,7.48e-19,6.16,31,96,6,41.01,1.0
Metformin/therapeutic use,7.61e-49,14.18,426,221,19,335.65,5.0
Quantitative Trait Loci,6.58e-10,1.48,67,50,2,87.31,6.0
"Intestine, Small/metabolism",1.17e-11,0.12,2,25,0,2.16,4.0
Oligopeptides/pharmacology,1.13e-10,0.26,8,66,0,8.97,3.0
Plasma,9.95e-08,0.35,4,119,0,4.13,3.0
"Carcinoma, Non-Small-Cell Lung/genetics",2.18e-07,3.23,2,686,1,2.01,5.0
Uterus/metabolism,6.7e-09,0.11,4,13,0,5.23,4.0
Hormone Replacement Therapy/adverse effects,1.24e-10,5.68,41,57,2,70.49,3.0
"Hernia, Hiatal/surgery",7.48e-11,3.9,22,81,9,27.98,5.0
Breeding,9.54e-10,0.29,3,66,1,3.14,3.0
"Renal Insufficiency, Chronic/metabolism",4.07e-07,5.54,13,64,3,15.64,5.0
Glaucoma/surgery,2.22e-12,0.03,1,4,0,1.25,3.0
Pneumonectomy,1.77e-06,1.57,9,542,7,9.15,4.0
Occupational Diseases/chemically induced,8.32e-17,0.27,4,104,0,4.15,1.0
Glomerular Filtration Rate,3.1e-78,4.78,161,367,24,231.63,3.0
Obesity/genetics,1.08e-13,24.56,1559,25,32,25.4,4.0
Insulin-Secreting Cells/metabolism,2.68e-14,2.17,66,13,0,15.56,3.0
Cell Differentiation/drug effects,1.43e-19,0.07,1,21,1,1.05,3.0
Lung Neoplasms/radiography,4.59e-06,1.63,11,456,0,11.27,3.0
Dyslipidemias/complications,5.69e-19,11.03,39,50,3,69.42,4.0
Mothers/statistics & numerical data,3.62e-14,6.44,63,75,5,115.92,3.0
Interprofessional Relations,1.98e-42,0.07,4,53,0,4.3,4.0
Staphylococcus aureus/isolation & purification,8.3e-08,1.08,2,211,0,2.02,6.0
Energy Metabolism/physiology,7.07e-14,4.01,470,138,17,178.52,3.0
Nursing Process,1.17e-07,0.06,2,4,0,3.0,4.0
Comorbidity,5.65e-07,5.89,22,341,8,23.42,4.0
Occupational Medicine,4.23e-29,0.04,4,8,0,6.0,5.0
Hypertension/blood,8.05e-13,4.6,335,70,8,84.63,3.0
Biological Markers/analysis,1.93e-10,2.04,77,271,7,98.88,1.0
Diabetic Nephropathies/therapy,2.36e-08,4.84,13,134,13,14.26,4.0
Pericardium/pathology,1.83e-14,6.53,50,67,3,87.31,3.0
Radiology,1.71e-16,0.04,1,7,1,1.14,3.0
"Diet, Reducing",1.37e-15,12.28,570,20,9,20.7,4.0
Self Efficacy,9.48e-24,2.23,144,38,2,48.03,5.0
Parkinson Disease/drug therapy,8.55e-14,0.2,7,60,0,7.82,3.0
Ethinyl Estradiol/administration & dosage,2.18e-06,2.38,23,2,0,2.17,6.0
Siblings,9.38e-11,2.56,51,150,1,68.34,2.0
Circadian Rhythm/physiology,4.18e-26,1.68,221,146,10,242.45,4.0
Polysaccharides/pharmacology,3.91e-07,0.25,3,39,0,3.23,2.0
"Antineoplastic Agents, Phytogenic/pharmacology",5.77e-18,0.26,4,105,0,4.15,5.0
Titanium/chemistry,5.44e-23,0.04,2,11,0,2.36,4.0
Blood Pressure/drug effects,2.08e-15,1.24,246,399,13,397.67,4.0
Obesity/complications,1.71e-289,33.14,4009,427,785,472.48,4.0
Liver Neoplasms/metabolism,2.77e-08,1.41,7,421,1,7.12,3.0
Feeding Behavior/physiology,1.17e-14,1.82,150,97,1,159.73,3.0
Dietary Fats/administration & dosage,6.02e-10,4.68,404,105,7,132.29,3.0
Estradiol/blood,8.75e-16,3.65,203,38,6,45.11,5.0
Ethanol/pharmacology,9.53e-32,0.14,13,81,0,15.09,3.0
Glycolysis,3.1e-08,0.12,1,16,1,1.06,4.0
Membrane Proteins/genetics,3.34e-06,1.08,161,295,3,248.87,3.0
Follicle Stimulating Hormone/blood,1.42e-10,1.32,66,4,0,4.24,6.0
Technetium,3.44e-11,0.07,4,7,0,6.29,4.0
Coronary Disease/psychology,3.73e-06,2.65,20,100,10,24.0,4.0
African Continental Ancestry Group/ethnology,2.06e-07,5.8,10,23,4,14.35,4.0
Heparin/pharmacology,1.11e-12,0.09,2,21,0,2.19,4.0
Vitamin D Deficiency/blood,1.51e-06,15.01,133,44,4,58.56,6.0
Fatty Acid-Binding Proteins/blood,3.78e-15,16.84,63,42,3,70.0,4.0
Students/statistics & numerical data,8.7e-11,5.48,249,38,1,43.8,2.0
Lipolysis,5.34e-06,1.91,23,5,1,6.09,4.0
Cholesterol,1.65e-08,0.06,2,5,0,2.8,4.0
Heart Diseases/epidemiology,4.35e-17,6.0,36,195,6,42.65,2.0
Arabs/statistics & numerical data,7.35e-14,7.95,20,39,1,30.26,4.0
"Muscle, Smooth, Vascular/cytology",5.77e-08,0.16,1,26,0,1.04,4.0
"Anesthesia, Dental",3.04e-07,0.04,1,3,0,1.33,2.0
"Pregnancy Complications, Cardiovascular/epidemiology",7.51e-11,6.84,18,91,4,21.56,2.0
Overweight/complications,1.11e-15,54.41,495,25,46,26.26,4.0
"Ventricular Dysfunction, Left/physiopathology",6.65e-37,4.45,93,346,13,118.0,4.0
Phospholipids/metabolism,3.13e-15,0.09,7,12,0,11.08,3.0
Stroke/etiology,5.18e-34,4.91,95,819,34,106.02,4.0
"Embryo, Mammalian",1.54e-08,0.07,2,8,0,2.5,2.0
Gases,4.72e-06,0.25,2,34,0,2.12,2.0
"Membranes, Artificial",3.46e-38,0.14,4,109,1,4.15,2.0
Carbon,2.04e-08,0.11,1,17,0,1.06,3.0
Liver/ultrastructure,3.21e-06,0.06,2,2,0,4.0,2.0
"Hernia, Umbilical/surgery",1.59e-08,3.92,21,53,1,29.32,3.0
Birds,4.11e-12,0.23,2,60,0,2.07,5.0
Cardiovascular Diseases/diet therapy,2.27e-07,8.41,22,26,0,40.62,1.0
Rectal Diseases/surgery,9.18e-12,3.58,30,134,11,36.72,4.0
Glycoproteins/analysis,1.04e-09,0.2,2,40,0,2.1,3.0
Mouth/microbiology,9.21e-07,0.11,1,14,0,1.07,2.0
Myocardial Ischemia/epidemiology,1.76e-44,9.56,51,179,17,65.53,3.0
"Abnormalities, Drug-Induced",2e-08,0.17,1,30,0,1.03,3.0
Protease Inhibitors/pharmacology,1.14e-06,0.27,4,42,0,4.38,5.0
Mental Disorders/diagnosis,2.81e-11,0.22,20,48,0,28.33,1.0
Insecticides/toxicity,1e-10,1.43,5,477,1,5.05,4.0
Lead/blood,3.68e-08,1.48,47,27,2,42.51,4.0
"Labor, Obstetric",1.24e-18,0.2,19,67,3,24.39,6.0
Vascular Diseases,7.14e-22,0.01,1,1,0,2.0,2.0
Staining and Labeling/methods,4.35e-12,0.06,1,13,0,1.08,5.0
Quinolines/pharmacology,5.81e-09,0.18,2,34,0,2.12,3.0
Prostatic Neoplasms/blood,9.4e-38,4.19,95,329,16,122.43,4.0
Hypertension/metabolism,3.93e-16,1.4,108,50,3,73.15,3.0
Erectile Dysfunction/etiology,1.4e-09,2.19,55,15,1,19.09,3.0
Neoplasms/radiotherapy,2.99e-21,0.29,4,160,2,4.1,1.0
T-Lymphocytes/immunology,3.75e-115,0.22,16,546,0,16.47,6.0
Carcinoma/pathology,1.13e-13,1.34,9,667,4,9.12,4.0
Mitral Valve Insufficiency/surgery,2.5e-07,3.21,3,829,3,3.01,4.0
Soil Pollutants/analysis,6.57e-24,0.08,1,37,0,1.03,4.0
Diabetic Angiopathies/etiology,4.38e-15,4.72,32,70,5,46.63,3.0
Colorectal Neoplasms/blood,1.71e-29,6.43,58,203,3,74.57,5.0
Drug Delivery Systems,6.34e-17,0.31,4,198,0,4.08,3.0
Cardiovascular Diseases/physiopathology,2.35e-134,7.33,186,452,43,262.54,1.0
Renal Insufficiency/therapy,1.97e-09,5.92,15,155,11,16.45,4.0
HIV-1/immunology,6.36e-17,0.21,6,78,0,6.46,7.0
HIV-1/drug effects,7.29e-07,0.41,4,138,4,4.12,7.0
Lower Extremity/physiology,1.78e-07,2.48,30,3,0,3.3,3.0
Women,6.64e-07,0.29,8,49,1,9.31,2.0
Tissue Engineering/methods,1.76e-27,0.13,1,70,0,1.01,5.0
Hypercholesterolemia/epidemiology,3.17e-06,13.82,79,30,7,41.39,6.0
Metabolic Syndrome X/etiology,3.3e-10,20.77,284,57,20,68.44,3.0
Lower Extremity/blood supply,1.2e-07,4.9,27,447,15,28.63,3.0
Insulin-Secreting Cells/physiology,1.63e-08,5.56,92,6,0,6.39,3.0
Blood-Brain Barrier,1.43e-08,0.08,1,11,0,1.09,2.0
Reading,1.19e-19,0.09,8,14,1,12.57,5.0
Saliva/chemistry,3.1e-14,1.5,78,19,0,23.63,3.0
Blood Preservation,2.14e-08,0.18,3,31,0,3.29,4.0
Macrophages/physiology,1.18e-10,0.21,5,48,0,5.52,3.0
Alcoholism,2.49e-09,0.06,1,9,0,1.11,4.0
Living Donors/statistics & numerical data,4.57e-10,9.26,14,117,5,15.68,3.0
Antidepressive Agents/pharmacology,7.35e-08,0.15,6,17,0,8.12,6.0
Osteoarthritis/radiography,1.49e-06,2.96,29,2,0,2.14,3.0
"Carcinoma, Hepatocellular/therapy",1.42e-07,4.06,4,1089,2,4.01,4.0
Estrogen Replacement Therapy/adverse effects,6.06e-07,3.68,65,91,3,111.43,4.0
Patients,8.2e-09,0.16,6,23,0,7.57,2.0
Heart/radionuclide imaging,1.43e-06,0.32,13,57,0,15.96,2.0
"Receptors, Immunologic/blood",1.61e-11,8.75,34,40,2,62.9,5.0
"Obesity, Morbid/complications",1.26e-23,31.46,430,46,67,50.92,5.0
Drinking,3.02e-08,1.61,46,25,0,38.59,5.0
Heart Failure/etiology,5.08e-11,3.42,52,541,24,57.0,3.0
Corneal Transplantation,4.4e-10,0.05,1,7,0,1.14,4.0
Posture/physiology,1.45e-15,1.2,129,29,2,35.52,3.0
Memory,2.52e-21,0.09,13,11,1,20.31,4.0
Titanium,1.15e-06,0.18,4,22,0,4.73,4.0
Dental Caries/prevention & control,3.37e-15,0.04,3,2,0,3.33,4.0
Spinal Fusion/adverse effects,3.55e-07,3.88,56,79,4,95.7,4.0
Embryonic Development,2.33e-06,0.23,2,31,0,2.13,6.0
Lipoprotein Lipase/blood,1.6e-06,2.63,23,1,0,1.04,6.0
Basal Metabolism,3.03e-14,4.53,115,4,4,4.14,4.0
Fasting,4.95e-10,1.23,80,28,1,37.8,4.0
Clomiphene/therapeutic use,1.19e-08,2.72,37,3,0,3.24,8.0
Potassium Channels/physiology,1.82e-13,0.05,1,12,0,1.08,6.0
"Efficiency, Organizational",4.59e-13,0.23,1,65,0,1.02,3.0
Streptococcal Infections/microbiology,8.51e-07,1.0,1,156,0,1.01,4.0
Bacteria/isolation & purification,3.09e-18,0.37,14,190,1,15.03,1.0
Coronary Artery Disease/radiography,2.08e-48,5.35,149,252,11,237.1,5.0
"Models, Genetic",1.12e-11,0.35,52,141,2,71.18,4.0
Nitrogen,9.12e-10,0.03,1,3,0,1.33,3.0
General Surgery/history,2.42e-09,0.11,1,20,0,1.05,4.0
Mutagens/toxicity,5.52e-15,0.12,2,36,0,2.11,4.0
Survivors,1.04e-47,6.72,90,653,30,102.4,2.0
Tobacco/genetics,1.08e-07,0.16,1,25,0,1.04,8.0
Air Pollutants/analysis,5.07e-16,0.38,12,225,2,12.64,4.0
Nerve Tissue Proteins/genetics,1.53e-06,0.44,29,127,0,35.62,3.0
Fossils,3.04e-11,0.13,5,24,0,6.04,5.0
Peritoneal Dialysis,1.31e-32,3.19,93,299,28,121.93,4.0
Hyperlipidemias/drug therapy,1.94e-13,2.47,65,197,5,86.45,5.0
"Pregnancy, Animal",5.63e-19,0.1,2,34,0,2.12,6.0
Protein-Energy Malnutrition/epidemiology,6.02e-08,10.37,26,20,11,35.38,6.0
Biliopancreatic Diversion/adverse effects,3.74e-06,15.22,12,9,6,15.75,3.0
"Education, Medical",5.04e-44,0.05,6,29,0,7.24,3.0
Diabetic Nephropathies/epidemiology,2.1e-20,7.7,45,68,7,74.78,4.0
Cardiovascular Physiological Phenomena,5.15e-17,1.42,104,48,12,70.15,2.0
Proteins/genetics,2.09e-48,1.89,324,135,14,191.25,2.0
Truth Disclosure,2.42e-09,0.28,7,63,0,7.78,5.0
Bulimia/psychology,4.01e-10,7.03,101,1,1,1.01,5.0
Dietary Carbohydrates/metabolism,1.4e-09,2.89,72,13,3,15.35,2.0
Diabetes Complications/physiopathology,2.92e-12,5.87,20,50,3,28.0,3.0
Women's Rights,1.13e-07,0.26,1,44,0,1.02,4.0
Athletic Performance,1.34e-10,3.03,45,2,0,2.09,5.0
Osteoporosis/complications,1.33e-12,4.02,82,123,10,136.67,4.0
Nitric Oxide/biosynthesis,5.51e-08,0.27,7,53,0,7.92,3.0
Corpus Striatum/metabolism,5.38e-11,0.1,7,8,0,13.12,8.0
"Kidney Failure, Chronic/etiology",2.44e-07,3.45,24,233,15,26.47,6.0
"Kidney Failure, Chronic/surgery",1.46e-22,5.19,53,573,31,57.9,6.0
Cardiovascular Diseases/chemically induced,2.46e-07,3.86,35,293,4,39.18,1.0
Adipose Tissue/metabolism,7.84e-56,5.15,753,65,15,70.61,3.0
Coronary Artery Disease/pathology,3.26e-16,3.97,52,107,7,77.27,5.0
Aggression,6.62e-10,0.16,6,27,0,7.33,4.0
Heart Diseases,6.69e-20,0.04,1,7,1,1.14,2.0
Diabetic Angiopathies/epidemiology,2.44e-67,11.59,84,143,20,133.34,3.0
Eating,6.17e-26,2.78,253,65,9,81.7,4.0
Cross Infection/prevention & control,2.37e-22,0.94,4,558,3,4.03,3.0
Psychological Tests,2.41e-19,0.07,9,7,0,12.44,2.0
Awards and Prizes,3.89e-19,0.1,4,24,2,4.67,2.0
Length of Stay,3.29e-15,3.84,63,453,11,71.76,4.0
Protein-Serine-Threonine Kinases/physiology,1.22e-06,0.2,2,27,0,2.15,7.0
"Carcinoma, Squamous Cell/pathology",3.96e-27,1.76,6,1351,4,6.03,5.0
Triiodothyronine/pharmacology,1.53e-07,0.06,1,6,0,1.17,5.0
Carcinogens,1.71e-22,0.06,1,26,0,1.04,4.0
Sports,4.09e-06,0.98,126,121,2,237.2,4.0
Transducers,3.69e-06,0.15,9,6,0,10.0,3.0
Cell Cycle,3.72e-13,0.1,1,24,1,1.04,3.0
Mass Screening/methods,1.53e-65,3.07,284,1099,23,357.39,3.0
Science,1.74e-16,0.04,2,7,0,2.57,2.0
Antipsychotic Agents/adverse effects,1.46e-11,4.51,382,317,26,580.06,6.0
Brain Neoplasms/radiotherapy,2.12e-06,2.58,6,605,0,6.06,4.0
Stomach,1.04e-13,0.11,6,21,0,7.71,4.0
Cardiovascular System,5.81e-24,0.09,8,16,3,12.0,1.0
Piperazines/pharmacology,7.09e-11,0.28,12,78,0,13.85,3.0
Drug Prescriptions,1.27e-15,0.17,1,54,0,1.02,3.0
Patient Education as Topic/methods,1.4e-12,1.32,122,142,8,226.82,4.0
Cerebrovascular Disorders/epidemiology,1.48e-07,3.12,22,93,7,27.2,3.0
Estrogens/pharmacology,6.35e-07,0.25,13,36,0,17.69,6.0
Medicine,1.67e-79,0.04,3,52,0,3.17,2.0
Laparoscopy/statistics & numerical data,5.36e-49,13.35,42,90,16,61.6,4.0
Collagen/metabolism,1.06e-11,0.19,14,40,0,18.9,4.0
Weight-Bearing/physiology,3.01e-08,1.32,48,2,1,2.08,4.0
Brachial Artery/physiopathology,3.9e-20,8.23,80,85,7,155.29,4.0
Obesity/psychology,1.04e-10,25.99,1113,17,18,17.26,4.0
Vitamin E/blood,2.79e-06,1.55,31,13,0,18.45,4.0
Chromosome Aberrations/genetics,1.04e-08,0.07,1,10,0,1.1,3.0
Surgical Wound Infection/etiology,7.5e-18,4.9,90,125,19,154.8,4.0
"Antigens, Viral/immunology",2.81e-09,0.27,1,70,0,1.01,3.0
"Antigens, Bacterial/immunology",4.5e-14,0.28,3,109,0,3.08,3.0
Cardiovascular Diseases/blood,5.07e-287,13.87,311,530,84,493.49,1.0
General Surgery,1.85e-14,0.2,5,61,1,5.41,4.0
"Embolization, Therapeutic",1.5e-13,1.0,3,337,0,3.03,3.0
Hypertension/diagnosis,4.86e-21,4.44,242,275,20,454.96,3.0
Alzheimer Disease/pathology,1.1e-10,0.23,8,52,1,9.23,4.0
Endometrial Neoplasms/epidemiology,1.22e-08,17.74,111,37,7,49.33,6.0
Ubiquitin-Protein Ligases/metabolism,1.45e-07,0.27,1,50,0,1.02,5.0
Heart Ventricles/pathology,1.19e-28,4.0,67,169,11,93.56,3.0
Pre-Eclampsia/epidemiology,1.96e-25,10.72,79,82,5,155.11,4.0
Fundoplication,7.92e-07,3.92,13,38,4,17.45,3.0
Milk/microbiology,3.03e-08,0.11,1,15,1,1.07,3.0
Community Health Nursing,6.33e-14,0.08,2,19,0,2.21,4.0
Salaries and Fringe Benefits,1.54e-06,0.11,6,1,0,1.17,4.0
Iron/metabolism,3.62e-09,0.38,50,136,1,68.38,4.0
Climate Change,6.02e-07,0.91,4,186,0,4.09,5.0
Epidemiology,3.88e-15,0.1,1,26,1,1.04,4.0
Adenocarcinoma/epidemiology,3.13e-40,5.4,77,195,9,107.41,5.0
Iodine Radioisotopes,1.84e-17,0.08,3,23,0,3.39,4.0
"Indians, South American/statistics & numerical data",4.29e-08,8.64,10,21,1,14.76,5.0
Pregnancy Complications/etiology,3.68e-12,3.5,83,139,6,132.56,2.0
Glutathione Transferase/metabolism,2.34e-06,0.22,2,30,0,2.13,5.0
Mutation,3.8e-34,0.5,127,1638,4,136.85,3.0
Problem Solving,4.19e-11,0.11,8,11,0,13.82,4.0
Diabetic Angiopathies/complications,1.82e-09,4.37,19,46,3,26.85,3.0
Microspheres,1.38e-11,0.19,3,45,0,3.2,2.0
Terminology as Topic,1.41e-37,0.2,21,158,0,23.79,5.0
Duodenal Ulcer/drug therapy,2.38e-06,0.09,1,9,0,1.11,5.0
Adolescent Behavior,1.59e-13,2.41,218,109,3,163.5,3.0
Elective Surgical Procedures/methods,2.6e-08,7.94,10,99,7,11.01,2.0
Diabetes Mellitus/surgery,3.98e-12,4.94,20,54,6,27.41,2.0
Stomach Neoplasms/pathology,6.04e-11,2.38,18,1428,7,18.23,4.0
Emigrants and Immigrants/statistics & numerical data,4.75e-21,4.97,57,107,4,87.36,2.0
Nitrogen/metabolism,1.92e-20,0.1,7,29,0,8.69,3.0
Emigration and Immigration/statistics & numerical data,8.7e-10,3.17,31,83,2,42.58,5.0
Mass Spectrometry/methods,8.7e-25,0.11,10,39,0,12.56,3.0
"Hyperthermia, Induced",4.38e-11,1.1,1,349,4,1.0,2.0
Graft Rejection,2.29e-07,0.34,5,65,3,5.38,5.0
Anti-Bacterial Agents/pharmacology,5e-98,0.25,3,751,0,3.01,5.0
Trans-Activators/physiology,8.26e-08,0.17,2,27,0,2.15,4.0
CD40 Ligand/blood,1.68e-06,6.14,17,25,4,28.56,5.0
Epitopes/immunology,1.11e-14,0.15,1,44,0,1.02,3.0
Hemorrhage/therapy,6.01e-07,2.2,1,352,0,1.0,3.0
Laparoscopy/adverse effects,8.43e-46,5.81,175,242,44,301.55,4.0
Pre-Eclampsia/physiopathology,6.75e-12,3.42,54,108,3,81.0,4.0
"Immunity, Cellular",5.92e-23,0.15,3,71,0,3.13,4.0
Life Style,1.27e-56,11.66,1744,586,146,782.9,3.0
Electrodes,2.33e-12,0.09,4,13,0,5.23,3.0
Vascular Endothelial Growth Factor A/blood,9.89e-14,4.34,35,132,4,44.28,5.0
Pancreatic Neoplasms/etiology,2.98e-06,5.23,30,37,9,54.32,3.0
Radiotherapy Dosage,2.12e-12,0.2,1,51,0,1.02,3.0
Laparotomy/methods,5.95e-28,6.73,44,246,17,51.87,2.0
Tunica Intima/ultrasonography,2.41e-08,10.07,64,39,8,62.77,3.0
Parents/psychology,2.83e-11,1.22,147,182,0,265.73,2.0
"Kidney Failure, Chronic/blood",1.58e-60,4.36,132,454,36,170.38,6.0
Carrier Proteins,1.66e-11,0.09,2,17,0,2.24,3.0
Kidney Calculi/therapy,2.38e-11,1.62,51,6,1,6.71,5.0
Women's Health,1.88e-74,3.29,298,678,40,428.98,3.0
Transplantation Immunology,1.15e-19,0.21,1,85,0,1.01,3.0
Recovery of Function,7.83e-12,2.54,62,232,5,78.57,2.0
Anti-Infective Agents/pharmacology,4.56e-24,0.23,2,118,0,2.03,4.0
Live Birth/epidemiology,8.81e-10,9.01,16,26,0,25.85,7.0
"Quantitative Trait, Heritable",6.17e-08,2.09,71,33,3,48.34,3.0
Transcriptional Activation,1.88e-15,0.08,1,24,0,1.04,4.0
Coronary Angiography/methods,1.01e-23,3.75,164,261,8,267.05,5.0
Spinal Fractures/epidemiology,2.66e-10,8.19,43,45,0,84.09,3.0
Symporters,3.36e-06,0.04,1,1,0,2.0,6.0
Transcription Factors/metabolism,5.75e-67,0.23,22,342,0,23.42,3.0
Population Surveillance,6.54e-20,3.02,131,918,18,149.69,4.0
Child Development,4.93e-50,1.73,322,158,4,235.53,3.0
Physical Exertion,8.95e-14,0.26,70,47,4,78.56,4.0
Dogs,4.58e-07,0.29,4,49,0,4.33,8.0
"Medical Records Systems, Computerized",1.25e-09,0.22,6,45,0,6.8,5.0
Behavior,9.44e-08,0.22,20,24,0,36.67,2.0
"Influenza, Human/prevention & control",5.64e-12,1.48,12,700,2,12.21,3.0
Fever,8.66e-07,0.12,1,15,0,1.07,4.0
Carcinoma,2.64e-40,0.01,1,1,0,2.0,4.0
Intracranial Aneurysm/therapy,2.4e-06,2.75,1,410,0,1.0,4.0
"Anti-Inflammatory Agents, Non-Steroidal/pharmacology",6.7e-11,0.34,11,106,2,12.14,5.0
Public Opinion,4.79e-16,0.18,4,60,0,4.27,4.0
Cornea/pathology,2.92e-06,0.12,5,5,0,10.0,4.0
"Arthritis, Rheumatoid/epidemiology",4.62e-15,4.05,36,84,5,51.43,3.0
Visual Fields/physiology,2.87e-07,0.07,3,3,0,6.0,2.0
"Stress Disorders, Post-Traumatic/psychology",2.4e-06,0.29,9,46,1,10.76,4.0
Accreditation,2.74e-08,0.13,1,21,0,1.05,4.0
Testosterone/analogs & derivatives,1.1e-07,2.13,33,6,1,7.09,6.0
Coronary Disease/etiology,9.82e-15,3.88,230,267,35,428.13,4.0
Parenting,6e-16,2.56,89,15,0,17.53,5.0
"Neoplasms, Multiple Primary/pathology",1.66e-10,0.86,2,258,3,2.02,2.0
Membrane Proteins/physiology,8.95e-16,0.16,3,52,0,3.17,3.0
Brain Neoplasms/metabolism,1.01e-09,1.28,2,306,0,2.01,4.0
Bone Neoplasms/surgery,7.35e-10,1.35,3,352,0,3.03,3.0
Pre-Eclampsia/genetics,1.28e-11,4.16,26,65,3,36.4,4.0
Plants/chemistry,7.69e-08,0.13,1,20,0,1.05,2.0
Spinal Cord/cytology,3.03e-07,0.04,1,2,0,1.5,3.0
Athletic Performance/physiology,1.87e-26,4.53,160,3,0,3.06,5.0
Gypsies/statistics & numerical data,9.32e-07,11.26,6,12,2,9.0,1.0
Specimen Handling/methods,6.7e-09,0.17,4,28,0,4.57,3.0
Anticoagulants/therapeutic use,4.43e-06,2.16,43,1498,8,44.23,5.0
Tobacco,2.81e-10,0.18,2,38,1,2.11,8.0
Peptides/pharmacology,6.81e-14,0.25,20,81,0,24.94,2.0
Immunosuppression,7.78e-08,0.33,3,92,0,3.1,3.0
Tibia,1.22e-06,0.11,1,13,0,1.08,6.0
"Hypertension, Pregnancy-Induced/epidemiology",5.48e-13,17.35,43,32,2,55.81,3.0
Brain/radionuclide imaging,3.01e-14,0.05,1,13,0,1.08,3.0
Permeability,4.33e-07,0.05,1,4,0,1.25,3.0
Developing Countries/statistics & numerical data,2.91e-12,7.12,27,273,7,29.67,4.0
Physical Exertion/physiology,7.67e-35,1.78,156,42,1,53.31,4.0
Gamma Rays,1.36e-10,0.25,2,58,0,2.07,4.0
Myocardial Infarction/diagnosis,4.24e-07,1.91,22,1087,13,22.45,4.0
Hippocampus/pathology,2.09e-06,0.34,9,61,0,10.33,5.0
Melanoma/diagnosis,3.04e-12,1.46,1,396,0,1.0,4.0
Memory/drug effects,9.39e-08,0.16,8,17,0,11.76,4.0
Breast Neoplasms/ethnology,5.46e-39,8.72,61,298,10,73.49,3.0
Photons,3.43e-06,0.06,1,4,0,1.25,3.0
"Infant, Newborn",5.65e-14,0.22,15,65,1,18.46,4.0
Eye Movements,4.67e-20,0.02,2,1,0,1.5,3.0
Lectins/metabolism,2.26e-07,0.17,2,25,0,2.16,3.0
Amygdala/physiology,1.26e-11,0.02,1,2,0,1.5,5.0
Fatty Acids,1.23e-09,0.04,1,5,0,1.2,2.0
Bone Remodeling/physiology,8.84e-11,2.17,53,12,0,14.72,4.0
Cold Temperature,1.01e-17,0.3,30,145,0,36.21,4.0
Respiratory Physiological Phenomena,1.92e-07,1.25,53,26,9,38.75,2.0
Laboratories/standards,8.65e-07,0.1,2,10,0,2.4,3.0
"Transcription, Genetic",1.2e-73,0.09,14,106,1,15.85,4.0
Intellectual Disability,6.99e-16,0.09,5,20,0,6.25,3.0
T-Lymphocytes/cytology,2.86e-09,0.2,1,37,1,1.03,6.0
"Fractures, Bone/prevention & control",2.77e-08,2.79,30,88,3,40.23,2.0
"Vocalization, Animal/physiology",1.27e-06,0.05,1,3,0,1.33,5.0
Jews/statistics & numerical data,1.1e-07,7.08,11,27,1,15.48,4.0
Liver Neoplasms/secondary,4.37e-11,3.54,8,1913,11,8.03,3.0
Durapatite/chemistry,2.39e-06,0.03,1,1,0,2.0,5.0
Malnutrition/blood,7.86e-12,22.49,24,20,3,36.67,3.0
Polymers,4.75e-11,0.21,2,48,2,2.08,2.0
Cerebral Cortex/metabolism,4.55e-19,0.11,9,27,0,12.0,7.0
Eating/physiology,1.01e-22,3.42,195,26,5,29.47,4.0
Fetus/drug effects,2.48e-07,0.29,5,51,0,5.49,2.0
Liver Neoplasms/drug therapy,4.52e-11,2.89,3,1145,6,3.01,3.0
Apoptosis/physiology,1.91e-35,0.27,13,231,1,13.73,4.0
"Memory, Short-Term",2.81e-06,0.09,3,4,0,5.25,5.0
Axons/physiology,1.25e-22,0.02,1,5,0,1.2,3.0
Image Enhancement/methods,1.19e-18,0.21,26,77,0,34.78,4.0
Substance-Related Disorders/therapy,2.69e-10,0.19,3,41,0,3.22,2.0
"Hypertrophy, Left Ventricular/ultrasonography",7.08e-22,9.69,61,67,13,116.54,4.0
Amines/chemistry,3.39e-09,0.02,1,1,0,2.0,2.0
Pregnancy Outcome,1.89e-108,4.49,300,1218,30,373.89,3.0
Colonic Neoplasms/surgery,1.01e-18,4.16,57,566,31,62.74,6.0
Atrial Fibrillation/epidemiology,3.3e-48,7.76,67,277,21,83.21,4.0
Urinary Bladder Neoplasms/surgery,1.53e-06,4.0,46,737,16,48.87,4.0
"Genetics, Population",2.01e-21,0.23,12,113,0,13.27,5.0
Hispanic Americans/statistics & numerical data,1.6e-84,7.85,170,280,9,273.21,4.0
Social Environment,6.81e-09,0.99,172,150,2,280.81,4.0
Child Nutrition Disorders/prevention & control,8.58e-08,5.67,14,41,1,18.78,3.0
Isoproterenol/pharmacology,1.31e-11,0.07,3,8,0,4.12,4.0
Glycoproteins/immunology,6.25e-07,0.25,2,37,0,2.11,3.0
Drug Contamination,1.5e-06,0.3,2,51,0,2.08,3.0
Muscles/enzymology,2.98e-16,0.03,3,1,0,1.33,2.0
Brain/metabolism,9.21e-98,0.17,73,288,1,91.5,3.0
Cyclic AMP/metabolism,3.2e-29,0.04,1,17,1,1.06,4.0
Coronary Disease/epidemiology,4.14e-151,8.12,276,453,77,444.16,4.0
Computational Biology/methods,9e-29,0.12,8,58,0,9.1,3.0
Nutritional Support,5.78e-10,3.5,33,149,5,40.31,3.0
Water Supply,2.08e-21,0.2,2,92,1,2.04,4.0
Social Behavior,2e-11,0.35,64,132,2,95.03,3.0
Amlodipine/therapeutic use,1.37e-10,3.73,28,75,2,38.45,5.0
Cell Separation/methods,9.36e-10,0.14,7,17,0,9.88,3.0
European Continental Ancestry Group,1.61e-75,7.09,518,480,55,924.79,4.0
Methicillin Resistance,9.27e-09,1.15,3,287,1,3.03,6.0
Bacteria/growth & development,8.31e-10,0.23,5,49,0,5.51,1.0
Diabetes Complications/drug therapy,5.78e-07,4.52,16,66,2,19.88,3.0
"Immunoglobulins, Intravenous/therapeutic use",2.83e-08,1.08,1,205,0,1.0,7.0
Polycystic Ovary Syndrome/drug therapy,3.04e-08,15.79,271,6,1,6.13,4.0
Liver/metabolism,5.1e-36,0.3,192,271,0,328.03,2.0
Bone and Bones/pathology,6.68e-08,1.38,60,51,0,94.35,3.0
Sarcoplasmic Reticulum/metabolism,4.66e-07,0.1,1,12,0,1.08,6.0
"Arthroplasty, Replacement, Hip/methods",8.43e-11,3.17,116,184,4,189.13,4.0
Glutamic Acid/metabolism,3.35e-12,0.12,3,26,0,3.35,4.0
Sick Role,4.35e-10,0.17,4,32,1,4.5,5.0
"Emergency Service, Hospital/organization & administration",4.95e-11,0.92,3,258,0,3.03,4.0
Rural Health/statistics & numerical data,6.7e-27,5.92,45,128,9,60.82,3.0
Lipopolysaccharides/pharmacology,1.46e-11,0.33,4,155,0,4.1,2.0
Environmental Monitoring,3.79e-13,0.4,24,176,0,27.27,4.0
Biocompatible Materials/chemistry,7.62e-25,0.03,1,13,0,1.08,2.0
Gene Transfer Techniques,2.28e-29,0.15,1,90,0,1.01,3.0
"Chromatography, Liquid/methods",2.4e-24,0.05,4,15,0,5.07,4.0
Coronary Disease,3.98e-08,0.08,3,5,0,4.8,4.0
"Diabetes Mellitus, Type 1/blood",3.46e-15,4.09,279,60,2,72.9,3.0
Tissue Scaffolds,3.73e-06,0.18,3,21,0,3.43,3.0
Adenocarcinoma/metabolism,3.83e-08,2.34,7,805,4,7.06,5.0
Norepinephrine/metabolism,8.29e-18,0.07,6,10,0,9.6,4.0
HIV Infections/complications,1.82e-36,2.89,262,1694,26,302.52,3.0
Research,3.99e-321,0.02,7,109,0,7.45,3.0
"Kidney Failure, Chronic/physiopathology",5.71e-48,4.34,102,336,29,132.96,6.0
Health Status,1.6e-319,4.38,1088,2071,131,1659.58,3.0
Brain/anatomy & histology,1.78e-09,0.17,20,9,0,13.05,3.0
"Osteoarthritis, Knee/pathology",3.59e-08,9.86,118,1,1,1.01,4.0
Cell Membrane/chemistry,3.74e-06,0.12,3,9,0,4.0,3.0
Vasodilator Agents/pharmacology,8.31e-09,0.29,15,65,1,18.46,5.0
Asian Continental Ancestry Group/statistics & numerical data,1.4e-81,15.44,220,192,34,359.56,4.0
Endometrial Neoplasms/complications,3.19e-06,7.94,13,17,5,22.94,6.0
Occupations/statistics & numerical data,2.93e-18,6.82,34,62,3,52.65,3.0
Smoking/ethnology,4.18e-07,3.75,27,52,3,41.02,4.0
Kidney Diseases/complications,3.31e-08,3.17,44,471,21,48.11,3.0
Phylogeny,1.37e-64,0.12,11,144,0,11.84,2.0
Diabetic Angiopathies/diagnosis,7.31e-07,3.58,15,40,6,20.62,3.0
Health Surveys,2.7e-06,2.89,231,298,16,410.06,4.0
Exercise/psychology,1.23e-09,7.81,294,27,4,29.48,2.0
Bone Density,6.27e-18,8.37,917,91,27,100.03,3.0
Viral Vaccines/immunology,1.92e-13,0.93,1,276,0,1.0,4.0
Phospholipids,4.92e-09,0.09,1,14,0,1.07,3.0
"Death, Sudden, Cardiac/epidemiology",2.82e-06,11.67,10,635,15,10.16,4.0
Sex,8.4e-07,0.18,7,20,0,9.45,3.0
Nursing Assessment,3.92e-08,0.21,6,36,0,7.0,5.0
Albuminuria/physiopathology,1.38e-06,7.75,36,31,5,57.69,5.0
Peptides,2.41e-18,0.07,2,22,0,2.18,2.0
"Ventricular Dysfunction, Left/ethnology",1.52e-06,19.18,3,7,3,4.29,4.0
Nephrectomy/adverse effects,2.33e-12,4.14,30,88,3,40.23,4.0
Cervix Uteri,1.03e-10,0.04,1,5,0,1.2,5.0
"Fatty Acids, Nonesterified/blood",7.04e-23,2.96,125,12,1,13.15,3.0
Lymphocytes/metabolism,3.1e-06,0.31,15,51,2,19.41,5.0
Peptides/analysis,1.19e-12,0.12,4,24,0,4.67,2.0
Immunotherapy/methods,6e-16,0.92,1,317,0,1.0,4.0
Laparotomy/adverse effects,6.41e-09,4.9,17,76,5,20.8,2.0
Vaccination,5.44e-41,0.27,10,254,0,10.39,5.0
"Receptor, Epidermal Growth Factor/genetics",7.16e-09,2.21,1,451,0,1.0,7.0
Renal Insufficiency/epidemiology,4.8e-10,10.01,12,91,5,13.58,4.0
Mixed Function Oxygenases/metabolism,1.35e-10,0.05,2,6,0,2.67,5.0
Vascular Diseases/epidemiology,1.77e-17,7.0,25,52,5,37.02,2.0
"Diabetes Mellitus, Type 2/ethnology",7.17e-07,14.6,187,51,14,64.91,3.0
Sepsis/etiology,2.06e-07,1.27,2,259,1,2.02,3.0
Diabetes Mellitus/etiology,8.79e-13,7.24,151,99,30,163.91,2.0
Patient Care Team/organization & administration,2.5e-06,1.03,12,303,1,12.48,3.0
"Carcinoma, Hepatocellular/pathology",2.35e-09,2.02,5,700,4,5.04,4.0
Zinc/metabolism,1.77e-08,0.2,10,30,0,13.33,4.0
"Natriuretic Peptide, Brain/blood",5.03e-122,8.34,196,1125,46,230.15,4.0
Neurons/drug effects,1.48e-51,0.09,2,91,0,2.04,2.0
Muscles/drug effects,2.87e-07,0.09,3,7,0,4.29,2.0
Muscles/physiology,2.64e-25,0.08,14,4,0,5.14,2.0
Retina/drug effects,2.36e-06,0.05,1,3,0,1.33,3.0
Phenols/pharmacology,3.06e-09,0.3,5,69,0,5.36,6.0
Extracellular Signal-Regulated MAP Kinases/metabolism,4.35e-07,0.28,2,46,0,2.09,5.0
Fatty Liver/complications,1.77e-12,15.29,187,72,5,99.72,3.0
"Hypertrophy, Left Ventricular/physiopathology",3.59e-21,7.54,110,105,19,205.23,4.0
Hemorrhage/etiology,1.84e-08,1.48,10,494,0,10.2,3.0
Schizophrenic Psychology,2.65e-11,0.31,53,85,4,86.05,2.0
Metals/analysis,1.39e-08,0.1,1,16,0,1.06,2.0
Facility Design and Construction,1.43e-06,0.16,3,18,0,3.5,3.0
Color,5e-10,0.09,4,9,0,5.78,4.0
Foot/physiopathology,5.39e-07,2.8,29,2,0,2.14,4.0
Peripheral Vascular Diseases/physiopathology,3.33e-13,6.83,22,41,7,33.8,3.0
"Antibodies, Monoclonal/therapeutic use",1.71e-14,1.55,51,1583,6,52.64,7.0
gamma-Glutamyltransferase/blood,1.46e-08,9.06,154,75,14,111.53,6.0
Proto-Oncogene Proteins/physiology,7.5e-07,0.19,3,26,0,3.35,5.0
Escherichia coli,6.62e-24,0.07,1,32,0,1.03,6.0
Stroke Volume/physiology,3.3e-15,4.68,44,362,14,49.35,5.0
"Models, Theoretical",2.01e-51,0.43,66,745,11,71.85,2.0
Dentistry,5.87e-20,0.01,1,2,0,1.5,1.0
Software,6.82e-41,0.19,41,146,2,52.51,3.0
Anastomotic Leak/etiology,1.51e-15,14.35,12,56,7,14.57,4.0
"Antibodies, Viral/analysis",1.1e-24,0.05,1,22,0,1.05,7.0
Biometry,1.9e-31,0.06,3,32,0,3.28,4.0
Fetus/metabolism,5.47e-07,0.2,8,25,0,10.56,2.0
Carotid Stenosis/epidemiology,7e-07,4.98,13,28,1,19.04,4.0
Cell Movement/physiology,8.13e-20,0.15,1,60,0,1.02,3.0
Infection,3.91e-13,0.05,1,10,0,1.1,2.0
Ethanol/toxicity,2.23e-08,0.31,3,65,0,3.14,3.0
"Hernia, Abdominal/epidemiology",2.75e-07,27.51,9,6,6,10.0,4.0
Public Health Nursing,2.01e-08,0.04,1,4,0,1.25,4.0
Goats,1.68e-06,0.09,1,9,0,1.11,8.0
Cachexia/epidemiology,6.03e-07,30.61,7,6,4,11.14,7.0
Heart Failure/diagnosis,7.26e-13,4.82,47,771,28,49.87,3.0
Forensic Psychiatry,4.48e-07,0.06,1,6,0,1.17,4.0
Gait/physiology,5.07e-27,1.68,126,31,5,38.63,4.0
Adenosine/pharmacology,2.45e-07,0.13,2,17,0,2.24,4.0
Coronary Artery Disease/prevention & control,9.06e-19,5.36,44,182,3,54.64,5.0
Imidazoles/pharmacology,3.64e-11,0.28,13,78,0,15.17,4.0
Calcium Channel Blockers/pharmacology,3.29e-20,0.13,2,54,0,2.07,5.0
Postmenopause,4.33e-09,9.0,467,175,27,240.58,5.0
Lymphocytes/immunology,5.95e-37,0.13,9,89,1,9.91,5.0
Kidney Transplantation/adverse effects,1.39e-71,4.72,188,1094,47,220.31,3.0
Computers,9.07e-31,0.1,25,9,1,12.24,4.0
Kidney/metabolism,5.75e-25,0.23,34,119,1,43.71,3.0
Biocompatible Materials,2.25e-15,0.2,7,61,2,7.8,2.0
Alcohol Drinking/adverse effects,9.13e-65,4.84,183,349,24,278.96,4.0
Urography,5.08e-11,0.02,1,2,0,1.5,4.0
Proton Pump Inhibitors/therapeutic use,3.88e-06,2.52,27,74,0,36.85,5.0
Aortic Valve Stenosis/epidemiology,7.79e-08,9.78,8,34,3,9.88,4.0
Fatty Acids/blood,5.92e-12,2.94,95,18,2,21.41,2.0
Cardiovascular Diseases/complications,1.05e-75,7.23,94,365,46,118.21,1.0
Epinephrine/pharmacology,4.81e-16,0.07,6,10,0,9.6,4.0
Hippocampus/metabolism,5.29e-30,0.07,2,39,0,2.1,5.0
Prostatic Neoplasms/etiology,2.05e-08,7.46,60,43,19,73.82,4.0
Anti-Infective Agents/therapeutic use,6.32e-10,1.49,8,566,3,8.11,4.0
Malnutrition/complications,1.45e-66,13.31,64,117,27,99.01,3.0
Intracranial Aneurysm/surgery,3.57e-11,1.57,1,455,2,1.0,4.0
Food,2.75e-27,1.3,204,56,2,71.37,2.0
Tretinoin/pharmacology,7.47e-15,0.11,1,31,0,1.03,5.0
"Fatty Acids, Omega-3/administration & dosage",5.93e-30,4.83,75,151,6,112.25,4.0
"Delivery, Obstetric/adverse effects",9.98e-08,4.09,34,57,0,54.28,3.0
Protein Kinases/metabolism,3.19e-34,0.07,2,46,0,2.09,6.0
Hypercholesterolemia/drug therapy,7.66e-07,2.06,63,273,2,77.54,6.0
Pharmacies,4.09e-06,0.11,4,5,0,7.2,3.0
Dairy Products,4.35e-15,2.43,84,15,3,17.68,3.0
Body Size,2.81e-10,15.56,317,77,26,95.7,4.0
Epithelial Cells/drug effects,4.32e-07,0.29,2,49,0,2.08,2.0
Cerebrovascular Circulation/drug effects,1.45e-09,0.22,2,45,1,2.09,5.0
"Genes, p53/genetics",4.5e-06,0.84,1,124,0,1.01,8.0
"Ventricular Dysfunction, Left/diagnosis",8.64e-07,3.14,34,185,1,40.25,4.0
Pancreatic Neoplasms/pathology,3.43e-08,2.0,6,762,8,6.05,3.0
Plants,1.65e-20,0.1,3,39,0,3.23,2.0
Meat/analysis,2.93e-09,0.11,3,16,0,3.56,3.0
Calcinosis/epidemiology,1.79e-14,10.36,48,46,7,90.08,4.0
Cerebral Hemorrhage/epidemiology,5.99e-07,5.33,17,107,2,19.7,5.0
Myocardium/metabolism,3.04e-37,0.38,70,480,6,80.21,3.0
Psychotherapy,1.42e-41,0.07,11,36,0,14.36,2.0
Lipocalins/blood,1.11e-21,9.27,31,79,1,43.16,4.0
"Heart Defects, Congenital/surgery",2.32e-09,3.28,10,1438,5,10.07,3.0
Ultrasonography,1.8e-60,0.03,4,19,0,4.84,4.0
Rectal Neoplasms,1.08e-07,0.05,1,4,0,1.25,6.0
Eye Movements/physiology,1.49e-08,0.06,3,3,0,6.0,3.0
Hypothyroidism/blood,2.01e-06,2.63,43,10,0,12.33,3.0
Classification,1.94e-08,0.03,1,2,0,1.5,2.0
Ovulation Induction/methods,2.36e-23,2.66,80,2,0,2.05,4.0
Cryopreservation/methods,2.17e-08,0.23,3,42,0,3.21,3.0
Antioxidants/metabolism,5.28e-11,1.44,152,176,5,283.27,4.0
"Societies, Medical",7.03e-27,0.26,13,167,1,14.01,4.0
"Infant, Small for Gestational Age",2.21e-31,6.56,103,144,8,176.67,6.0
Neuroprotective Agents/pharmacology,5.08e-10,0.32,2,156,0,2.03,5.0
"Carcinoma, Renal Cell/surgery",2.57e-21,5.75,62,665,18,67.78,5.0
Urine,4.89e-30,0.05,4,14,1,5.14,3.0
Self Concept,7.08e-82,2.39,587,156,11,197.46,4.0
Consumer Behavior,5.13e-08,0.17,11,16,0,18.56,3.0
Health Education/methods,2.4e-06,1.69,113,111,1,220.04,3.0
"Hypertrophy, Left Ventricular/etiology",6.95e-36,10.13,97,107,20,184.93,4.0
Income/statistics & numerical data,5.01e-20,4.69,47,181,7,59.2,3.0
Insulin/therapeutic use,4.6e-50,4.14,282,449,12,459.11,7.0
Nutritional Sciences,6.86e-11,0.07,4,5,0,7.2,2.0
Continental Population Groups,5.97e-19,2.8,73,197,6,100.05,3.0
Fiber Optic Technology/instrumentation,3.35e-06,0.05,1,3,0,1.33,4.0
Feeding Behavior,5.09e-10,5.34,536,127,8,157.09,3.0
Vagotomy,3.64e-11,0.04,1,5,0,1.2,4.0
Running/physiology,2.57e-32,3.62,237,22,2,24.04,3.0
"Vision, Ocular",2.96e-18,0.06,5,7,0,8.57,3.0
Depressive Disorder/drug therapy,9.58e-09,0.37,20,107,1,23.74,3.0
Tobacco Smoke Pollution/adverse effects,4.24e-08,2.26,68,165,5,96.02,4.0
Cultural Diversity,7.08e-08,0.23,5,36,2,5.69,5.0
Chickens/growth & development,1.69e-06,0.96,1,143,0,1.01,7.0
Refuse Disposal,1.66e-06,0.17,2,21,0,2.19,6.0
Hypnotics and Sedatives,1.45e-06,0.13,2,12,1,2.33,5.0
Coronary Artery Disease/radionuclide imaging,2.72e-12,4.67,28,117,5,34.7,5.0
Sensory Receptor Cells/physiology,1.37e-08,0.03,1,1,0,2.0,3.0
Gallbladder Diseases/surgery,1.15e-11,4.46,24,67,4,32.6,3.0
T-Lymphocytes/drug effects,1.07e-12,0.2,2,53,0,2.08,6.0
"Antigens, CD14/blood",1.42e-06,6.1,8,22,3,10.91,5.0
Chromosome Aberrations,1.89e-10,0.39,5,522,0,5.05,3.0
Diabetes Complications/prevention & control,2.57e-12,5.37,27,105,2,33.94,3.0
"Fracture Fixation, Internal/methods",1.74e-09,0.35,12,94,3,13.53,4.0
"Animals, Newborn/physiology",3.66e-10,0.28,2,66,2,2.06,4.0
Anorexia Nervosa/psychology,1.97e-06,9.21,201,11,6,11.6,3.0
Oceanic Ancestry Group/statistics & numerical data,3.19e-36,8.37,50,165,10,65.15,4.0
"Plants, Toxic",7.28e-24,0.05,1,23,0,1.04,3.0
Cell Differentiation/genetics,1.6e-06,0.14,4,14,0,5.14,3.0
Erythrocytes/enzymology,3.39e-12,0.13,12,12,0,24.0,3.0
Cerebral Cortex/physiology,2.81e-39,0.06,15,8,0,12.27,7.0
Waist Circumference,4.42e-14,54.17,669,22,59,22.72,5.0
Anticonvulsants/pharmacology,8.96e-07,0.38,9,76,0,10.07,5.0
Communication,7.46e-46,0.19,31,173,0,36.55,2.0
Cell Membrane/metabolism,1.69e-43,0.06,2,46,1,2.09,3.0
Regeneration/physiology,4.56e-07,0.31,5,54,0,5.46,3.0
Leukocytes,3.29e-11,0.17,10,32,0,13.12,3.0
Protein-Serine-Threonine Kinases/metabolism,5.02e-34,0.23,5,172,0,5.15,7.0
Infertility/therapy,2.58e-07,1.64,35,15,1,21.43,3.0
Micronutrients/deficiency,2.11e-07,6.67,22,30,1,38.13,3.0
Glucose,1.11e-08,0.1,6,4,0,6.67,4.0
Fatty Liver/surgery,1.93e-19,19.65,12,23,9,18.26,3.0
Cardiac Surgical Procedures,5.09e-11,0.97,26,664,17,27.02,3.0
Palliative Care/methods,1.52e-08,2.62,3,745,3,3.01,3.0
Information Storage and Retrieval/methods,8.47e-13,0.11,3,20,1,3.45,2.0
Water,9.51e-20,0.16,17,49,1,22.9,4.0
Extracellular Matrix/metabolism,4.41e-10,0.24,5,55,0,5.45,4.0
"Arthroplasty, Replacement, Hip/adverse effects",2.15e-28,3.48,85,206,7,120.07,4.0
Brain/growth & development,1.61e-07,0.24,11,37,0,14.27,3.0
Deafness,8.46e-10,0.02,1,1,0,2.0,5.0
Diabetes Mellitus/ethnology,1.44e-09,9.13,63,48,3,84.57,2.0
Cardiovascular Diseases/rehabilitation,6.5e-08,3.8,18,50,3,24.48,1.0
Bronchi/drug effects,8.48e-07,0.14,1,18,0,1.06,3.0
Patient Participation,2.16e-06,0.39,12,81,3,13.78,5.0
Hypertension/genetics,4.57e-08,6.39,421,76,6,89.72,3.0
gamma-Aminobutyric Acid/pharmacology,4.87e-06,0.06,1,5,0,1.2,4.0
Diabetic Diet,1.75e-10,2.08,46,9,2,10.76,1.0
Diabetes Mellitus/metabolism,3.5e-07,1.39,66,69,2,129.13,2.0
Prosthesis-Related Infections/epidemiology,2.39e-06,5.06,11,46,3,13.63,3.0
Hepatocytes/drug effects,4.32e-06,0.31,3,46,0,3.2,3.0
"Hypertrophy, Left Ventricular/pathology",2.57e-11,8.68,36,40,4,68.4,4.0
Low Back Pain/etiology,3.39e-08,2.6,49,9,1,10.65,5.0
Adenocarcinoma/drug therapy,3.84e-13,3.01,8,1520,5,8.04,5.0
Hydrocephalus/surgery,2.75e-06,1.08,3,191,0,3.05,4.0
Electricity,1.23e-15,0.07,1,19,0,1.05,4.0
Gastrectomy/adverse effects,7.58e-29,4.7,63,139,26,91.55,3.0
Computer Simulation,2.68e-46,0.24,24,256,4,26.25,3.0
Tissue and Organ Harvesting/methods,1.62e-09,2.74,40,147,5,50.88,3.0
Gastroplasty/methods,8.33e-48,31.08,302,50,93,58.28,3.0
"DNA, Viral/analysis",3.19e-16,0.24,2,84,1,2.05,4.0
Tooth Extraction,1.48e-07,0.11,3,11,0,3.82,3.0
Diagnostic Imaging,4.42e-09,0.32,2,132,0,2.03,3.0
Questionnaires/standards,3.67e-25,1.77,162,77,1,113.6,1.0
"Disease Models, Animal",1.98e-37,0.77,21,1414,1,21.31,2.0
Substance-Related Disorders/psychology,1.55e-06,0.23,14,25,0,21.84,2.0
Infection Control/methods,2.96e-09,1.1,5,304,0,5.08,5.0
Anoxia,6.93e-08,0.21,7,32,1,8.53,4.0
Magnetic Resonance Imaging/methods,2.49e-07,0.57,219,575,5,302.41,5.0
Testis/drug effects,2.03e-09,0.13,2,23,0,2.17,4.0
Peptide Fragments/metabolism,6.41e-10,0.28,8,66,3,8.97,3.0
Amino Acids/analysis,3.39e-16,0.02,2,1,0,1.5,2.0
Surgical Stapling/methods,1.16e-08,4.91,18,37,7,26.76,4.0
Gastroesophageal Reflux/physiopathology,4.81e-09,2.13,40,8,0,9.6,6.0
Heart,9.47e-44,0.04,4,22,1,4.73,2.0
Acclimatization,1.24e-07,0.23,8,38,0,9.68,4.0
Cesarean Section/statistics & numerical data,2.01e-45,6.57,90,166,8,138.8,4.0
Lymph Node Excision/methods,1.86e-15,5.15,59,595,9,64.85,2.0
"Kidney Failure, Chronic/diagnosis",1.84e-11,5.19,24,139,7,28.14,6.0
Kidney Diseases/therapy,1.97e-09,3.85,33,359,18,36.03,3.0
Hypoglycemia/epidemiology,7.8e-09,5.59,15,41,2,20.49,4.0
Coronary Vessels/pathology,4.47e-06,1.87,58,249,8,71.51,4.0
"Sexual Behavior, Animal/physiology",5.96e-09,0.28,6,60,0,6.6,5.0
Cardiovascular Diseases/metabolism,1.74e-46,5.79,86,201,7,122.8,1.0
Heart Atria/ultrasonography,1.58e-10,3.61,29,69,7,41.19,3.0
African Continental Ancestry Group/statistics & numerical data,1.32e-61,10.31,78,212,10,106.7,4.0
Liver/cytology,7.91e-19,0.09,3,30,0,3.3,2.0
DNA/isolation & purification,8.46e-10,0.05,1,6,0,1.17,3.0
Child Behavior/psychology,8.75e-20,2.48,71,4,0,4.23,3.0
Geriatric Nursing,7.03e-09,0.1,1,17,0,1.06,4.0
Rectum/surgery,5.49e-09,2.61,45,413,32,49.9,5.0
Enzyme Inhibitors/pharmacology,2.31e-51,0.2,14,225,0,14.87,4.0
Herpesviridae Infections/veterinary,3.32e-06,1.2,1,172,0,1.01,3.0
Hip Fractures/blood,5.08e-08,8.89,11,26,0,15.65,3.0
"Hepatitis B, Chronic/complications",2.8e-11,4.32,34,160,2,41.23,4.0
Natural Orifice Endoscopic Surgery/methods,3.11e-07,4.69,27,43,2,43.95,4.0
Attention,7.41e-22,0.15,32,24,0,42.0,4.0
Diabetes Complications/blood,4.6e-12,11.41,30,33,2,57.27,3.0
"Education, Medical/methods",1.17e-07,0.19,2,30,0,2.13,3.0
Marital Status/statistics & numerical data,1.72e-06,7.32,7,52,5,7.94,4.0
Health Services,9.58e-14,0.08,1,21,0,1.05,2.0
Atherosclerosis/ultrasonography,2.82e-07,6.31,23,31,3,40.06,5.0
Bile Ducts,1.94e-08,0.07,1,10,0,1.1,3.0
Confidentiality,6.91e-11,0.15,2,33,0,2.12,4.0
Body Size/physiology,1.21e-09,13.78,126,52,7,73.46,4.0
Pregnancy Complications/prevention & control,9.98e-29,4.17,74,179,2,104.59,2.0
Biological Markers/metabolism,3.25e-17,2.55,76,215,7,102.87,1.0
Hemodynamics/drug effects,7.62e-27,0.25,16,157,1,17.63,3.0
"Pattern Recognition, Visual/physiology",3.01e-21,0.04,5,3,0,4.8,5.0
Patient Care Planning,3.16e-15,0.25,9,92,0,9.88,4.0
Parent-Child Relations,3.17e-14,1.08,161,56,1,75.48,5.0
Discrimination Learning/physiology,4.31e-07,0.04,1,2,0,1.5,4.0
Splints,5.47e-07,0.09,3,5,0,4.8,6.0
Magnetic Resonance Spectroscopy,1.39e-10,0.22,22,38,0,34.74,4.0
Calcinosis/blood,7.84e-12,12.19,24,28,3,44.57,4.0
Biosensing Techniques,1.04e-12,0.08,2,15,0,2.27,3.0
"Antineoplastic Agents, Hormonal/adverse effects",1.13e-10,3.39,30,75,5,42.0,5.0
Sports Medicine,3.21e-07,0.14,7,9,0,12.44,3.0
Psychiatry,7.64e-30,0.03,1,12,1,1.08,3.0
Enzyme-Linked Immunosorbent Assay/methods,1.47e-10,0.2,9,40,0,11.03,5.0
Overweight,4.72e-06,43.47,440,13,38,13.38,4.0
Fear/physiology,4.41e-07,0.09,1,11,0,1.09,3.0
Electrocardiography,1.58e-10,0.99,130,1507,40,141.21,4.0
Hip Joint/surgery,1.14e-06,1.43,57,54,0,105.16,4.0
Naloxone/pharmacology,2.59e-09,0.04,1,4,0,1.25,4.0
Bacterial Infections/prevention & control,7.8e-09,1.2,1,261,1,1.0,2.0
DNA Repair,1.41e-28,0.12,6,67,0,6.54,3.0
Personnel Management,3.96e-15,0.03,2,1,0,1.5,3.0
Tunica Media/ultrasonography,1.35e-06,10.15,42,28,4,46.67,3.0
Wounds and Injuries/therapy,2.13e-09,2.18,5,823,6,5.03,1.0
Urinary Bladder Neoplasms/pathology,1.87e-07,1.8,10,602,2,10.17,4.0
Pancreaticoduodenectomy/adverse effects,3.16e-19,10.42,22,231,14,24.1,3.0
"Malaria, Falciparum/drug therapy",1.77e-06,0.97,1,146,0,1.01,4.0
Abdominal Wall/surgery,5.14e-11,6.3,84,79,8,153.3,4.0
Drug Delivery Systems/methods,7.52e-15,0.31,8,116,0,8.55,3.0
Metabolism,1.38e-43,0.03,6,3,0,4.5,2.0
Oxidation-Reduction,3.43e-19,0.05,4,7,0,6.29,4.0
Nursing Staff/psychology,3.95e-10,0.1,3,14,0,3.64,3.0
Hematopoietic Stem Cells/metabolism,1.32e-07,0.26,1,43,0,1.02,3.0
Heptanoic Acids/therapeutic use,3.75e-21,4.28,56,167,2,74.78,3.0
Potassium/metabolism,3.65e-24,0.08,8,17,1,11.76,4.0
Metabolic Diseases/epidemiology,5.67e-09,20.54,74,27,6,36.85,2.0
Age Factors,3.01e-07,2.19,75,178,6,106.6,4.0
Child Welfare/statistics & numerical data,7.99e-12,4.83,30,117,1,37.69,4.0
Spinal Cord/physiology,3.39e-27,0.03,2,12,0,2.33,3.0
Stillbirth/epidemiology,8.3e-18,12.74,27,269,5,29.71,4.0
Adrenocorticotropic Hormone,6.56e-07,0.11,5,6,0,9.17,7.0
Informed Consent,3.37e-15,0.23,3,76,0,3.12,4.0
X Chromosome,1.03e-16,0.05,1,13,0,1.08,5.0
Accidents,2.12e-23,0.16,3,78,0,3.12,3.0
Breast,5.42e-15,0.04,2,7,0,2.57,2.0
"Diabetes Mellitus, Type 2/complications",8.32e-269,8.61,803,980,99,1460.97,3.0
MAP Kinase Signaling System/physiology,8.47e-07,0.13,1,16,0,1.06,4.0
Statistics as Topic,3.66e-36,0.11,12,61,0,14.36,3.0
Reproductive History,1.83e-08,7.7,43,40,5,77.21,4.0
Agriculture/methods,1.67e-07,0.21,2,33,0,2.12,2.0
Otolaryngology,1.1e-08,0.05,2,3,0,3.33,4.0
Dermatology,7.22e-11,0.07,3,7,0,4.29,3.0
Conditioning (Psychology),5.76e-08,0.03,1,1,0,2.0,4.0
Azetidines/therapeutic use,4.17e-07,3.86,25,48,1,38.02,4.0
Angiotensin II Type 1 Receptor Blockers/therapeutic use,1.17e-15,5.15,51,399,6,57.52,5.0
Kidney Transplantation/physiology,8.84e-51,4.37,106,468,44,130.01,3.0
Plant Leaves/chemistry,6.01e-07,0.33,4,59,0,4.27,3.0
Protein Precursors/blood,2.27e-09,4.19,45,396,4,50.11,3.0
Pregnancy/blood,8.8e-23,2.19,97,15,1,17.32,5.0
Bariatric Surgery/economics,3.81e-07,17.97,16,12,4,21.0,2.0
Diabetes Complications/epidemiology,5.45e-57,11.93,93,134,10,157.54,3.0
Streptococcal Infections/diagnosis,3.48e-06,0.99,1,143,0,1.01,4.0
Recombinant Fusion Proteins/metabolism,1.15e-07,0.1,1,13,0,1.08,4.0
Interleukin-18/blood,6.11e-08,7.39,35,35,6,70.0,5.0
Spermatogenesis,3.21e-07,0.04,1,3,0,1.33,5.0
African Americans,1.23e-80,5.24,433,573,51,760.21,4.0
Prenatal Care/methods,8.48e-12,3.1,44,142,2,57.63,3.0
Bronchi,2.44e-17,0.11,1,37,0,1.03,3.0
Poverty/statistics & numerical data,4.45e-31,5.52,60,127,3,88.35,3.0
Suburethral Slings,6e-09,3.85,54,3,0,3.17,3.0
Environmental Exposure/statistics & numerical data,1.92e-09,3.17,37,154,3,45.89,4.0
Decision Making,1.95e-09,0.54,48,541,5,52.26,4.0
Physical Endurance,2.72e-12,2.79,92,18,3,21.52,3.0
Melatonin/pharmacology,3.75e-06,0.32,6,51,0,6.71,3.0
Ferric Compounds/chemistry,1.5e-10,0.03,1,3,0,1.33,3.0
Preanesthetic Medication,9e-07,0.06,1,6,0,1.17,2.0
"Repetitive Sequences, Nucleic Acid",2.72e-15,0.05,1,7,1,1.14,4.0
Breast/pathology,7.53e-08,1.48,74,71,4,139.12,2.0
"Surgical Procedures, Operative",1.3e-47,0.22,16,227,6,17.13,1.0
Educational Measurement,2.02e-13,0.08,6,9,0,10.0,2.0
Radionuclide Imaging,3e-26,0.02,1,5,0,1.2,4.0
Mycobacterium tuberculosis/genetics,1.67e-07,0.27,1,51,0,1.02,7.0
"Genes, MHC Class II",3.09e-07,0.13,1,18,0,1.06,4.0
Hyperglycemia/blood,7.6e-15,6.75,53,67,7,94.93,4.0
Gastrectomy/methods,6.11e-265,10.78,264,623,93,375.87,3.0
Stroke/epidemiology,1.56e-114,7.94,170,988,60,199.25,4.0
Epilepsy/diagnosis,1.88e-08,0.28,4,57,0,4.28,4.0
Atherosclerosis/blood,3.41e-14,11.09,131,75,8,117.94,5.0
"Ventricular Dysfunction, Left/epidemiology",8.54e-21,8.57,27,87,6,35.38,4.0
Periodicity,4.62e-09,0.25,15,49,1,19.59,3.0
"Stress, Psychological/physiopathology",1.69e-11,1.3,99,77,3,136.89,3.0
Diagnosis,8.74e-31,0.06,2,35,0,2.11,1.0
"Renal Insufficiency, Chronic/blood",4.81e-32,9.33,41,129,8,54.03,5.0
Urban Population/statistics & numerical data,1.97e-90,6.43,230,378,15,369.95,3.0
Leg/physiology,2.27e-14,1.72,61,5,0,5.41,4.0
Health Care Reform/legislation & jurisprudence,6.12e-10,0.09,1,16,0,1.06,3.0
"Fractures, Bone/epidemiology",3.74e-21,6.45,112,125,8,212.35,2.0
Fibromyalgia/physiopathology,1.32e-06,2.64,28,2,1,2.14,3.0
Mental Disorders/rehabilitation,5.93e-13,0.12,4,22,1,4.73,1.0
"Sodium Chloride, Dietary/adverse effects",1.8e-15,5.88,30,59,1,45.25,4.0
Mass Screening/statistics & numerical data,2.05e-12,4.13,41,255,7,47.59,3.0
"Muscle, Skeletal/physiology",9.63e-50,1.3,347,40,7,44.61,3.0
Laparoscopy,1.44e-228,5.08,715,1243,192,1126.28,4.0
Deoxycytidine/analogs & derivatives,6.88e-10,3.08,9,1132,0,9.07,4.0
Myocardial Contraction,4.23e-10,0.3,16,80,1,19.2,4.0
Learning/physiology,2.28e-18,0.07,6,10,0,9.6,3.0
Genomics,1.91e-08,0.36,5,93,1,5.27,5.0
Cholinesterase Inhibitors/pharmacology,3.95e-06,0.17,3,19,0,3.47,5.0
Amino Acids/chemistry,2.8e-14,0.04,3,2,0,3.33,2.0
Primary Health Care/statistics & numerical data,1.34e-09,2.64,38,104,4,51.88,4.0
Intraoperative Complications/epidemiology,1.88e-27,7.41,41,162,10,51.38,3.0
Colorectal Neoplasms/etiology,3.83e-16,6.55,85,93,7,162.69,5.0
Water/metabolism,2.26e-13,0.18,7,46,0,8.07,4.0
Liver Circulation,9.58e-07,0.28,1,41,1,1.02,6.0
Transplant Recipients,1.06e-07,7.89,10,64,4,11.56,2.0
Emergency Medical Services,3.74e-15,1.36,4,558,1,4.03,3.0
Anatomy,4.03e-08,0.03,1,2,0,1.5,3.0
Asthma,1.49e-07,0.08,3,5,0,4.8,3.0
Antioxidants/administration & dosage,6.86e-14,2.99,79,165,4,116.82,4.0
Premature Birth,3.66e-06,4.05,20,96,0,24.17,5.0
Horses/physiology,2.47e-11,0.1,4,16,0,5.0,8.0
Hand,3.28e-06,0.25,13,31,0,18.45,4.0
Lung Neoplasms/genetics,6.36e-21,2.03,5,1103,0,5.02,3.0
Periodicals as Topic,1.03e-29,0.08,7,36,0,8.36,5.0
"Chromatography, High Pressure Liquid/methods",1.79e-60,0.04,5,27,0,5.93,5.0
"RNA, Messenger/biosynthesis",3.15e-13,0.2,7,54,0,7.91,4.0
Adenocarcinoma/surgery,7.89e-18,5.26,84,2267,69,87.11,5.0
Mitochondria/metabolism,1.7e-30,0.2,25,125,0,30.0,4.0
Organometallic Compounds,4.3e-09,0.13,2,21,0,2.19,2.0
Epithelial Cells/cytology,2.15e-08,0.15,2,23,0,2.17,2.0
"Reagent Kits, Diagnostic",3e-10,0.16,1,33,0,1.03,2.0
Epitopes,1.24e-09,0.04,1,4,0,1.25,3.0
Health Surveys/statistics & numerical data,1.79e-16,10.3,37,46,4,66.76,4.0
Spectrum Analysis,1.69e-09,0.02,1,1,0,2.0,3.0
Pregnancy Outcome/ethnology,4.36e-12,8.64,20,76,0,25.26,3.0
Epithelial Cells/metabolism,1.74e-18,0.16,2,59,0,2.07,2.0
"Social Control, Informal",4.14e-09,1.82,35,6,0,7.03,3.0
Amenorrhea/etiology,2.25e-06,1.67,25,2,0,2.16,4.0
Water-Electrolyte Balance,4.78e-07,0.32,22,62,2,29.81,3.0
Dexamethasone/pharmacology,5.7e-12,0.24,14,67,0,16.93,4.0
Motion Perception/physiology,4e-18,0.01,1,1,0,2.0,5.0
Bacteria/genetics,1.81e-17,0.1,1,33,0,1.03,1.0
Polycystic Ovary Syndrome/blood,4.22e-09,28.3,403,1,2,1.0,4.0
Obesity/metabolism,1.12e-18,11.88,1454,92,43,97.82,4.0
"Decision Making, Organizational",1.04e-06,0.13,3,13,0,3.69,3.0
Coronary Artery Disease/ultrasonography,1.72e-08,3.11,29,100,3,37.41,5.0
Breast Neoplasms/surgery,2.3e-28,2.76,189,998,12,224.79,3.0
Serum Albumin/analysis,6.82e-19,3.21,46,148,20,60.3,4.0
Endoplasmic Reticulum/metabolism,4.19e-17,0.07,2,18,0,2.22,7.0
DNA/biosynthesis,2.55e-25,0.02,1,5,0,1.2,3.0
Coronary Artery Disease/epidemiology,1.2e-116,11.88,211,283,30,368.32,5.0
"Image Processing, Computer-Assisted/methods",4.21e-12,0.26,40,62,1,65.81,3.0
Venous Thromboembolism/epidemiology,5.53e-46,9.87,55,118,9,80.64,5.0
Triazoles/therapeutic use,5.81e-09,3.01,50,274,2,59.12,4.0
Premature Birth/etiology,6.27e-21,7.29,39,69,1,61.04,5.0
DNA Damage,6.71e-14,0.31,45,118,1,62.16,3.0
Coronary Stenosis/blood,3e-06,7.4,6,16,3,8.25,5.0
United States Food and Drug Administration,4.41e-07,0.24,2,36,0,2.11,7.0
"Killer Cells, Natural/immunology",1.56e-15,0.35,8,239,0,8.27,6.0
Nutritional Support/methods,9.89e-21,6.8,29,95,9,37.85,3.0
Hearing/physiology,2.26e-06,0.1,4,4,0,8.0,4.0
Biological Markers/blood,1.08e-231,6.43,493,896,39,764.26,1.0
Myocardial Ischemia/blood,3.41e-07,3.8,17,94,7,20.07,3.0
Pesticide Residues/analysis,1.54e-09,0.12,5,16,0,6.56,4.0
"Carcinoma, Squamous Cell/genetics",5.43e-14,1.81,3,639,0,3.01,5.0
Esophagectomy/adverse effects,4.17e-06,6.91,12,195,7,12.74,3.0
Motor Activity/drug effects,7.55e-11,0.25,16,58,1,20.41,3.0
Nutritional Sciences/education,1.7e-11,2.1,69,22,0,29.01,2.0
Hibernation,2.41e-06,0.07,1,7,0,1.14,5.0
Hydrogen Peroxide/pharmacology,1.31e-11,0.05,1,10,0,1.1,4.0
Serotonin Antagonists/pharmacology,1.19e-06,0.07,2,4,0,3.0,6.0
"Embolization, Therapeutic/methods",1.11e-13,1.72,4,626,0,4.03,3.0
Clinical Laboratory Techniques,1.03e-10,0.11,3,19,0,3.47,2.0
Medical Errors/prevention & control,1.51e-09,0.88,2,204,0,2.02,3.0
Electroencephalography,2.65e-63,0.11,18,116,0,20.79,4.0
Thiazolidinediones/therapeutic use,3.05e-20,8.91,185,130,7,221.35,4.0
Dyslipidemias/diagnosis,7.91e-07,15.15,23,18,0,32.09,4.0
Heart Transplantation/immunology,3.08e-06,0.99,4,189,0,4.08,4.0
Sarcopenia/etiology,8.06e-10,23.78,13,12,5,23.08,5.0
"Evoked Potentials, Visual/physiology",5.19e-10,0.04,2,1,0,1.5,2.0
Legislation as Topic,2.78e-18,0.04,1,10,0,1.1,3.0
Cisplatin/therapeutic use,7.72e-08,2.59,1,467,0,1.0,3.0
Leukocytes/drug effects,3.21e-06,0.19,2,24,0,2.17,3.0
Housing,6.1e-07,0.33,5,59,2,5.42,4.0
Bone Density/drug effects,4.06e-16,4.4,256,42,3,48.89,3.0
Pulmonary Embolism/epidemiology,1e-18,7.77,26,146,10,30.63,3.0
Lung/immunology,3.44e-06,0.82,2,161,1,2.02,2.0
"Infant, Premature",1.37e-08,1.45,45,1011,0,47.0,5.0
Angiogenesis Inhibitors/therapeutic use,6.78e-08,1.58,6,460,2,6.08,5.0
Lung Diseases,1.3e-20,0.01,1,2,0,1.5,2.0
Dentists,5.99e-16,0.06,1,17,0,1.06,3.0
"Imaging, Three-Dimensional/methods",6.04e-07,0.36,50,83,1,80.12,4.0
Gastric Bypass/education,4e-08,23.26,2,7,5,2.57,3.0
"Infertility, Female/drug therapy",9.78e-13,1.88,47,2,0,2.09,5.0
Geriatric Assessment/statistics & numerical data,4.27e-07,4.27,18,88,3,21.68,3.0
"RNA, Transfer/metabolism",2.34e-07,0.03,1,1,0,2.0,4.0
Exercise Test,5.22e-31,2.68,190,446,24,270.94,3.0
Public Policy,3.83e-31,0.23,6,155,0,6.23,4.0
Myocardium,1.44e-12,0.08,2,16,0,2.25,3.0
Micronutrients/administration & dosage,8.57e-15,8.81,83,72,3,134.46,3.0
Fibrinolytic Agents/therapeutic use,1.73e-09,2.66,11,1232,6,11.1,5.0
Alcohol Drinking,1.24e-08,1.33,96,124,10,170.32,4.0
"Technology, Radiologic",7.55e-07,0.1,1,5,2,1.2,2.0
Gynecology,3.04e-14,0.11,4,28,0,4.57,4.0
Appendectomy/methods,1.02e-10,3.18,35,87,1,49.08,3.0
Coronary Artery Disease/drug therapy,5.43e-10,4.44,40,338,5,44.73,5.0
Prefrontal Cortex/physiology,1.55e-06,0.14,9,3,0,4.0,9.0
Military Personnel/statistics & numerical data,1.72e-26,4.75,91,159,0,143.08,3.0
Brain/drug effects,2.47e-47,0.19,9,190,0,9.43,3.0
"Education, Medical, Continuing",3.19e-09,0.22,9,44,0,10.84,4.0
"Antiretroviral Therapy, Highly Active/adverse effects",1.27e-39,5.85,72,151,6,106.33,4.0
Frail Elderly/statistics & numerical data,1.48e-18,8.37,22,187,15,24.59,5.0
Membrane Transport Proteins/metabolism,4.6e-12,0.13,1,30,0,1.03,4.0
Chromosome Mapping,2.91e-14,0.19,31,29,0,56.13,3.0
Calcium/metabolism,3.03e-88,0.16,69,238,7,89.0,3.0
Central Nervous System/metabolism,1.54e-07,0.13,3,17,0,3.53,2.0
"Renal Insufficiency, Chronic/complications",3.16e-17,7.69,37,418,11,40.28,5.0
"Muscle, Smooth, Vascular/metabolism",1.15e-18,0.14,2,54,0,2.07,4.0
Government Agencies,1.21e-06,0.12,1,15,0,1.07,3.0
Kidney Neoplasms/epidemiology,1.02e-29,8.39,48,84,7,75.43,4.0
Analgesics/pharmacology,1.57e-14,0.07,2,17,0,2.24,5.0
"Renal Insufficiency, Chronic/therapy",5.08e-10,6.52,18,219,11,19.48,5.0
Cell Division,7.08e-27,0.04,1,20,0,1.05,3.0
"Coated Materials, Biocompatible/chemistry",2.36e-06,0.09,1,9,0,1.11,3.0
DNA/genetics,1.01e-15,0.25,32,89,1,43.51,3.0
Bibliometrics,1.11e-07,0.22,1,35,0,1.03,4.0
Penicillins/therapeutic use,1.63e-12,0.21,1,54,0,1.02,4.0
gamma-Aminobutyric Acid/metabolism,3.68e-17,0.03,1,7,0,1.14,4.0
"RNA, Ribosomal, 16S/genetics",2.72e-06,0.2,3,26,0,3.35,5.0
Fetal Growth Retardation/epidemiology,3.48e-14,6.42,21,51,4,29.65,3.0
Muscle Contraction/drug effects,2.8e-22,0.05,4,10,1,5.6,4.0
Corticosterone/blood,3.84e-06,0.17,3,19,0,3.47,6.0
Peripheral Arterial Disease/diagnosis,8.45e-10,6.6,14,65,5,17.02,4.0
Serotonin/pharmacology,8.7e-16,0.02,1,2,0,1.5,4.0
Endothelial Cells/drug effects,8.8e-07,0.31,4,52,0,4.31,3.0
Biomass,8.35e-07,0.33,2,65,1,2.06,4.0
Auditory Perception/physiology,3.34e-20,0.02,2,2,0,4.0,4.0
Kidney/physiopathology,3.52e-31,2.58,147,512,22,189.21,3.0
Blood Vessel Prosthesis,2.23e-21,1.56,6,970,3,6.04,3.0
Iodine Radioisotopes/therapeutic use,1.18e-06,1.24,4,252,0,4.06,4.0
Aneurysm/surgery,1.19e-06,1.36,1,207,0,1.0,3.0
Urban Health/statistics & numerical data,1.14e-43,7.63,68,202,8,90.89,3.0
Memory/physiology,4.32e-18,0.14,25,17,0,28.56,4.0
Water Pollutants/analysis,3.05e-12,0.11,1,26,0,1.04,4.0
Postural Balance/physiology,2.2e-25,1.67,118,23,3,27.48,3.0
Exercise Tolerance/physiology,2.42e-23,7.61,156,132,25,243.69,4.0
Curriculum,2.87e-31,0.1,10,43,0,12.33,2.0
Testosterone/deficiency,2.51e-09,7.24,36,41,3,67.61,6.0
Albuminuria/epidemiology,7.23e-29,15.5,94,72,13,127.15,5.0
Rivers/chemistry,2.13e-06,0.28,4,41,0,4.39,3.0
Stomach Neoplasms/diagnosis,1.79e-07,1.23,7,325,0,7.15,4.0
Adiponectin/blood,8.12e-12,31.77,939,83,52,90.34,4.0
Economics,3.35e-20,0.12,3,46,0,3.2,2.0
Gene Expression Profiling,1.06e-16,0.86,34,722,4,35.6,3.0
Fetus,1.68e-22,0.05,2,11,1,2.36,2.0
"Carcinoma, Squamous Cell/metabolism",4.68e-10,2.39,5,766,1,5.03,5.0
Living Donors,2.37e-66,5.9,163,1076,28,187.69,3.0
Myocardium/cytology,2.13e-09,0.22,3,44,0,3.2,3.0
"Bile Ducts, Intrahepatic",2.36e-06,2.81,1,416,0,1.0,3.0
Neuropsychological Tests,7.35e-10,0.19,15,27,0,23.33,3.0
Neoplasms/enzymology,1.08e-07,0.17,1,27,0,1.04,1.0
"Analgesics, Opioid/pharmacology",5.58e-08,0.14,3,19,0,3.47,6.0
Amyloid beta-Peptides/metabolism,3.24e-12,0.11,3,24,0,3.38,3.0
Blood Glucose/analysis,3.86e-12,4.45,545,433,28,777.02,5.0
Lung Neoplasms/drug therapy,4.13e-31,3.28,10,3260,7,10.03,3.0
Angiotensin II/pharmacology,1.24e-11,0.14,10,21,0,14.76,5.0
Gene Expression/drug effects,1.53e-07,0.27,9,48,0,10.69,3.0
Coronary Stenosis/epidemiology,1.7e-06,9.69,8,16,0,12.0,5.0
Venous Thrombosis/epidemiology,4.32e-32,7.18,47,140,10,62.78,5.0
Albuminuria/etiology,4e-10,7.32,56,53,6,103.16,5.0
Temperature,3.02e-36,0.38,30,435,4,32.07,3.0
Brain Neoplasms/surgery,2.06e-09,2.34,11,889,0,11.14,4.0
Dietary Carbohydrates/pharmacology,1.51e-11,2.22,52,9,1,10.56,2.0
Uterine Cervical Neoplasms/diagnosis,2.66e-09,1.11,10,411,2,10.24,6.0
Stroke/blood,6.29e-22,6.13,48,270,7,56.53,4.0
Database Management Systems,5.53e-08,0.17,1,27,0,1.04,4.0
Cell Nucleus/metabolism,1.18e-34,0.16,4,117,0,4.14,4.0
Dopamine/metabolism,3.37e-25,0.1,16,22,0,27.64,4.0
Substance-Related Disorders/rehabilitation,2.6e-11,0.11,3,21,0,3.43,2.0
Cachexia/complications,1.13e-06,8.57,5,13,4,6.92,7.0
Nitrogen/analysis,1.1e-07,0.09,1,12,0,1.08,3.0
Adenosine Triphosphate/metabolism,1.36e-19,0.13,12,37,0,15.89,5.0
School Health Services/organization & administration,4.81e-13,2.36,66,12,0,14.18,4.0
Venous Thrombosis/etiology,2.71e-09,2.95,47,249,5,55.87,5.0
Allergens,8.09e-09,0.06,2,6,0,2.67,3.0
Community Mental Health Services,2.25e-08,0.05,2,3,0,3.33,3.0
"Gene Expression Regulation, Enzymologic/drug effects",2.5e-06,0.15,1,19,0,1.05,4.0
Parents,3.25e-18,2.04,213,119,8,185.48,2.0
Nitric Oxide/physiology,1.93e-16,0.23,7,82,1,7.6,3.0
"Lymphoma, Non-Hodgkin/pathology",4.5e-07,0.91,1,149,0,1.01,4.0
"DNA, Viral/genetics",1.13e-14,0.19,2,57,0,2.07,4.0
"Cholesterol, LDL/blood",4.53e-42,7.02,302,281,18,542.46,4.0
"Genetics, Medical",9.52e-18,0.03,2,2,0,4.0,3.0
Coronary Artery Bypass/adverse effects,3.74e-17,5.12,46,762,37,48.78,5.0
Oxygen/pharmacology,9.2e-11,0.14,2,29,0,2.14,3.0
Cadherins/metabolism,6.32e-09,0.85,1,177,0,1.01,5.0
Simvastatin/therapeutic use,4.9e-14,4.07,41,150,2,52.21,5.0
Anti-Obesity Agents/therapeutic use,3.21e-10,17.96,255,60,20,74.12,5.0
Endometrial Neoplasms/pathology,9.16e-21,3.81,60,314,18,71.46,6.0
"Intestine, Small",1.11e-11,0.33,5,99,1,5.25,4.0
Ovarian Neoplasms/pathology,2.84e-11,1.57,13,758,3,13.22,3.0
Cleft Lip/surgery,1.18e-07,0.12,1,18,0,1.06,4.0
Sheep/physiology,1.02e-12,0.15,2,37,0,2.11,8.0
Leukocytes/immunology,8.5e-09,0.24,6,48,0,6.75,3.0
Nerve Net/physiology,1.16e-15,0.07,7,2,0,2.57,2.0
Head,3.62e-11,0.08,3,11,0,3.82,2.0
Perfusion,1.54e-08,0.2,1,35,1,1.03,2.0
Carbohydrate Metabolism,4.81e-15,0.19,33,22,2,36.67,3.0
Lumbar Vertebrae/pathology,3.52e-10,1.77,49,18,0,24.61,5.0
Hematopoietic Stem Cell Transplantation,2.02e-10,3.54,19,2036,4,19.18,5.0
Paper,1.25e-06,0.12,1,15,0,1.07,3.0
Learning Curve,1.06e-10,6.57,34,45,7,59.69,5.0
Cell Proliferation/drug effects,2.57e-17,0.29,3,156,0,3.06,4.0
"Education, Medical, Graduate",2.32e-16,0.13,1,40,1,1.03,4.0
Analgesia,7.91e-21,0.03,2,6,0,2.67,2.0
Nursing,8.69e-36,0.04,2,21,0,2.19,2.0
Maternal Welfare,2.28e-08,3.13,45,270,3,52.5,4.0
Carrier Proteins/chemistry,1.48e-12,0.03,1,5,0,1.2,3.0
Continental Population Groups/statistics & numerical data,7.52e-28,7.82,41,135,7,53.45,3.0
Vitamin D Deficiency/complications,7.27e-23,6.47,93,116,11,167.56,6.0
"Lens Implantation, Intraocular",2.37e-06,0.04,1,2,0,1.5,4.0
Odors,3.29e-07,0.13,7,8,0,13.12,3.0
Risk Assessment,2.91e-14,2.63,91,606,26,104.67,4.0
"Pattern Recognition, Automated/methods",5.21e-24,0.11,8,42,0,9.52,2.0
Breast Neoplasms/complications,9.67e-12,3.5,70,124,15,109.52,3.0
RNA-Binding Proteins/metabolism,1.62e-16,0.21,2,74,0,2.05,4.0
Immune Tolerance,4.19e-26,0.18,2,95,0,2.04,4.0
Head and Neck Neoplasms/drug therapy,2.05e-07,1.96,2,407,1,2.01,3.0
Nerve Tissue Proteins/metabolism,1.26e-35,0.16,7,115,0,7.43,3.0
Risk Reduction Behavior,2.34e-61,8.32,266,272,27,526.13,3.0
Low Back Pain/epidemiology,2.45e-06,8.49,91,3,0,3.1,5.0
Sewage/chemistry,6.22e-10,0.04,1,6,0,1.17,4.0
Social Class,3.61e-204,5.88,504,897,50,787.18,3.0
Postpartum Period/physiology,7e-07,2.16,32,7,0,8.53,3.0
Stomach Neoplasms/surgery,2.05e-26,4.95,109,1780,55,115.67,4.0
Liver/drug effects,3.31e-23,0.39,50,312,2,58.01,2.0
"Tuberculosis, Pulmonary",3.27e-24,0.02,2,4,0,3.0,3.0
Skin/immunology,1.48e-10,0.08,1,15,0,1.07,2.0
Peptide Fragments/pharmacology,4.6e-12,0.19,12,41,0,15.51,3.0
Affect,5e-06,0.94,96,42,2,60.38,3.0
Waist-Hip Ratio,4.19e-11,61.2,344,10,36,10.29,4.0
"Arthroplasty, Replacement, Knee/statistics & numerical data",2.81e-07,9.38,35,30,1,55.71,4.0
Postural Balance,1.96e-11,1.48,61,16,3,20.2,3.0
Adenocarcinoma/secondary,9.9e-13,2.71,4,1043,2,4.02,5.0
"Lipoproteins, HDL/blood",2.06e-07,2.21,87,44,2,66.25,3.0
Menstrual Cycle/physiology,9.78e-14,2.82,76,9,1,10.07,3.0
Scoliosis/surgery,2.78e-06,1.3,52,50,3,98.08,5.0
Oxidoreductases/metabolism,9.71e-19,0.11,8,29,0,10.21,3.0
Heart/embryology,4.62e-07,0.23,2,36,0,2.11,2.0
"RNA, Messenger/analysis",5.35e-08,0.39,17,104,2,19.78,4.0
Triglycerides/metabolism,2.89e-15,2.42,102,24,4,29.65,3.0
Insulin/blood,2.89e-57,6.12,871,52,21,55.1,7.0
Pyrimidines/pharmacology,2.97e-11,0.32,4,97,1,4.16,3.0
Mental Health Services/organization & administration,1.07e-12,0.12,1,31,0,1.03,2.0
Isoquinolines/pharmacology,1.2e-06,0.1,1,12,0,1.08,3.0
"Pulmonary Disease, Chronic Obstructive/diagnosis",2.35e-45,5.65,68,169,23,95.36,4.0
Personality Development,1.11e-12,0.07,4,4,1,8.0,3.0
Spinal Cord/metabolism,3.58e-13,0.07,2,13,0,2.31,3.0
Antihypertensive Agents/therapeutic use,9.05e-60,3.02,309,1617,40,368.05,5.0
Brain,5.62e-47,0.01,1,7,0,1.14,3.0
Mosaicism,8.28e-07,0.29,4,47,0,4.34,5.0
Clinical Trials as Topic,6.74e-10,0.77,5,360,1,5.07,5.0
Transcription Factors/physiology,1.33e-22,0.16,5,72,0,5.35,3.0
Dietary Carbohydrates/administration & dosage,6.12e-12,6.07,271,33,2,37.02,2.0
Cross Infection/microbiology,3.15e-12,1.76,1,480,0,1.0,3.0
Peptides/metabolism,5.55e-23,0.2,7,99,0,7.49,2.0
Dog Diseases/diagnosis,1.49e-16,0.99,1,357,0,1.0,2.0
Temporal Lobe/physiology,5.44e-08,0.03,1,2,0,1.5,8.0
"Abortion, Spontaneous",8.72e-08,0.08,2,8,0,2.5,3.0
Urinary Bladder Neoplasms/diagnosis,7.64e-08,0.98,1,174,0,1.01,4.0
Iron/blood,1.58e-07,1.42,66,65,3,129.02,4.0
Family Practice,9.59e-15,0.26,34,89,0,46.99,4.0
"Contraceptives, Oral/administration & dosage",3.68e-06,2.31,26,4,0,4.62,7.0
Nematode Infections/veterinary,4.48e-06,0.29,1,53,0,1.02,3.0
Bacterial Proteins/genetics,1.07e-56,0.18,3,211,0,3.04,3.0
Liver Transplantation/adverse effects,7.39e-09,5.13,44,1138,32,45.7,3.0
"Muscle, Smooth, Vascular/drug effects",4.72e-20,0.11,3,42,0,3.21,4.0
Rectum,1.8e-11,0.06,2,6,1,2.67,5.0
"Sequence Analysis, DNA/methods",2.08e-18,0.08,4,23,0,4.7,4.0
Asthma/therapy,5.48e-07,0.47,19,130,0,21.78,3.0
Peptides/immunology,1.51e-10,0.21,1,46,0,1.02,2.0
"Receptors, Cytoplasmic and Nuclear/metabolism",1.82e-06,0.29,8,46,0,9.39,3.0
Vasopressins/pharmacology,1.08e-07,0.11,1,15,0,1.07,4.0
Cleft Palate/surgery,7.94e-08,0.14,3,18,0,3.5,4.0
"Gene Expression Regulation, Developmental",1.59e-35,0.11,8,66,0,8.97,4.0
Students/psychology,9.51e-47,1.69,219,35,2,40.59,2.0
Donor Selection,1.27e-08,8.95,11,155,8,11.78,4.0
Pain Management,1.05e-15,0.18,16,48,0,21.33,2.0
Protons,5.65e-17,0.06,2,15,0,2.27,3.0
Coloring Agents,2.83e-22,0.1,9,27,0,12.0,3.0
"Ventricular Function, Left",5.79e-27,3.33,99,486,22,119.17,5.0
Estrogens,4.87e-10,0.11,4,16,0,5.0,6.0
"Societies, Nursing",4.48e-14,0.02,1,2,0,1.5,4.0
Coronary Artery Disease/surgery,9.9e-16,7.76,27,1227,49,27.59,5.0
"Carcinoma, Squamous Cell",4.12e-08,0.08,1,11,0,1.09,5.0
Abscess,1.51e-10,0.04,1,5,0,1.2,4.0
Premature Birth/epidemiology,2.03e-51,9.24,73,205,6,99.0,5.0
Drug Carriers/chemistry,2.45e-17,0.11,1,37,0,1.03,3.0
Lung,2.02e-34,0.05,2,25,1,2.16,2.0
"Water Pollutants, Chemical/toxicity",4.44e-12,1.58,21,987,5,21.45,5.0
Cardiovascular Diseases/ethnology,1.1e-81,18.02,154,157,25,305.06,1.0
Puberty/physiology,3.17e-09,10.64,217,8,1,8.29,3.0
Cell Cycle/drug effects,1.22e-09,0.18,1,36,0,1.03,3.0
Nitriles/therapeutic use,4.9e-14,3.54,41,107,2,56.71,2.0
Sleep/physiology,1.31e-41,2.19,311,105,8,140.45,3.0
"Hepatitis C, Chronic/drug therapy",8.55e-13,2.21,134,312,1,191.55,4.0
Heart Rate/physiology,2.37e-60,3.43,346,654,55,529.05,4.0
Interferon-gamma/pharmacology,5.05e-13,0.08,1,15,1,1.07,5.0
Administrative Personnel,5.78e-09,0.08,3,8,0,4.12,3.0
Coronary Vessels/radiography,1.1e-06,4.07,16,35,2,23.31,4.0
Movement,6.73e-08,0.24,35,18,0,27.26,3.0
"Rehabilitation, Vocational",1.19e-06,0.05,1,3,0,1.33,3.0
Fishes/metabolism,6.28e-12,0.11,2,24,0,2.17,5.0
"Evoked Potentials, Auditory/physiology",7.29e-11,0.03,1,2,0,1.5,4.0
"Adipose Tissue, Brown/metabolism",1.07e-06,1.52,31,6,1,7.16,4.0
Prostheses and Implants,3.48e-24,0.27,39,158,3,48.63,2.0
Hunger,6.44e-07,2.5,46,11,1,13.63,3.0
"Arthritis, Rheumatoid/blood",6.05e-07,1.88,59,33,4,51.46,3.0
Hippocampus/drug effects,5.51e-21,0.1,2,39,0,2.1,5.0
Urea,4.27e-07,0.03,1,1,0,2.0,2.0
Food Habits/psychology,1.49e-07,10.88,155,4,1,4.1,4.0
Brain Mapping,1.22e-22,0.11,17,17,0,34.0,4.0
Laryngeal Neoplasms/pathology,1.69e-06,1.12,2,188,0,2.02,3.0
P-Glycoprotein/metabolism,3.77e-06,0.28,1,42,0,1.02,7.0
Teaching,1.38e-15,0.09,8,9,0,15.11,2.0
Drinking/physiology,9.4e-07,2.34,26,3,0,3.35,5.0
"DNA, Ribosomal/genetics",2.33e-07,0.06,1,7,0,1.14,4.0
Sarcoidosis/complications,1.03e-06,0.27,1,43,0,1.02,4.0
Anti-Bacterial Agents/metabolism,1.42e-08,0.06,1,8,0,1.12,5.0
Cardiovascular Diseases/epidemiology,0.0,15.88,1351,1705,264,2421.5,1.0
Schizophrenia/epidemiology,3.28e-06,2.53,58,120,9,86.03,3.0
Attention/physiology,3.16e-17,0.14,27,4,1,4.59,4.0
Lectins/blood,4.06e-16,11.45,39,45,1,72.8,3.0
Predictive Value of Tests,2.18e-08,4.59,27,200,4,30.65,5.0
Gene Expression/physiology,4.69e-06,0.12,1,13,0,1.08,3.0
Plasminogen Activator Inhibitor 1/blood,1.37e-06,10.75,95,46,3,68.27,4.0
Adrenocorticotropic Hormone/therapeutic use,2.09e-10,0.03,1,4,0,1.25,7.0
Breast Feeding,1.17e-22,1.32,206,180,5,337.28,4.0
Hydrogen Peroxide/metabolism,1.48e-07,0.11,3,11,0,3.82,4.0
Educational Measurement/methods,1.78e-08,0.09,4,6,0,6.67,2.0
Doxorubicin/administration & dosage,6.54e-07,1.09,1,175,0,1.01,6.0
Mental Health Services,1.31e-07,0.15,5,17,0,6.47,2.0
Vascular Stiffness,2.45e-40,14.08,113,100,19,188.5,3.0
Heart Failure/epidemiology,2.01e-71,11.34,83,602,36,94.44,3.0
Proto-Oncogene Proteins,5.85e-08,0.21,3,35,0,3.26,5.0
Genetic Predisposition to Disease/epidemiology,4.85e-09,3.7,28,118,3,34.64,3.0
Peptide Fragments/blood,1.7e-97,6.5,172,683,34,215.31,3.0
Alternative Splicing,3.2e-10,0.19,5,41,0,5.61,5.0
Neoplasm Proteins/analysis,4.22e-10,1.2,1,271,0,1.0,3.0
Glioma/pathology,1.05e-09,0.95,1,225,1,1.0,5.0
Malnutrition/etiology,3.29e-30,20.35,101,65,13,106.83,3.0
Membrane Glycoproteins/metabolism,9.47e-14,0.34,7,173,0,7.28,4.0
"Models, Chemical",1.38e-70,0.02,2,14,0,2.29,3.0
Lipids/chemistry,4.8e-08,0.17,7,17,2,9.88,1.0
Metabolic Syndrome X/chemically induced,2.74e-08,18.63,52,23,5,33.17,3.0
Fibroblasts/metabolism,5.27e-25,0.14,1,69,0,1.01,3.0
Hyperlipidemias/epidemiology,8.93e-08,13.09,76,33,9,47.33,5.0
Membrane Glycoproteins,6.7e-12,0.14,4,32,0,4.5,4.0
Colorectal Neoplasms/complications,5.92e-14,7.21,18,128,11,20.53,5.0
Polymers/chemistry,3.98e-58,0.04,1,39,0,1.03,2.0
Proteomics/methods,3.31e-21,0.3,11,160,0,11.76,4.0
Adipose Tissue,5.4e-12,10.53,433,8,24,8.15,3.0
Bicycling/statistics & numerical data,1.61e-07,6.55,14,25,0,21.84,5.0
Bone and Bones/anatomy & histology,2.57e-08,1.56,41,15,1,20.49,3.0
Psychology,7.84e-07,0.18,10,14,0,17.14,3.0
Phosphoproteins/metabolism,2.73e-15,0.22,12,71,0,14.03,3.0
Multiple Sclerosis/drug therapy,6.15e-07,0.18,4,24,0,4.67,4.0
Herniorrhaphy/methods,1.58e-16,6.69,63,78,8,113.88,3.0
Smoking/epidemiology,2.21e-64,4.31,341,536,48,557.94,4.0
Hippocampus/physiology,3.29e-36,0.03,4,9,0,5.78,5.0
Breast Neoplasms/prevention & control,5.93e-13,2.48,94,500,11,111.67,3.0
Prosthesis Failure,2.02e-09,1.98,81,308,6,102.3,3.0
Adrenalectomy/methods,4.61e-35,6.2,49,128,17,67.76,3.0
Liver Diseases,1.34e-20,0.02,1,5,0,1.2,2.0
Phagocytosis/drug effects,1.28e-06,0.15,2,18,0,2.22,3.0
Satiation/physiology,1.11e-06,6.59,59,1,0,1.02,3.0
"Schools, Medical",6.14e-13,0.07,4,10,0,5.6,4.0
Heat-Shock Proteins/metabolism,2.5e-07,0.35,5,66,1,5.38,4.0
"Pulmonary Disease, Chronic Obstructive/etiology",1.83e-10,5.47,22,88,2,27.5,4.0
Pulmonary Circulation,9.72e-15,0.22,3,70,0,3.13,4.0
Electromagnetic Fields,1.58e-11,0.18,5,41,0,5.61,4.0
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,7.87e-48,5.41,164,1625,33,180.55,5.0
Aged/physiology,2.52e-12,5.8,34,53,12,55.81,4.0
"Evolution, Molecular",4.03e-76,0.08,1,125,0,1.01,4.0
Bariatric Surgery,2.01e-24,25.0,394,77,46,92.05,2.0
Vitamins,8.02e-19,0.05,5,3,0,4.8,4.0
Inflammation Mediators/blood,1.12e-59,10.36,187,197,18,364.51,2.0
Proto-Oncogene Proteins/genetics,3.1e-10,0.97,19,447,0,19.81,5.0
Flavonoids/pharmacology,1.89e-10,0.35,11,103,0,12.17,5.0
Brain Mapping/methods,5.17e-16,0.09,5,18,0,6.39,4.0
Virus Replication,8.28e-29,0.21,1,126,0,1.01,4.0
Body Water/metabolism,2.01e-08,1.44,46,14,2,18.26,3.0
Nerve Regeneration,1.94e-13,0.02,1,3,0,1.33,4.0
Histocompatibility Antigens Class II/immunology,7.46e-09,0.16,1,28,0,1.04,5.0
Antimalarials/therapeutic use,9.6e-11,1.18,2,309,0,2.01,7.0
Neurons/metabolism,7.8e-72,0.08,12,88,0,13.64,2.0
"Arthritis, Rheumatoid",3.93e-11,0.02,1,1,0,2.0,3.0
Escherichia coli/drug effects,4.22e-26,0.17,1,91,0,1.01,6.0
Inpatients,3.86e-11,3.67,51,431,12,57.03,3.0
Multiple Myeloma/drug therapy,1.86e-08,2.51,3,635,1,3.01,4.0
Interinstitutional Relations,5.61e-09,0.17,2,31,0,2.13,4.0
Disease,2.88e-146,0.01,1,37,0,1.03,3.0
Pravastatin/therapeutic use,7.3e-09,4.4,21,116,6,24.8,4.0
Kidney Neoplasms/surgery,4.86e-45,4.58,142,930,26,163.68,4.0
Residence Characteristics/classification,3.86e-10,9.33,21,28,3,36.75,3.0
Nurses,1.89e-13,0.21,23,46,0,34.5,3.0
User-Computer Interface,8.02e-19,0.16,19,40,0,28.02,4.0
Congenital Abnormalities,4.67e-24,0.02,1,8,0,1.12,2.0
Industry,3.9e-14,0.29,21,110,1,25.01,2.0
Antioxidants/chemistry,8.41e-08,0.07,2,6,0,2.67,4.0
"Education, Nursing, Continuing",8.22e-15,0.06,2,14,0,2.29,4.0
HIV Infections/pathology,3.55e-06,2.76,26,100,2,32.76,3.0
"Chromatography, Gas/methods",3.01e-08,0.07,3,3,0,6.0,4.0
Sex Factors,6.83e-20,4.02,139,206,10,232.79,4.0
"Carcinoma, Squamous Cell/drug therapy",2.36e-09,2.45,5,857,4,5.03,5.0
Autonomic Nervous System,7.26e-09,0.04,1,4,0,1.25,3.0
Protein-Serine-Threonine Kinases,6.01e-07,0.17,4,21,0,4.76,7.0
Liver Cirrhosis/epidemiology,8.93e-15,6.85,25,103,4,31.07,3.0
Reflex,2.07e-29,0.03,3,6,1,4.5,3.0
Outcome Assessment (Health Care),1e-11,4.0,123,1972,26,130.67,4.0
Wasting Syndrome/etiology,4.45e-08,13.76,6,12,3,9.0,3.0
Hypothalamo-Hypophyseal System/physiopathology,7.33e-07,1.52,42,28,0,46.67,3.0
Apoptosis/drug effects,3.56e-67,0.26,4,517,0,4.03,4.0
Family Planning Services,4.58e-16,0.07,1,21,0,1.05,4.0
Verbal Behavior,5.75e-07,0.15,10,6,0,9.6,4.0
Myocardium/enzymology,1.72e-16,0.2,6,71,0,6.51,3.0
Acute Coronary Syndrome/rehabilitation,7.06e-07,13.84,9,13,0,15.23,4.0
Geriatric Assessment/methods,3.57e-57,5.58,101,308,23,134.12,3.0
Oocytes/metabolism,8.36e-07,0.12,6,5,0,9.17,4.0
Brain Injuries/physiopathology,7.02e-08,0.91,5,217,0,5.12,4.0
Dental Materials/chemistry,2.26e-07,0.06,2,3,0,3.33,2.0
Food Preferences,1.02e-21,3.68,143,10,1,10.7,4.0
"Hepatitis C, Chronic/complications",6.92e-49,5.35,142,248,3,223.31,4.0
Brain/physiology,7.92e-72,0.09,46,43,0,83.2,3.0
Global Health,5.25e-08,1.9,26,1161,10,26.58,3.0
"Arthroplasty, Replacement, Hip/statistics & numerical data",1.63e-16,7.94,32,52,1,51.69,4.0
Pancreas Transplantation/adverse effects,1.85e-07,5.77,5,66,12,5.38,3.0
Norepinephrine/pharmacology,2.1e-21,0.06,3,16,0,3.56,4.0
Minority Groups/statistics & numerical data,3.95e-07,3.5,23,95,2,28.57,4.0
Synaptic Transmission/drug effects,7.27e-15,0.03,1,4,0,1.25,4.0
Gene Expression Profiling/methods,2.55e-11,0.33,3,158,1,3.06,3.0
"Animals, Newborn",2.54e-06,0.33,2,73,0,2.05,4.0
Gastroplasty,3.74e-13,24.49,168,31,28,36.72,3.0
"Education, Medical, Undergraduate/methods",3.09e-08,0.1,2,12,0,2.33,4.0
African Americans/statistics & numerical data,4.63e-220,8.95,302,730,34,426.94,4.0
"Diabetes Mellitus, Type 2/epidemiology",6.96e-73,18.43,1103,347,77,456.17,3.0
Cardiovascular Diseases/pathology,2.11e-18,6.06,33,81,2,46.44,1.0
Gastric Bypass,8.03e-15,25.48,481,56,56,62.52,3.0
Gastric Bypass/statistics & numerical data,7.4e-13,41.27,32,17,4,26.03,3.0
"RNA, Viral/analysis",2.87e-09,0.2,1,37,1,1.03,4.0
Antibody Formation/drug effects,4.39e-07,0.1,2,11,0,2.36,3.0
Dyslipidemias/etiology,2.01e-08,16.7,45,26,1,41.02,4.0
Sarcopenia/complications,9.69e-12,30.68,28,15,7,23.04,5.0
Guanidines/pharmacology,1.17e-07,0.2,2,32,0,2.12,3.0
Environmental Monitoring/methods,1.02e-37,0.3,14,282,1,14.7,4.0
Signal Transduction/drug effects,5.3e-19,0.33,9,224,0,9.36,3.0
Counseling,6.31e-11,1.24,107,99,8,190.6,3.0
Tandem Mass Spectrometry/methods,8.83e-18,0.09,6,19,0,7.89,4.0
"Models, Neurological",2.94e-48,0.02,1,14,0,1.07,4.0
Hyperglycemia/drug therapy,1.37e-09,4.71,35,259,2,39.73,4.0
Acetylcholine/pharmacology,1.01e-09,0.1,8,2,0,2.5,4.0
Antibody Specificity,3.4e-09,0.12,1,21,0,1.05,2.0
"Tobacco, Smokeless/adverse effects",2.56e-08,4.06,18,51,3,24.35,4.0
Prostate-Specific Antigen/blood,2.36e-49,4.6,162,966,17,189.17,4.0
Membrane Glycoproteins/genetics,4.57e-07,0.45,13,113,0,14.5,4.0
Beverages,1.25e-07,3.56,126,32,4,40.13,2.0
Liver Neoplasms/pathology,2.4e-14,2.04,10,1110,4,10.09,3.0
"Antigens, Viral/analysis",5.98e-10,0.07,1,11,0,1.09,3.0
Pregnancy Complications/ethnology,2.96e-06,8.08,20,23,0,37.39,2.0
Professional Autonomy,1.54e-08,0.11,2,15,0,2.27,4.0
Dietary Supplements,3.27e-78,4.0,538,819,29,891.41,3.0
Cell Division/physiology,7.53e-07,0.14,3,16,0,3.56,3.0
"Gene Expression Regulation, Developmental/physiology",6.09e-12,0.09,1,20,0,1.05,4.0
Diabetic Angiopathies/drug therapy,1.33e-08,4.39,23,125,4,27.23,3.0
Hydrocortisone/analysis,3.34e-09,3.39,61,6,1,6.59,6.0
Nonlinear Dynamics,2.78e-07,0.28,9,49,0,10.65,3.0
Anti-Bacterial Agents/therapeutic use,1.86e-51,1.33,64,2903,6,65.41,5.0
Losartan/therapeutic use,5.75e-08,3.94,24,129,4,28.47,5.0
Quality of Health Care,6.29e-17,1.03,38,950,8,39.52,2.0
"Obesity, Morbid/epidemiology",1.5e-11,43.31,185,10,32,10.54,5.0
Nephrectomy/methods,1.89e-116,5.48,217,510,27,309.33,4.0
"Diabetes Mellitus, Type 2/economics",1.05e-10,6.45,31,45,2,52.36,3.0
Soccer/physiology,4.04e-12,4.86,81,1,1,1.01,5.0
Kidney Diseases/epidemiology,2.05e-40,6.83,65,179,9,88.6,3.0
Knee Joint/pathology,5.84e-16,3.64,120,12,1,13.2,4.0
Space Flight,5.93e-08,0.18,13,12,1,23.08,4.0
Regeneration,1.64e-24,0.14,1,70,0,1.01,3.0
"Cholesterol, HDL/blood",2.37e-23,9.49,464,223,32,330.17,4.0
"Animals, Laboratory",2.13e-14,0.1,1,29,0,1.03,4.0
Postoperative Complications/etiology,4.5e-77,3.24,282,1472,87,336.02,3.0
Lung Neoplasms,8.63e-17,0.12,4,38,0,4.42,3.0
Mean Platelet Volume,1.71e-06,6.21,10,27,1,13.7,3.0
Genomics/methods,1.18e-12,0.17,4,43,0,4.37,5.0
Schizophrenia/drug therapy,5.8e-30,1.93,295,162,18,250.96,3.0
CD4 Lymphocyte Count,3.38e-07,3.85,17,107,8,19.7,6.0
"Kidney Failure, Chronic/epidemiology",3.08e-72,9.01,95,408,27,117.12,6.0
Geriatric Assessment,2.52e-54,3.67,148,413,22,201.04,3.0
HLA Antigens/analysis,5.6e-08,0.15,1,23,0,1.04,5.0
Mitochondria/enzymology,1.68e-15,0.1,3,27,0,3.33,4.0
Prenatal Exposure Delayed Effects,3.88e-08,1.39,141,191,2,245.09,4.0
Retina/metabolism,2.1e-16,0.02,1,3,0,1.33,3.0
"Kidney Failure, Chronic/ethnology",7.06e-13,8.71,15,85,7,17.65,6.0
Myocardial Infarction/epidemiology,8.23e-66,7.64,93,759,54,104.4,4.0
Body Weights and Measures,3.61e-10,5.99,111,3,3,3.08,3.0
Occupational Diseases/prevention & control,6.13e-07,0.29,22,46,2,32.52,1.0
Integrins/metabolism,2.73e-08,0.1,1,15,0,1.07,6.0
Alcohol Drinking/epidemiology,4.08e-27,3.2,156,310,14,234.5,4.0
Verbal Learning,8.04e-08,0.06,3,1,0,1.33,4.0
Carrier Proteins/metabolism,5.14e-51,0.17,23,166,0,26.19,3.0
Violence,1.46e-10,0.32,8,89,0,8.72,4.0
"Biopsy, Needle",1.65e-06,0.23,5,32,0,5.78,3.0
Neoplasms/genetics,6.58e-15,0.4,14,252,4,14.78,1.0
Albuminuria/urine,8.7e-07,4.88,39,50,3,69.42,5.0
Behavior Therapy/methods,1.59e-43,1.96,165,26,4,30.1,3.0
Seizures/physiopathology,3.98e-09,0.22,2,42,0,2.1,3.0
"Muscle, Skeletal/metabolism",5.1e-66,1.73,308,89,10,114.72,3.0
Vasoconstriction/drug effects,1.05e-08,0.17,5,28,0,5.89,5.0
Breast/physiology,3.52e-06,2.03,20,2,0,2.2,2.0
DNA-Binding Proteins/genetics,1.61e-06,0.54,42,510,0,45.46,3.0
"Carcinoma, Squamous Cell/radiotherapy",5.39e-10,2.8,6,995,2,6.04,5.0
Polyethylene Glycols/chemistry,1.17e-19,0.07,1,25,0,1.04,3.0
Air Pollution,2.32e-10,0.24,4,56,1,4.29,4.0
